UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
þ
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2018

Commission file number 001-35260
MTGEINVESTMENTCORPLOGOA06.JPG

MTGE INVESTMENT CORP.
(Exact name of registrant as specified in its charter)
Maryland
 
45-0907772
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
2 Bethesda Metro Center
12th Floor
Bethesda, Maryland 20814
(Address of principal executive offices)
 
(301) 968-9220
(Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes þ .        No ¨ .
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes þ .        No ¨ .
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
þ
 
Accelerated filer
o
Non-accelerated filer
o
(Do not check if a smaller reporting company)
Smaller Reporting Company
o
Emerging growth company
o
 
 
 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨     No þ

The number of shares of the issuer’s common stock outstanding as of May 1, 2018 was 45,797,687





MTGE INVESTMENT CORP.
TABLE OF CONTENTS
 

PART I. FINANCIAL INFORMATION
 
 
 
 
Item 1.
Financial Statements
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
Item 4.
Controls and Procedures
 
 
 
PART II. OTHER INFORMATION
 
Item 1.
Legal Proceedings
Item 1A.
Risk Factors
Item 2
Unregistered Sales of Equity Securities and Use of Proceeds
Item 3.
Defaults upon Senior Securities
Item 4.
Mine Safety Disclosures
Item 5.
Other Information
Item 6.
Exhibits
 
 
 
Signatures
 


1



PART I

Item 1. Financial Statements
MTGE INVESTMENT CORP.
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
 
March 31, 2018
 
December 31, 2017
 
(unaudited)
 
 
Assets:
 
 
 
Agency securities, at fair value (including pledged securities of $3,434,631 and $3,581,868, respectively)
$
3,660,403

 
$
3,758,181

Non-agency securities, at fair value (including pledged securities of $760,144 and $743,278, respectively)
833,681

 
872,084

U.S. Treasury securities, at fair value (including pledged securities of $24,903 and $0, respectively)
24,924

 

Land
17,201

 
16,641

Buildings, furniture, fixtures and equipment, net of accumulated depreciation
259,775

 
240,352

Cash and cash equivalents
123,396

 
123,762

Restricted cash and cash equivalents
40,857

 
46,324

Interest receivable
14,919

 
14,608

Derivative assets, at fair value
29,726

 
14,712

Receivable under reverse repurchase agreements
836,901

 
843,130

Other assets
16,025

 
23,242

Total assets
$
5,857,808

 
$
5,953,036

Liabilities:
 
 
 
Repurchase agreements
$
3,743,436

 
$
3,863,719

Notes payable, net of deferred financing costs
201,986

 
186,500

Payable for securities purchased
58,182

 
4,357

Derivative liabilities, at fair value

 
4,454

Dividend payable
24,016

 
24,016

Obligation to return securities borrowed under reverse repurchase agreements, at fair value
824,688

 
830,776

Accounts payable and other accrued liabilities
44,904

 
33,592

Total liabilities
4,897,212

 
4,947,414

Equity:
 
 
 
Preferred stock, $0.01 par value; 50,000 shares authorized:
 
 
 
8.125% Series A Cumulative Redeemable Preferred Stock; 2,200 shares issued and outstanding (aggregate liquidation preference of $55,000)
53,039

 
53,039

Common stock, $0.01 par value; 300,000 shares authorized, 45,798 issued and outstanding
458

 
458

Additional paid-in capital
1,122,797

 
1,122,729

Retained deficit
(216,497
)
 
(171,119
)
Total stockholders’ equity
959,797

 
1,005,107

Noncontrolling interests
799

 
515

Total equity
960,596

 
1,005,622

Total liabilities and equity
$
5,857,808

 
$
5,953,036

See accompanying notes to consolidated financial statements.

2



MTGE INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)

 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Interest income:
 
 
 
 
Agency securities
 
$
27,511

 
$
17,901

Non-agency securities
 
11,994

 
15,696

Other
 
125

 
160

Interest expense
 
(17,053
)
 
(10,165
)
Net interest income
 
22,577

 
23,592

 
 
 
 
 
Healthcare real estate:
 
 
 
 
Healthcare real estate income
 
7,760

 
3,315

Healthcare real estate expense
 
(5,795
)
 
(2,653
)
Net healthcare investment income
 
1,965

 
662

 
 
 
 
 
Other gains (losses):
 
 
 
 
Realized loss on agency securities, net
 
(1,940
)
 
(212
)
Realized gain on non-agency securities, net
 
4,154

 
12,714

Realized gain (loss) on periodic settlements of interest rate swaps, net
 
358

 
(2,660
)
Realized gain on other derivatives and securities, net
 
2,736

 
2,167

Unrealized loss on agency securities, net
 
(76,170
)
 
(115
)
Unrealized gain (loss) on non-agency securities, net
 
(3,337
)
 
13,014

Unrealized gain (loss) on other derivatives and securities, net
 
33,457

 
(2,839
)
Servicing income
 
50

 
2,558

Servicing expense
 
(250
)
 
(4,985
)
Total other gains (losses), net
 
(40,942
)
 
19,642

Expenses:
 
 
 
 
Management fees
 
3,389

 
3,376

General and administrative expenses
 
1,578

 
1,719

Total expenses
 
4,967

 
5,095

Net income (loss)
 
(21,367
)
 
38,801

Dividend on preferred stock
 
(1,117
)
 
(1,117
)
Noncontrolling interest in net loss (income)
 
5

 
(2
)
Net income (loss) available to common stockholders
 
$
(22,479
)
 
$
37,682

 
 
 
 
 
Net income (loss) per common share — basic and diluted
 
$
(0.49
)
 
$
0.82

 
 
 
 
 
Weighted average common shares — basic
 
45,810

 
45,798

Weighted average common shares — diluted
 
45,822

 
45,806

 
 
 
 
 
Dividend declared per common share
 
$
0.50

 
$
0.45

See accompanying notes to consolidated financial statements.

3



MTGE INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF EQUITY
(in thousands)
(unaudited)

 
Preferred Stock
 
Common Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings (Deficit)
 
Noncontrolling Interests
 
Total Equity
 
Shares
 
Amount
 
Shares
 
Amount
 
Balance, December 31, 2016
2,200

 
$
53,039

 
45,798

 
$
458

 
$
1,122,493

 
$
(243,260
)
 
$
315

 
$
933,045

Net income

 

 

 

 

 
38,799

 
2

 
38,801

Distribution to noncontrolling interest

 

 

 

 

 

 
(11
)
 
(11
)
Stock-based compensation

 

 


 


 
34

 

 

 
34

Preferred dividends declared


 


 


 


 

 
(1,117
)
 

 
(1,117
)
Common dividends declared

 

 

 

 

 
(20,609
)
 

 
(20,609
)
Balance, March 31, 2017
2,200

 
$
53,039

 
45,798

 
$
458

 
$
1,122,527

 
$
(226,187
)
 
$
306

 
$
950,143

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, December 31, 2017
2,200

 
$
53,039

 
45,798

 
$
458

 
$
1,122,729

 
$
(171,119
)
 
$
515

 
$
1,005,622

Net income

 

 

 

 

 
(21,362
)
 
(5
)
 
(21,367
)
Issuance of noncontrolling interest

 

 

 

 

 

 
293

 
293

Distribution to noncontrolling interest

 

 

 

 

 

 
(4
)
 
(4
)
Stock-based compensation

 

 

 

 
68

 

 

 
68

Preferred dividends declared

 

 

 

 

 
(1,117
)
 

 
(1,117
)
Common dividends declared

 

 

 

 

 
(22,899
)
 

 
(22,899
)
Balance, March 31, 2018
2,200

 
$
53,039

 
45,798

 
$
458

 
$
1,122,797

 
$
(216,497
)
 
$
799

 
$
960,596

See accompanying notes to consolidated financial statements.


4



MTGE INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
 
For the Three Months Ended March 31,
 
2018
 
2017
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
Net income (loss)
$
(21,367
)
 
$
38,801

Adjustments to reconcile net income to net cash flows from operating activities:
 
 
 
Amortization of net premium on agency securities
4,486

 
5,481

Accretion of net discount on non-agency securities
(3,768
)
 
(6,783
)
Depreciation and amortization on real estate investments
2,059

 
771

Realization of cash flows from MSR

 
1,089

Unrealized loss (gain) on securities, MSR and derivatives, net
46,050

 
(10,060
)
Realized loss (gain) on agency securities, net
1,940

 
212

Realized gain on non-agency securities, net
(4,154
)
 
(12,714
)
Realized loss (gain) on other derivatives and securities, net
(3,094
)
 
592

Stock-based compensation
68

 
34

Increase in interest receivable
(311
)
 
(826
)
Decrease in other assets
4,024

 
4,799

Increase (decrease) in operating accounts payable and other accrued liabilities
(38
)
 
5,511

Net cash flows from operating activities
25,895

 
26,907

CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
Purchases of agency securities
(284,077
)
 
(485,296
)
Purchases of non-agency securities
(65,690
)
 
(77,819
)
Purchases of healthcare real estate investments
(21,984
)
 
(26,634
)
Proceeds from sale of agency securities
220,435

 
208,457

Proceeds from sale of non-agency securities
89,902

 
260,473

Proceeds from sale of MSR
3,193

 
43,823

Principal collections on agency securities
107,745

 
85,136

Principal collections on non-agency securities
18,776

 
43,258

Net proceeds from (payments on) reverse repurchase agreements
6,229

 
(847,588
)
Purchases of U.S. Treasury securities
(141,912
)
 
(332,959
)
Proceeds from sale of U.S. Treasury securities
153,449

 
1,193,721

Payments for the termination of interest rate swaps

 
(3,841
)
Other investing cash flows, net
10,788

 
(12,098
)
  Net cash flows from investing activities
96,854

 
48,633

CASH FLOWS USED IN FINANCING ACTIVITIES:
 
 
 
Dividends paid
(24,016
)
 
(19,436
)
Issuance of noncontrolling interest
293

 

Distributions to noncontrolling interest
(4
)
 
(11
)
Proceeds from repurchase agreements and Federal Home Loan Bank advances
5,503,995

 
5,987,161

Repayments on repurchase agreements and Federal Home Loan Bank advances
(5,624,278
)
 
(6,035,054
)
Proceeds from notes payable, net of deferred financing costs
15,938

 
19,774

Repayments of notes payable
(510
)
 
(93
)
Net cash flows used in financing activities
(128,582
)
 
(47,659
)
Net increase (decrease) in cash and cash equivalents and restricted cash
(5,833
)
 
27,881

Cash and cash equivalents and restricted cash at beginning of the period
170,086

 
136,645

Cash and cash equivalents and restricted cash at end of period
$
164,253

 
$
164,526

See accompanying notes to consolidated financial statements.

5


MTGE INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Unaudited Interim Consolidated Financial Statements

The unaudited interim consolidated financial statements of MTGE Investment Corp. (referred to throughout this report as the “Company”, “we”, “us” and “our”) are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the requirements for reporting on Form 10-Q and Article 10 of Regulation S-X. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

Our unaudited interim consolidated financial statements include the accounts of all of our subsidiaries. Significant intercompany accounts and transactions have been eliminated. In the opinion of management, all adjustments, consisting solely of normal recurring accruals, necessary for the fair presentation of financial statements for the interim period have been included. The current period’s results of operations are not necessarily indicative of results that ultimately may be achieved for the year.
Note 2. Organization
We were incorporated in Maryland and commenced operations in 2011 following the completion of our initial public offering (“IPO”). We are externally managed by MTGE Management, LLC (our “Manager”), an affiliate of AGNC Investment Corp. (“AGNC”). Our common stock is traded on the Nasdaq Global Select Market under the symbol “MTGE.”

We invest in, finance and manage a leveraged portfolio of real estate-related investments, which include agency residential mortgage-backed securities (“agency RMBS”), non-agency securities, other mortgage-related investments and other real estate investments. Agency RMBS include residential mortgage pass-through certificates and collateralized mortgage obligations (“CMOs”) structured from residential mortgage pass-through certificates for which the principal and interest payments are guaranteed by a government-sponsored enterprise (“GSE”), such as Federal National Mortgage Association (“Fannie Mae”) and Federal Home Loan Mortgage Corporation (“Freddie Mac”), or by a U.S. Government agency, such as Government National Mortgage Association (“Ginnie Mae”). Non-agency securities include securities backed by residential mortgages that are not guaranteed by a GSE or U.S. Government agency and credit risk transfer securities (“CRT”). Other mortgage-related investments may include mortgage servicing rights (“MSR”), commercial mortgage-backed securities (“CMBS”), prime and non-prime residential mortgage loans, commercial mortgage loans and mortgage-related derivatives. Other real estate investments include equity investments in healthcare and senior living facilities that are leased to or operated by third parties who conduct all business operations of the facilities.
Our objective is to provide attractive risk-adjusted returns to our stockholders through a combination of dividends and net asset value appreciation. In pursuing this objective, we rely on our Manager’s expertise to construct and manage a diversified investment portfolio by selecting assets that, when properly financed and hedged, are expected to produce attractive risk-adjusted returns across a variety of market conditions and economic cycles.
We have elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”). As such, we are required to distribute annually at least 90% of our taxable income. As a REIT, we will generally not be subject to U.S. Federal or state corporate taxes on our taxable income to the extent that we distribute all of our annual taxable income to our stockholders. It is our intention to distribute 100% of our taxable income, after application of available tax attributes, within the time limits prescribed by the Internal Revenue Code, which may extend into the subsequent taxable year.


6


Note 3. Summary of Significant Accounting Policies

Fair Value of Financial Assets

We have elected the option to account for all of our financial assets, including all mortgage-related investments, at estimated fair value, with changes in fair value reflected in income during the period in which they occur. In management's view, this election more appropriately reflects the results of our operations for a particular reporting period, as financial asset fair value changes are presented in a manner consistent with the presentation and timing of the fair value changes of hedging instruments. See Note 10 - Fair Value Measurements.

Interest Income

Interest income is accrued based on the outstanding principal amount of the securities and their contractual terms. Premiums or discounts associated with the purchase of agency RMBS and non-agency securities of high credit quality are amortized or accreted into interest income, respectively, over the projected lives of the securities, including contractual payments and estimated prepayments, using the effective interest method.

We estimate long-term prepayment speeds using a third-party service and market data. Actual and anticipated prepayment experience is reviewed at least quarterly and effective yields are recalculated when differences arise between the previously estimated future prepayments and the amounts received plus currently anticipated future prepayments. If the actual and anticipated future prepayment experience differs from our prior estimate of prepayments, we are required to record an adjustment in the current period to the amortization or accretion of premiums and discounts for the cumulative difference in the effective yield through the reporting date.

At the time we purchase non-agency securities that are not of high credit quality, we determine an effective yield based on our estimate of the timing and amount of future cash flows and our cost basis. Our initial cash flow estimates for these investments are based on our observations of current information and events and include assumptions related to interest rates, prepayment rates and the impact of default and severity rates on the timing and amount of credit losses. On at least a quarterly basis, we review the estimated cash flows and make appropriate adjustments, based on inputs and analysis received from external sources, internal models, and our judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Any resulting changes in effective yield are recognized prospectively based on the current amortized cost of the investment as adjusted for credit impairment, if any.

Real Property Owned

Tangible assets primarily consist of land, buildings and furniture, fixtures and equipment. Depreciable tangible assets are depreciated on a straight-line basis over their estimated useful lives, which can range from 3 years for furniture, fixtures and equipment to 40 years for buildings.

On January 1, 2017 the Company adopted Accounting Standards Update (“ASU”) No. 2017-01, Clarifying the Definition of a Business (“ASU 2017-01”) which provides a framework to determine whether a transaction involves an asset, or a group of assets, or a business. ASU 2017-01 states that when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, the transaction should not be considered a business combination. The ASU also clarifies the requirements for a set of activities to be considered a business and narrows the definition of outputs that would lead to business combination accounting treatment. As a result of these changes, the Company expects that a majority of its future real estate acquisitions and dispositions will be deemed asset transactions rather than business combinations. For asset acquisitions subsequent to January 1, 2017, the Company records identifiable assets acquired, liabilities assumed and any associated noncontrolling interests at cost on a relative fair value basis, with no goodwill recognized and third-party transaction costs capitalized.
 
The net book value of long-lived assets is reviewed quarterly on a property by property basis to determine if facts and circumstances suggest that the assets may be impaired or that depreciable lives may need to be changed. We consider external factors relating to each asset and the existence of a master lease that may link the cash flows of an individual asset to a larger portfolio of assets leased to the same tenant. If these factors and the projected undiscounted cash flows of the asset over the remaining depreciation period indicate that the asset will not be recoverable, the carrying value is reduced to the estimated fair market value. In addition, we are exposed to the risks inherent in investments in real estate and, in particular, the senior housing and healthcare industries. A downturn in these industries or in the real estate markets in which our properties are located could adversely affect the value of our properties and our ability to sell properties for a price or terms acceptable to us.

7


Intangible Assets
Intangible assets can include goodwill and identifiable intangible assets such as above or below market component of in-place leases and the value associated with the presence of in-place tenants or residents. Goodwill is calculated as the excess of consideration transferred over the estimated fair value of net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Goodwill and intangible assets are included in other assets on the consolidated balance sheets and tested for impairment annually or more frequently if events and circumstances indicate that the asset might be impaired.
Healthcare Real Estate Income

Healthcare real estate income consists primarily of lease and rental income. For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight line basis over the lease term when collectability is reasonably assured. Recognizing lease income on a straight line basis results in a difference in the timing of revenue amounts from what is contractually due. If the Company determines that collectability of straight line lease income is not reasonably assured, future revenue recognition is limited to amounts contractually owed and paid, and, when appropriate, an allowance for estimated losses is established.

Resident rental income is recorded when services are rendered and includes resident room and care charges, community fees and other resident charges. Residency agreements are generally for a term of 30 days to one year, with resident fees billed monthly. Revenue for certain care-related services is recognized as the services are provided.

Noncontrolling Interests
    
Arrangements with noncontrolling interest holders are reported as a component of equity separate from the Company’s stockholders' equity, recorded at the initial carrying amount, and increased or decreased for the noncontrolling interest’s share of net income or loss. Net income attributable to a noncontrolling interest is included in net income on the consolidated statements of operations.

Deferred Loan Expenses

We amortize deferred financing costs, which are reported within notes payable, net of deferred financing costs on our consolidated balance sheets, as a component of interest expense of the debt over the terms of the related borrowings using a method that approximates a level yield.

Repurchase Agreements

We finance the acquisition of agency RMBS and non-agency securities through repurchase transactions under master repurchase agreements. We account for repurchase transactions as collateralized financing transactions which are carried at their contractual amounts, including accrued interest, as specified in the respective transaction agreements. The contractual amounts approximate fair value due to their short-term maturities or floating rate coupons.

Reverse Repurchase Agreements and Obligation to Return Securities Borrowed under Reverse Repurchase Agreements

We borrow securities to cover short sales of U.S. Treasury securities through reverse repurchase transactions under our master repurchase agreements (see Derivatives below). We account for these as securities borrowing transactions and recognize an obligation to return the borrowed securities at fair value on the consolidated balance sheets based on the value of the underlying borrowed securities as of the reporting date. The fair value of our reverse repurchase agreements is assumed to equal cost as they generally mature daily or have interest rates that are reset daily.
Derivatives
We utilize a risk management strategy, under which we may use a variety of derivative instruments to mitigate our exposure to market risks, including interest rate risk, prepayment risk, extension risk and credit risk. The objective of our risk management strategy is to reduce fluctuations in net asset value over a range of market conditions. The principal instruments that we currently use are interest rate swaps and options to enter into interest rate swaps (“interest rate swaptions”). We also utilize forward contracts for the purchase or sale of agency RMBS, or to-be-announced forward (“TBA”) contracts, and short sales of U.S. Treasury securities and U.S. Treasury futures contracts. We may also purchase or sell options on TBA securities and utilize other types of derivative instruments.

8


We also enter into TBA contracts as a means of investing in and financing agency RMBS (thereby increasing our “at
risk” leverage) or as a means of disposing of or reducing our exposure to agency RMBS (thereby reducing our “at risk” leverage). Pursuant to TBA contracts, we agree to purchase or sell, for future delivery, agency RMBS with certain principal and interest terms and certain types of collateral, but the particular agency RMBS to be delivered are not identified until shortly before the TBA settlement date. We may also choose, prior to settlement, to move the settlement of these securities out to a later date by entering into an offsetting short or long position (referred to as a “pair off”), net settling the paired off positions for cash, and simultaneously purchasing or selling a similar TBA contract for a later settlement date. This transaction is commonly referred to as a “dollar roll.” The agency RMBS purchased or sold for a forward settlement date are typically priced at a discount to agency RMBS for settlement in the current month. This difference (or discount) is referred to as the “price drop.” The price drop is the economic equivalent of net interest carry income on the underlying agency RMBS over the roll period (interest income less implied financing cost) and is commonly referred to as “dollar roll income (loss).” Consequently, forward purchases of agency RMBS and dollar roll transactions represent a form of off-balance sheet financing.
We present all derivative instruments as either assets or liabilities at fair value on our consolidated balance sheets and report all changes in fair value in earnings in our consolidated statements of operations in unrealized gain (loss) on other derivatives and securities, net during the period in which they occur. Derivatives in a gain position are reported as derivative assets at fair value and derivatives in a loss position are reported as derivative liabilities at fair value in our consolidated balance sheets. Cash receipts and payments related to derivative instruments are classified in our consolidated statements of cash flows according to the underlying nature or purpose of the derivative transaction, generally in the investing section.
Our derivative agreements generally contain provisions that allow for netting or setting off derivative assets and liabilities with each counterparty; however, we report related assets and liabilities on a gross basis in our consolidated balance sheets.

The use of derivative instruments creates exposure to credit risk relating to potential losses that could be recognized in the event counterparties to these instruments fail to perform their obligations under the contracts. Our derivative agreements require that we post or receive collateral based on daily market value changes. We also attempt to minimize our risk of loss by limiting our counterparties to major financial institutions with acceptable credit ratings, monitoring positions with individual counterparties and adjusting posted collateral as required.

Interest rate swap agreements

We use interest rate swaps to hedge the variable cash flows associated with short-term borrowings made under our repurchase agreement and other financing facilities. Under our interest rate swap agreements, we typically pay a fixed rate and receive a floating rate based on one, three or six-month LIBOR (“payer swaps”) with terms up to 15 years. The floating rate we receive under our swap agreements has the effect of offsetting the repricing characteristics of our repurchase agreements and cash flows on such liabilities. Our swap agreements are privately negotiated in the over-the-counter (“OTC”) market. Swap agreements entered into subsequent to May 2013 are centrally cleared through the Chicago Mercantile Exchange (“CME”), a registered commodities exchange.
    
We estimate the fair value of our centrally cleared interest rate swaps using the daily settlement price determined by the respective exchange. Centrally cleared swaps are valued by the exchange using a pricing model that references observable market inputs, including LIBOR, swap rates and the forward yield curve, to produce the daily settlement price.

Our centrally cleared swaps require that we post an “initial margin” to our counterparties for an amount determined by the CME, which is generally intended to be set at a level sufficient to protect the CME from the maximum estimated single-day price movement in that market participant’s contracts. We also exchange cash “variation margin” with our counterparties on our centrally cleared swaps based upon daily changes in the fair value as measured by the CME. Beginning in the first quarter of 2017, as a result of a CME amendment to its rule book governing central clearing activities, the daily exchange of variation margin associated with a CME centrally cleared derivative instrument is legally characterized as the daily settlement of the derivative instrument itself, as opposed to a pledge of collateral. Accordingly, beginning in 2017, we account for the daily receipt or payment of variation margin associated with our centrally cleared interest rate swaps as a direct reduction to the carrying value of the interest rate swap derivative asset or liability, respectively. Beginning in 2017, the carrying amount of centrally cleared interest rate swaps reflected in our consolidated balance sheets is equal to the unsettled fair value of such instruments.

We estimate the fair value of our “non-centrally cleared” interest rate swaps based on valuations obtained from third-party pricing services and the swap counterparty (collectively, “third-party valuations”). The third-party valuations are model-driven using observable inputs, including LIBOR, swap rates and the forward yield curve. We also consider the creditworthiness of both us and our counterparties and the impact of netting and credit enhancement provisions contained in each derivative

9


agreement, such as collateral postings. All of our “non-centrally cleared” interest rate swaps are subject to bilateral collateral arrangements. Consequently, no credit valuation adjustment was made in determining the fair value of such instruments.

The payment of periodic settlements of net interest on interest rate swaps is reported in realized loss on periodic settlements of interest rate swaps, net in our consolidated statements of operations. Cash payments received or paid for the early termination of an interest rate swap agreement are recorded as realized loss on other derivatives and securities, net in our consolidated statements of operations. Changes in fair value of our interest rate swap agreements are reported in unrealized gain (loss) on other derivatives and securities, net in our consolidated statements of operations.

Interest rate swaptions

We purchase interest rate swaptions to help mitigate the potential impact of larger, more rapid changes in interest rates
on the performance of our investment portfolio. The interest rate swaptions provide us the option to enter into an interest rate swap agreement for a predetermined notional amount, stated term and pay or receive interest rates in the future. The premium paid for interest rate swaptions is reported as a derivative asset in our consolidated balance sheets. We estimate the fair value of interest rate swaptions based on the fair value of the future interest rate swap that we have the option to enter into as well as the remaining length of time that we have to exercise the option. The difference between the premium and the fair value of the swaption is reported in unrealized gain (loss) on other derivatives and securities, net in our consolidated statements of operations. If a swaption expires unexercised, the realized loss on the swaption would be equal to the premium paid and reported in realized loss on other derivatives and securities, net in our consolidated statements of operations. If we exercise a swaption, the realized gain or loss on the swaption would be equal to the difference between the fair value of the underlying interest rate swap and the premium paid and reported in realized gain (loss) on other derivatives and securities, net in our consolidated statements of operations.

Interest rate swaption agreements are privately negotiated in the OTC market and are not subject to central clearing. We estimate the fair value of our interest rate swaption agreements based on model-driven valuations obtained from third-party
pricing services and the swaption counterparty. These estimates incorporate observable inputs and include the fair value of the future interest rate swaps that we have the option to enter into, as well as the remaining length of time that we have to exercise the options, adjusted for non-performance risk, if any.

TBA securities

TBA securities are forward contracts for the purchase (“long position”) or sale (“short position”) of agency RMBS at a predetermined price, face amount, issuer, coupon and stated maturity on an agreed-upon future date. The specific agency RMBS delivered into the contract upon the settlement date, published each month by the Securities Industry and Financial Markets Association, are not known at the time of the transaction. We may enter into TBA contracts as a means of hedging against short-term changes in interest rates. We may also enter into TBA dollar roll transactions to finance agency RMBS purchases.

We account for all TBA contracts as derivatives since we cannot assert that it is probable at the inception and throughout the term of the contract that it will not settle net and will result in physical delivery of an agency security when it is issued. A TBA dollar roll transaction is a series of derivative transactions. The net settlement of a TBA contract is reported as realized gain (loss) on other derivatives and securities, net and changes in the fair value of our TBA contracts are reported as unrealized gain (loss) on other derivatives and securities, net in our consolidated statements of operations.

We estimate the fair value of TBA securities based on similar methods used to value our agency RMBS.

U.S. Treasury securities

We purchase or sell short U.S. Treasury securities and U.S. Treasury futures contracts to help mitigate the potential impact of changes in interest rates on the performance of our portfolio. Realized gains and losses associated with purchases and short sales of U.S. Treasury securities and U.S. Treasury futures contracts are recognized in realized gain (loss) on other derivatives and securities, net, and unrealized gains and losses are recognized in unrealized gain (loss) on other derivatives and securities, net on our consolidated statements of operations.


10


Adoption of Accounting Standard Updates

As of January 1, 2018, we adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), and ASU 2016-18 , Statement of Cash Flows (Topic 230) - Restricted Cash. Net income was not impacted. The adoption of ASU 2016-18 resulted in the presentation of restricted cash with cash and cash equivalents on the consolidated statements of cash flows when reconciling the total beginning and ending amounts. Our prior period results have been revised to conform to the current presentation.
Note 4. Agency Securities
The following tables summarize our investments in agency RMBS as of March 31, 2018 and December 31, 2017 (dollars in thousands):
 
March 31, 2018
 
Fannie Mae
 
Freddie Mac
 
Total
Agency RMBS:
 
 
 
 
 
Par value
$
2,393,236

 
$
1,196,372

 
$
3,589,608

Unamortized premium
118,223

 
63,641

 
181,864

Amortized cost
2,511,459

 
1,260,013

 
3,771,472

Gross unrealized gains
688

 
281

 
969

Gross unrealized losses
(75,332
)
 
(36,706
)
 
(112,038
)
Agency RMBS, at fair value
$
2,436,815

 
$
1,223,588

 
$
3,660,403

 
 
 
 
 
 
Weighted average coupon as of March 31, 2018
3.61
%
 
3.73
%
 
3.65
%
Weighted average yield as of March 31, 2018
2.82
%
 
2.96
%
 
2.87
%
Weighted average yield for the three months ended March 31, 2018
2.94
%
 
3.12
%
 
3.00
%

 
 
March 31, 2018
 
 
Amortized Cost
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Fair Value
Agency RMBS:
 
 
 
 
 
 
 
 
Fixed rate
 
$
3,698,545

 
$
718

 
$
(111,935
)
 
$
3,587,328

Adjustable rate
 
72,927

 
251

 
(103
)
 
73,075

Total Agency RMBS
 
$
3,771,472

 
$
969

 
$
(112,038
)
 
$
3,660,403


 
December 31, 2017
 
Fannie Mae

Freddie Mac

Total
Agency RMBS:





Par value
$
2,485,055


$
1,117,551


$
3,602,606

Unamortized premium
127,008


63,466


190,474

Amortized cost
2,612,063


1,181,017


3,793,080

Gross unrealized gains
3,876


1,149


5,025

Gross unrealized losses
(28,364
)

(11,560
)

(39,924
)
Agency RMBS, at fair value
$
2,587,575


$
1,170,606


$
3,758,181

 
 
 
 



Weighted average coupon as of December 31, 2017
3.63
%

3.75
%

3.67
%
Weighted average yield as of December 31, 2017
2.78
%

2.89
%

2.82
%
Weighted average yield for the year ended December 31, 2017
2.67
%
 
2.69
%
 
2.68
%


11


 
 
December 31, 2017
 
 
Amortized Cost
 
Gross Unrealized Gain
 
Gross Unrealized Loss
 
Fair Value
Agency RMBS:
 
 
 
 
 
 
 
 
Fixed rate
 
$
3,717,285

 
$
3,707

 
$
(39,924
)
 
$
3,681,068

Adjustable rate
 
75,795

 
1,318

 

 
77,113

Total Agency RMBS
 
$
3,793,080

 
$
5,025

 
$
(39,924
)
 
$
3,758,181


Actual maturities of agency RMBS are generally shorter than the stated contractual maturities. Actual maturities are affected by the contractual lives of the underlying mortgages, periodic principal payments and principal prepayments.

The following table summarizes our agency RMBS as of March 31, 2018 and December 31, 2017 according to their estimated weighted average life classification (dollars in thousands):

 
March 31, 2018
 
December 31, 2017
 
 
 
 
 
 
Weighted Average
 
 
 
 
 
Weighted Average
Estimated Weighted
Average Life
 
Fair
Value
 
Amortized
Cost
 
Yield
 
Coupon
 
Fair
Value
 
Amortized
Cost
 
Yield
 
Coupon
Less than or equal to three years
 
$
42,371

 
$
43,132

 
2.10
%
 
3.93
%
 
$
40,404

 
$
40,815

 
2.06
%
 
3.92
%
Greater than three years and less than or equal to five years
 
489,624


498,048


2.39
%

3.15
%

534,299


535,608


2.38
%

3.19
%
Greater than five years and less than or equal to 10 years
 
2,872,403


2,967,793


2.94
%

3.74
%

3,149,565


3,182,468


2.90
%

3.75
%
Greater than 10 years
 
256,005


262,499


3.15
%

3.55
%

33,913


34,189


2.98
%

3.50
%
Total
 
$
3,660,403


$
3,771,472


2.87
%

3.65
%

$
3,758,181


$
3,793,080


2.82
%

3.67
%
As of March 31, 2018 and December 31, 2017 , the estimated weighted average life of our agency security portfolio was 8.0 years and 7.5 years , respectively, which incorporates anticipated future prepayment assumptions. As of March 31, 2018 and December 31, 2017 , our weighted average expected constant prepayment rate (“CPR”) over the remaining life of our aggregate agency investment portfolio was 7.6% and 8.4% , respectively.
Realized Gains and Losses
The following table summarizes our net realized gains and losses from the sale of agency RMBS during three months ended March 31, 2018 and 2017 (dollars in thousands):  
 
 
For the Three Months Ended March 31,
 

2018
 
2017
Proceeds from agency securities sold

$
220,435

 
$
208,457

Less agency securities sold, at cost

(222,375
)
 
(208,669
)
Realized loss on agency securities, net

$
(1,940
)
 
$
(212
)
 
 
 
 
 
Gross realized gains on sale of agency securities

$
14

 
$
1,270

Gross realized losses on sale of agency securities

(1,954
)
 
(1,482
)
Realized loss on agency securities, net

$
(1,940
)
 
$
(212
)

12


Pledged Assets
The following tables summarize our agency RMBS pledged as collateral under financing and derivative agreements by type as of March 31, 2018 and December 31, 2017 (dollars in thousands):
 
 
March 31, 2018

 
Fannie Mae
 
Freddie Mac
 
Total
Fair Value of Agency Securities Pledged Under:
 
 
 
 
 
 
Financing agreements
 
$
2,294,011

 
$
1,140,080

 
$
3,434,091

Derivative agreements
 
80

 
460

 
540

Total fair value
 
2,294,091

 
1,140,540

 
3,434,631

Accrued interest on pledged agency RMBS
 
6,800

 
3,476

 
10,276

Total Fair Value of Agency RMBS Pledged and Accrued Interest
 
$
2,300,891

 
$
1,144,016

 
$
3,444,907


 
 
December 31, 2017
 
 
Fannie Mae
 
Freddie Mac
 
Total
Fair Value of Agency Securities Pledged Under:
 
 
 
 
 
 
Financing agreements
 
$
2,443,591

 
$
1,137,587

 
$
3,581,178

Derivative agreements
 
84

 
606

 
690

Total fair value
 
2,443,675

 
1,138,193

 
3,581,868

Accrued interest on pledged agency RMBS
 
7,132

 
3,399

 
10,531

Total Fair Value of Agency RMBS Pledged and Accrued Interest
 
$
2,450,807

 
$
1,141,592

 
$
3,592,399

The following table summarizes our agency RMBS pledged as collateral under financings agreements, by remaining maturity, including securities pledged related to sold but not yet settled securities, as of March 31, 2018 and December 31, 2017 (dollars in thousands):
 
 
March 31, 2018
 
December 31, 2017
Remaining Maturity
 
Fair Value
 
Amortized
Cost
 
Accrued Interest
 
Fair Value
 
Amortized
Cost
 
Accrued Interest
30 days or less
 
$
1,102,225

 
$
1,136,865

 
$
3,262

 
$
940,788

 
$
949,282

 
$
2,765

31 - 59 days
 
985,955

 
1,015,732

 
2,974

 
1,298,331

 
1,311,882

 
3,818

60 - 90 days
 
359,108

 
370,094

 
1,096

 
261,823

 
262,908

 
785

Greater than 90 days
 
986,803

 
1,019,398

 
2,944

 
1,080,236

 
1,091,195

 
3,161

Total
 
$
3,434,091

 
$
3,542,089

 
$
10,276

 
$
3,581,178

 
$
3,615,267

 
$
10,529


As of March 31, 2018 and December 31, 2017 , none of our repurchase agreement borrowings backed by agency RMBS had original overnight maturities.

13


Note 5. Non-Agency Securities
The following tables summarize our non-agency securities as of March 31, 2018 and December 31, 2017 (dollars in thousands):
March 31, 2018
 
 
Fair
  Value
 
Gross Unrealized
 
Amortized Cost
 
Premium (Discount)
 
Par/ Current Face
 
Weighted Average
Category
 
 
Gains
 
Losses
 
 
 
 
Coupon (1)
 
Yield
Prime
 
$
139,841

 
$
9,529

 
$
(77
)
 
$
130,389

 
$
(13,262
)
 
$
143,651

 
3.86
%
 
5.89
%
CRT
 
300,338

 
16,465

 
(81
)
 
283,954

 
13,258

 
270,696

 
5.50
%
 
5.68
%
Alt-A
 
277,083

 
50,162

 
(628
)
 
227,549

 
(109,122
)
 
336,671

 
2.94
%
 
9.21
%
Option-ARM
 
84,683

 
12,790

 

 
71,893

 
(20,305
)
 
92,198

 
2.11
%
 
6.79
%
Subprime
 
13,337

 
873

 

 
12,464

 
(664
)
 
13,128

 
5.20
%
 
5.92
%
CMBS
 
18,399

 
171

 
(85
)
 
18,313

 
(187
)
 
18,500

 
5.68
%
 
6.04
%
Total
 
$
833,681

 
$
89,990

 
$
(871
)
 
$
744,562

 
$
(130,282
)
 
$
874,844

 
3.91
%
 
6.92
%
————————
(1)
Coupon rates are floating, except for $11.4 million , $5.6 million , $12.0 million , $13.3 million and $18.4 million fair value of fixed-rate prime, CRT, Alt-A, subprime and CMBS non-agency securities, respectively, as of March 31, 2018 .
December 31, 2017
 
 
Fair
  Value
 
Gross Unrealized
 
Amortized Cost
 
Premium (Discount)
 
Par/ Current Face
 
Weighted Average
Category
 
 
Gains
 
Losses
 
 
 
 
Coupon (1)
 
Yield
Prime
 
$
143,329

 
$
9,342

 
$
(12
)
 
$
133,999

 
$
(13,893
)
 
$
147,892

 
3.77
%
 
5.66
%
CRT
 
322,819

 
18,346

 

 
304,473

 
16,011

 
288,462

 
5.34
%
 
5.23
%
Alt-A
 
286,953

 
51,123

 
(774
)
 
236,604

 
(112,305
)
 
348,909

 
2.69
%
 
8.93
%
Option-ARM
 
86,886

 
13,114

 

 
73,772

 
(21,044
)
 
94,816

 
1.79
%
 
6.58
%
Subprime
 
13,374

 
929

 

 
12,445

 
(683
)
 
13,128

 
5.20
%
 
5.97
%
CMBS
 
18,723

 
387

 

 
18,336

 
(164
)
 
18,500

 
5.68
%
 
6.03
%
Total
 
$
872,084

 
$
93,241

 
$
(786
)
 
$
779,629

 
$
(132,078
)
 
$
911,707

 
3.73
%
 
6.59
%
————————
(1)
Coupon rates are floating, except for $11.8 million , $0.9 million , $12.2 million , $13.4 million and $18.7 million fair value of fixed-rate prime, CRT, Alt-A, subprime and CMBS non-agency securities, respectively, as of December 31, 2017 .
The following table summarizes our non-agency securities at fair value, by their estimated weighted average life classifications as of March 31, 2018 and December 31, 2017 (dollars in thousands): 
 
 
March 31, 2018
 
December 31, 2017
 
 
 
 
 
 
Weighted Average
 
 
 
 
 
Weighted Average
Estimated Weighted
Average Life
 
Fair Value
 
Amortized
Cost
 
Coupon
 
Yield
 
Fair
Value
 
Amortized
Cost
 
Coupon
 
Yield
≤ 5 years
 
$
285,566

 
$
244,884

 
3.33
%
 
8.44
%
 
$
302,797

 
$
258,501

 
3.11
%
 
8.31
%
> 5 to ≤ 7 years
 
258,753

 
226,721

 
4.17
%
 
7.05
%
 
398,712

 
361,649

 
4.33
%
 
5.97
%
> 7 years
 
289,362

 
272,957

 
4.35
%
 
5.43
%
 
170,575

 
159,479

 
3.61
%
 
5.18
%
Total
 
$
833,681

 
$
744,562

 
3.91
%
 
6.92
%
 
$
872,084

 
$
779,629

 
3.73
%
 
6.59
%

Our Prime non-agency securities include investments in securitization trusts collateralized by prime mortgage loans, which were originated between 2002 and 2006, a period of generally weaker underwriting standards and elevated housing prices. As a result, there is still material credit risk embedded in these loan origination vintages. As of March 31, 2018 , Prime non-agency securities also include $17.2 million in fair value of securities with underlying mortgage loans that were originated with more stringent underwriting standards beginning in 2010. As of March 31, 2018 , our Prime securities have both fixed and floating rate coupons ranging from 2.5% to 6.5% , with weighted average coupons of underlying collateral ranging from 3.5% to 5.0% .

14



Our CRT reference the performance of loans underlying agency RMBS issued by Fannie Mae or Freddie Mac, which were subject to their underwriting standards. As of March 31, 2018 , our CRT securities had fixed and floating rate coupons ranging from 1.3% to 8.8% , with weighted average coupons of underlying collateral ranging from 3.6% to 4.3% . The loans underlying our CRT securities were originated between 2012 and 2018.

Our Alt-A non-agency RMBS are collateralized by Alt-A mortgage loans that were originated from 2002 to 2007. Alt-A, or alternative A-paper, mortgage loans are considered to have more credit risk than prime mortgage loans and less credit risk than sub-prime mortgage loans. Alt-A loans are typically characterized by borrowers with less than full documentation, lower credit scores, higher loan-to-value ratios and a higher percentage of investment properties. As of March 31, 2018 , our Alt-A securities had both fixed and floating rate coupons ranging from 2.0% to 6.5% with weighted average coupons of underlying collateral ranging from 3.6% to 5.8% .

Our Option-ARM non-agency RMBS include senior tranches in securitization trusts that are collateralized by residential mortgages that have origination and underwriting characteristics similar to Alt-A mortgage loans, with the added feature of providing underlying mortgage borrowers the option, within certain constraints, to make lower payments than otherwise required by the stated interest rate for a number of years, leading to negative amortization and increased loan balances. This additional feature can increase the credit risk of these securities. As of March 31, 2018 , our Option-ARM securities had coupons ranging from 2.0% to 2.6% and have underlying collateral with weighted average coupons between 3.5% and 4.5% . The loans underlying our Option-ARM securities were originated between 2004 and 2007.

Our Subprime non-agency RMBS include investments in securitization trusts collateralized by residential mortgages originated during or before 2005 that were originally considered to be of lower credit quality. As of March 31, 2018 , our Subprime securities had a fair value of $13.3 million with fixed and floating rate coupons ranging from 5.0% to 5.5% and have underlying collateral with weighted-average coupons ranging from 5.5% to 5.7% .

Our CMBS are collateralized by a commercial mortgage loan originated in 2016 that is secured by first priority liens on 64 skilled nursing facilities. As of March 31, 2018 , our CMBS securities had a fair market value of $18.4 million with fixed rate coupons ranging from 5.2% to 6.6% and underlying collateral with a weighted average coupon of 4.5% .

More than 87% of our non-agency RMBS are rated below investment grade or have not been rated by credit agencies as of March 31, 2018 .
Realized Gains and Losses
The following table summarizes our net realized gains from the sale of non-agency securities during three months ended March 31, 2018 and 2017 (dollars in thousands):  
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Proceeds from non-agency securities sold
 
$
89,901

 
$
260,473

Increase in receivable for securities sold
 

 
5,748

Less: non-agency securities sold, at cost
 
(85,747
)
 
(253,507
)
Realized gain on non-agency securities, net
 
$
4,154

 
$
12,714

 
 
 
 
 
Gross realized gain on sale of non-agency securities
 
$
4,155

 
$
12,864

Gross realized loss on sale of non-agency securities
 
(1
)
 
(150
)
Realized gain on non-agency securities, net
 
$
4,154

 
$
12,714


Pledged Assets
Non-agency securities with a fair value of $0.8 billion and $0.7 billion were pledged as collateral under financing arrangements as of March 31, 2018 and December 31, 2017 , respectively, none of which had original overnight maturities.

15


The following table summarizes our non-agency securities pledged as collateral under repurchase agreements, by remaining maturity, including securities pledged related to sold but not yet settled securities, as of March 31, 2018 and December 31, 2017 (dollars in thousands):
 
 
March 31, 2018
 
December 31, 2017
Remaining Maturity
 
Fair Value
 
Amortized
Cost
 
Accrued Interest
 
Fair Value
 
Amortized
Cost
 
Accrued Interest
30 days or less
 
$
686,521

 
$
614,635

 
$
1,052

 
$
585,943

 
$
517,750

 
$
815

31 - 59 days
 
60,500

 
50,754

 
75

 
97,537

 
82,105

 
145

60 - 90 days
 
13,123

 
10,311

 
17

 
59,798

 
58,651

 
135

Total
 
$
760,144

 
$
675,700

 
$
1,144

 
$
743,278

 
$
658,506

 
$
1,095


Note 6. Investments in Real Property
Investment Activity

During March 2018, CHI acquired a senior living facility located in Kansas for total consideration of $21.5 million through an existing joint venture structured in a manner intended to comply with the REIT Income Diversification and Empowerment Act (“RIDEA”). The total purchase price has been allocated to assets and liabilities based upon their respective fair values in accordance with our accounting policies. As a result of these purchase price allocations, $20.0 million was allocated to buildings, $0.9 million to furniture, fixtures and equipment and $0.6 million to land during the first quarter of 2018.

The following table summarizes our real estate investments net of accumulated depreciation as of March 31, 2018 and December 31, 2017 (dollars in thousands):
 
 
March 31, 2018
 
December 31, 2017
Buildings and improvements
 
$
253,649

 
$
233,407

Furniture, fixtures and equipment
 
15,719

 
14,537

Less: accumulated depreciation
 
(9,593
)
 
(7,592
)
Buildings, furniture, fixtures and equipment, net of accumulated depreciation
 
259,775

 
240,352

Land
 
17,201

 
16,641

Goodwill
 
5,840

 
5,840

Net working capital (1)
 
16,369

 
18,994

Total real estate assets
 
$
299,185

 
$
281,827

————————
(1)  
Net working capital primarily includes $14.7 million and $16.1 million of cash and cash equivalents and $3.4 million and $2.8 million of rent receivable recorded in other assets on the consolidated balances sheets as of March 31, 2018 and December 31, 2017 , respectively.

Notes Payable

CHI finances its real estate investments primarily through secured debt. As of March 31, 2018 , CHI had fixed rate debt with a principal amount of $138.3 million , a weighted average maturity of 25.3 years and an interest rate of 3.81% and floating rate debt with a principal amount of $66.4 million , a weighted average maturity of 0.9 years and a weighted average interest rate of 4.63% . As of December 31, 2017 , CHI had floating rate debt with a principal amount of $50.3 million , a weighted average maturity of 0.8 years and a weighted average interest rate of 4.34% and fixed rate debt with a principal amount of $138.8 million , a weighted average maturity of 25.6 years and an interest rate of 3.80% .


16


The following is a summary of our notes payable activity for the three months ended March 31, 2018 and 2017 (dollars in thousands):
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Beginning balance
 
$
186,500

 
$
66,527

Debt issued and assumed, net of deferred financing costs
 
15,938

 
19,581

Amortization of deferred financing costs
 
58

 
193

Principal repayments
 
(510
)
 
(93
)
Ending balance
 
$
201,986

 
$
86,208


Our notes payable of $204.7 million , excluding $2.7 million of deferred financing costs, had a fair value of approximately $198 million as of March 31, 2018 . Our notes payable of $189.0 million , excluding $2.5 million of deferred financing costs, had a fair value of approximately $190 million as of December 31, 2017 .

Income from Healthcare Real Estate Investments

The following table presents the components of net income from our real property investments during the three months ended March 31, 2018 and 2017 (dollars in thousands):
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Lease income
 
$
5,706

 
$
2,253

Rental income
 
2,054

 
1,062

Healthcare real estate income
 
7,760

 
3,315

 
 
 
 
 
Interest expense
 
2,089

 
1,173

Depreciation
 
2,001

 
771

Tenant expenses
 
1,425

 
709

Other
 
280

 

Healthcare real estate expense
 
5,795

 
2,653

Net healthcare investment income
 
$
1,964

 
$
662


Healthcare lease income is derived from our real property investments subject to triple net lease arrangements, and rental income relates to investments made through RIDEA joint ventures. Under RIDEA, a REIT may lease “qualified healthcare properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such subsidiary by a person who qualifies as an “eligible independent contractor.” Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.” Resident level rents and related operating expenses are subject to federal and state income taxes as the operations of such facilities are included in a TRS.


17


At March 31, 2018 , future minimum lease payments receivable related to our healthcare and senior living facilities are as follows (dollars in thousands):
 
 
March 31, 2018
2018
 
$
15,301

2019
 
20,764

2020
 
21,191

2021
 
21,627

2022
 
22,073

Thereafter
 
193,233

Total
 
$
294,189

Note 7. Repurchase Agreements

We pledge certain of our securities as collateral under repurchase and other financing arrangements with financial institutions and the terms and conditions are negotiated on a transaction-by-transaction basis. Interest rates on these borrowings are generally based on LIBOR plus or minus a margin and amounts available to be borrowed are dependent upon the fair value of the securities pledged as collateral, which fluctuates with changes in interest rates, type of security and liquidity conditions within the banking, mortgage finance and real estate industries. In response to declines in fair value of pledged securities, lenders may require us to post additional collateral or pay down borrowings to re-establish agreed upon collateral requirements, referred to as margin calls. As of March 31, 2018 and December 31, 2017 , we have met all margin call requirements and had no agency or non-agency repurchase agreements with original overnight maturities. Repurchase agreements are carried at cost, which approximates fair value due to their short-term maturities or floating rate coupons.

As of March 31, 2018 and December 31, 2017 , our borrowings under repurchase agreements had the following collateral characteristics (dollars in thousands):
 
 
March 31, 2018
 
December 31, 2017
 
 
 
 
Weighted Average
 
 
 
Weighted Average
Collateral Type
 
Borrowings
Outstanding
 
Interest Rate
 
Days
to Maturity
 
Borrowings
Outstanding
 
Interest Rate
 
Days
to Maturity
Agency securities
 
$
3,170,784

 
1.78
%
 
106
 
$
3,307,662

 
1.54
%
 
114
Non-agency securities
 
569,380

 
2.93
%
 
18
 
556,057

 
2.72
%
 
24
U.S. Treasury securities
 
3,272

 
1.65
%
 
1
 

 
N/A

 
N/A
Total repurchase agreements
 
$
3,743,436

 
1.96
%
 
92
 
$
3,863,719

 
1.71
%
 
101

18



The following table summarizes our borrowings under repurchase arrangements as of March 31, 2018 and December 31, 2017 (dollars in thousands):
 
 
March 31, 2018
 
December 31, 2017
 
 
 
 
Weighted Average
 
 
 
Weighted Average
 
 
Borrowings
Outstanding
 
Interest Rate
 
Days
to Maturity
 
Borrowings
Outstanding
 
Interest Rate
 
Days
to Maturity
≤ 1 month
 
$
1,584,501

 
2.09
%
 
14
 
$
1,341,712

 
1.91
%
 
17
> 1 to ≤ 2 months
 
955,061

 
1.80
%
 
43
 
1,334,493

 
1.55
%
 
40
> 2 to ≤ 3 months
 
342,533

 
1.95
%
 
78
 
295,204

 
1.76
%
 
76
> 3 to ≤ 6 months
 
510,378

 
1.71
%
 
155
 
334,372

 
1.51
%
 
123
> 6 to ≤ 12 months
 
85,963

 
2.04
%
 
301
 
292,938

 
1.57
%
 
256
> 12 months
 
265,000

 
2.18
%
 
568
 
265,000

 
1.80
%
 
658
Total repurchase agreements
 
$
3,743,436

 
1.96
%
 
92
 
$
3,863,719

 
1.71
%
 
101
We had repurchase agreements with 36 financial institutions as of March 31, 2018 . Less than 4% of stockholders' equity was at risk due to collateral pledged in excess of borrowings under repurchase agreements with any one counterparty, with the top five counterparties representing approximately 17% of our stockholders' equity at risk as of March 31, 2018 .

We had agency RMBS with fair values of $3.4 billion and $3.6 billion pledged as collateral against repurchase agreements as of March 31, 2018 and December 31, 2017 , respectively. We had non-agency securities with fair values of $0.8 billion and $0.7 billion pledged as collateral against repurchase agreements as of March 31, 2018 and December 31, 2017 , respectively.
Note 8. Derivatives and Other Securities
In connection with our risk management strategy, we mitigate our exposure to market risks, including interest rate risk, prepayment risk and credit risk, by entering into derivative and other hedging instrument contracts. We may enter into agreements for interest rate swaps, interest rate swaptions, interest rate cap or floor contracts and futures or forward contracts. We may also purchase or short TBA and U.S. Treasury securities, purchase or sell options on TBA securities or we may invest in other types of derivative securities, including synthetic total return swaps and credit default swaps. Our risk management strategy attempts to manage the overall risk of the portfolio and reduce fluctuations in net asset value. Derivatives have not been designated as hedging instruments. For additional information regarding our derivative instruments and our overall risk management strategy, please refer to the discussion of derivatives in Note 3.

The table below presents the balance sheet location and fair value information for our derivatives outstanding as of March 31, 2018 and December 31, 2017 (in thousands):
 
 
March 31, 2018
 
December 31, 2017
Derivative assets:
 
 
 
 
Interest rate swaps
 
$
7,195

 
$
4,894

Interest rate swaptions
 
12,820

 
6,728

TBA securities
 
9,711

 
3,090

Derivative assets, at fair value
 
$
29,726

 
$
14,712

 
 
 
 
 
Derivative liabilities:
 
 
 
 
TBA securities
 

 
1,339

Credit default swaps
 

 
3,115

Derivative liabilities, at fair value
 
$

 
$
4,454



19



The following tables summarize the effect of our outstanding derivatives and other securities on our consolidated statements of operations during three months ended March 31, 2018 and 2017 (in thousands):
 
For the Three Months Ended March 31,
 
2018
 
2017
 
Realized Gain on Periodic Settlements of Interest Rate Swaps, net
Realized Gain (Loss)
on Other Derivatives and Securities, net
Unrealized Gain
(Loss) on Other Derivatives and Securities, net
 
Realized Loss on Periodic Settlements of Interest Rate Swaps, net
Realized Gain (Loss)
on Other Derivatives and Securities, net
Unrealized Gain (Loss) on Other Derivatives and Securities, net
Interest rate swaps
$
358

$
47,929

$
2,120

 
$
(2,660
)
$
26,021

$
(21,830
)
Interest rate swaptions


5,322

 


(428
)
TBA securities

(43,145
)
7,959

 

(24,290
)
29,510

Short sales of U.S. Treasuries

(389
)
16,503

 

251

(9,641
)
Credit default swaps

(1,648
)
1,528

 

(43
)
(457
)
Other

(11
)
25

 

228

7

Total
$
358

$
2,736

$
33,457

 
$
(2,660
)
$
2,167

$
(2,839
)

The following tables summarize changes in notional amounts for our outstanding derivatives and other securities during three months ended March 31, 2018 and 2017 (in thousands):
 
December 31, 2017
Notional
Amount
 
Additions/ Long Positions
 
Expirations/
Terminations/ Short Positions
 
March 31, 2018
Notional
Amount
Interest rate swaps
$
3,530,000

 
100,000

 

 
$
3,630,000

Interest rate swaptions
$
425,000

 
75,000

 

 
$
500,000

TBA securities
$
1,704,386

 
5,057,110

 
(5,174,652
)
 
$
1,586,844

U.S. Treasuries
$

 
119,500

 
(94,500
)
 
$
25,000

Short sales of U.S. Treasuries
$
(846,700
)
 
49,500

 
(60,500
)
 
$
(857,700
)
Credit default swaps
$
48,000

 

 
(48,000
)
 
$


 
December 31, 2016
Notional
Amount
 
Additions/ Long Positions
 
Expirations/
Terminations/ Short Positions
 
March 31, 2017
Notional
Amount
Interest rate swaps
$
2,975,000

 
75,000

 
(75,000
)
 
$
2,975,000

Interest rate swaptions
$
150,000

 

 

 
$
150,000

TBA securities
$
886,042

 
7,928,617

 
(6,774,908
)
 
$
2,039,751

U.S. Treasuries
$
21,000

 
22,500

 
(43,500
)
 
$

Short sales of U.S. Treasuries
$
(511,000
)
 
318,500

 
(1,172,000
)
 
$
(1,364,500
)
Credit default swaps
$
49,000

 

 
(500
)
 
$
48,500




20



Interest Rate Swap Agreements
Our derivative portfolio includes interest rate swaps, which are used to manage our exposure to interest rate risk. Under our interest rate swaps, we typically pay a fixed rate and receive a floating rate based on LIBOR with terms usually ranging up to 15 years. As of March 31, 2018 and December 31, 2017 , we had interest rate swap agreements summarized in the table below (dollars in thousands).
 
 
March 31, 2018
 
December 31, 2017
 
 
Notional
Amount
 
Weighted Average
 
Notional
Amount
 
Weighted Average
Current Maturity Date (1)
 
 
Fixed
Pay Rate
(2)
 
Receive 
Rate
(3)
 
Maturity
(Years)
 
 
Fixed
Pay Rate
(2)
 
Receive 
Rate
(3)
 
Maturity
(Years)
 ≤ 3 years
 
$
1,600,000


1.31
%

1.90
%

1.2
 
$
1,500,000

 
1.26
%
 
1.46
%
 
1.3
> 3 to ≤ 5 years
 
935,000


1.77
%

1.94
%

3.9
 
985,000

 
1.79
%
 
1.47
%
 
4.0
> 5 to ≤ 7 years
 
400,000


1.98
%

1.79
%

5.4
 
350,000

 
1.78
%
 
1.40
%
 
5.7
> 7 years
 
695,000

 
2.26
%
 
1.96
%
 
9.6
 
695,000

 
2.26
%
 
1.47
%
 
9.9
Total
 
$
3,630,000


1.68
%

1.91
%

4.0
 
$
3,530,000

 
1.65
%
 
1.46
%
 
4.2
————————
(1)  
Includes swaps with an aggregate notional of $0.2 billion and $0.4 billion with deferred start dates averaging 0.0 years and 0.1 years from March 31, 2018 and December 31, 2017 , respectively.
(2)  
Excluding forward starting swaps, the weighted average pay rate was 1.64% and 1.58% as of March 31, 2018 and December 31, 2017 , respectively.
(3)  
Weighted average receive rate excludes impact of forward starting interest rate swaps.
Interest Rate Swaption Agreements
Our interest rate swaption agreements provide us the option to enter into interest rate swap agreements in the future where we would pay a fixed rate and receive LIBOR. The following tables present certain information about our interest rate swaption agreements as of March 31, 2018 and December 31, 2017 (dollars in thousands):
March 31, 2018
 
 
Option
 
Underlying Swap
Current Option Expiration Date
 
Cost
 
Fair Value
 
Weighted Average Years to Expiration
 
Notional Amount
 
Pay Rate
 
Weighted Average Term (Years)
 
 
 
 
 
 
≤ 12 months
 
$
2,341

 
$
3,979

 
0.7
 
$
200,000

 
2.73
%
 
8.4
>12 to ≤ 24 months
 
2,623

 
3,077

 
1.2
 
125,000

 
2.86
%
 
8.4
> 24 months
 
7,951

 
5,764

 
3.2
 
175,000

 
2.87
%
 
8.7
Total / weighted average
 
$
12,915

 
$
12,820

 
1.7
 
$
500,000

 
2.81
%
 
8.5
December 31, 2017
 
 
Option
 
Underlying Swap
Current Option Expiration Date
 
Cost
 
Fair Value
 
Weighted Average Years to Expiration
 
Notional Amount
 
Pay Rate
 
Weighted Average Term (Years)
 
 
 
 
 
 
< 12 months
 
$
2,111

 
$
1,621

 
0.9
 
$
175,000

 
2.71
%
 
8.6
>12 to ≤ 24 months
 
2,083

 
1,400

 
1.5
 
75,000

 
2.73
%
 
10.0
> 24 months
 
7,951

 
3,707

 
3.4
 
175,000

 
2.87
%
 
8.9
Total / weighted average
 
$
12,145

 
$
6,728

 
2.0
 
$
425,000

 
2.78
%
 
8.9

21



TBA Securities
As of March 31, 2018 and December 31, 2017 , we had contracts to purchase (“long position”) and sell (“short position”) TBA securities on a forward basis, presented in the following table (in thousands):  
 
 
March 31, 2018
 
December 31, 2017
Purchase and Sale Contracts for TBA Securities
 
Notional 
Amount (1)

Fair
Value (2)

Notional 
Amount (1)

Fair
Value (2)
TBA assets:
 
 
 
 
 
 
 
 
Purchase of TBA securities
 
$
1,586,844

 
$
9,711

 
$
1,386,416

 
$
3,089

Sale of TBA securities
 

 

 
(1,200
)
 
1

Total TBA assets
 
1,586,844

 
9,711

 
1,385,216

 
3,090

 
 
 
 
 
 
 
 
 
TBA liabilities:
 
 
 
 
 
 
 
 
Purchase of TBA securities
 

 

 
319,170

 
(1,339
)
Sale of TBA securities
 

 

 

 

Total TBA liabilities
 

 

 
319,170

 
(1,339
)
Total net TBA
 
$
1,586,844

 
$
9,711

 
$
1,704,386

 
$
1,751

————————
(1)  
Notional amount represents the par value or principal balance of the underlying agency security.
(2)  
Fair value represents the current market value of the agency RMBS underlying the TBA contract as of period end, less the forward price to be paid for the underlying agency RMBS.

U.S. Treasury Securities and Futures
We purchase or sell short U.S. Treasury securities and U.S. Treasury futures contracts to mitigate our exposure to changes in interest rates.
We had U.S. Treasury securities with a fair value of $24.9 million and a face amount of $25.0 million as of March 31, 2018 , which are presented as U.S. Treasury securities, at fair value on the consolidated balance sheets. In addition, we had obligations to return U.S. Treasury securities borrowed under reverse repurchase agreements accounted for as securities borrowing transactions with a fair value of $0.8 billion as of both March 31, 2018 and December 31, 2017 . The borrowed securities were collateralized by cash payments of $0.8 billion as of both March 31, 2018 and December 31, 2017 , which are presented as receivable under reverse repurchase agreements on the consolidated balance sheets. All changes in fair value of long and short U.S. Treasury securities and futures are recorded in realized and unrealized gain (loss) on other derivatives and securities, net in our consolidated statements of operations.
Credit Risk-Related Contingent Features
The use of derivatives creates exposure to credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts. We minimize this risk by limiting our counterparties for instruments which are not centrally cleared on a registered exchange to major financial institutions with acceptable credit ratings and monitoring positions with individual counterparties. In addition, both we and our counterparties may be required to pledge collateral for our derivatives, based on the market value, notional amount and remaining term of the derivative contract. In the event of a default by a counterparty, we may not receive payments provided for under the terms of our derivative agreements, and may have difficulty obtaining our assets pledged as collateral for our derivatives. The cash and cash equivalents pledged as collateral for our derivative instruments is included in restricted cash and cash equivalents on our consolidated balance sheets.
Each of our ISDA Master Agreements contains provisions pursuant to which we are required to fully collateralize our obligations under our interest rate swap agreements if at any point the fair value of the swap represents a liability greater than the minimum transfer amount contained within our ISDA Master Agreements. We are also required to post initial collateral upon execution of certain of our swap transactions. If we breach any of these provisions, we will be required to settle our obligations under the agreements at their termination values, which approximates fair value.
Further, each of our ISDA Master Agreements contain cross default provisions under which a default under certain of our other indebtedness in excess of a certain threshold causes an event of default under the agreement. Threshold amounts vary by

22



lender. Following an event of default, we could be required to settle our obligations under the agreements at their termination values. Additionally, under certain of our ISDA Master Agreements, we could be required to settle our obligations under the agreements at their termination values if we fail to maintain either our REIT status or certain minimum equity thresholds, or comply with limits on our leverage above certain specified levels. As of March 31, 2018 , the fair value of the additional collateral that could be required to be posted as a result of the credit-risk related contingent features being triggered was not material to our consolidated financial statements.

We did not have counterparty credit risk with any single counterparty in excess of 1% of our equity, as of March 31, 2018 under our non-centrally cleared interest rate swap and swaption agreements.

In the case of centrally cleared interest rate swap contracts, we could be exposed to credit risk if the central clearing agency or a clearing member defaults on its respective obligation to perform under the contract. The risk is considered minimal, however, due to initial and daily exchange of mark to market margin requirements, the clearinghouse guarantee fund and other resources that are available in the event of a clearing member default.

Note 9. Offsetting Assets and Liabilities
Certain of our repurchase agreements and derivative transactions are governed by underlying agreements that generally provide for a right of offset under master netting arrangements (or similar agreements), including in the event of default or in the event of bankruptcy of either party to the transactions.  We present our assets and liabilities subject to such arrangements on a gross basis in our consolidated balance sheets.  The following tables present information about our assets and liabilities that are subject to such agreements and can potentially be offset on our consolidated balance sheets as of March 31, 2018 and December 31, 2017 (in thousands):
Offsetting of Financial Assets and Derivative Assets:
 
 
Gross Amounts of Recognized Assets
 
Gross Amounts Offset in the Consolidated Balance Sheets
 
Net Amounts Presented
in the Consolidated Balance Sheets
 
Gross Amounts Not Offset in the Consolidated Balance Sheets
 
 
 
 
 
 
 
Financial Instruments
 
Collateral Received (1)
 
Net Amount
March 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps and swaptions (2)
 
$
20,015

 
$

 
$
20,015

 
$

 
$
(16,891
)
 
$
3,124

TBA
 
9,711

 

 
9,711

 

 

 
9,711

Receivable under reverse repurchase agreements
 
836,901

 

 
836,901

 
(666,306
)
 
(170,595
)
 

Total
 
$
866,627

 
$

 
$
866,627

 
$
(666,306
)
 
$
(187,486
)
 
$
12,835

 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps and swaptions (2)
 
$
11,622

 
$

 
$
11,622

 
$

 
$
(5,642
)
 
$
5,980

TBA
 
3,090

 

 
3,090

 
(1,339
)
 

 
1,751

Receivable under reverse repurchase agreements
 
843,130

 

 
843,130

 
(725,319
)
 
(117,811
)
 

Total
 
$
857,842

 
$

 
$
857,842

 
$
(726,658
)
 
$
(123,453
)
 
$
7,731


23



Offsetting of Financial Liabilities and Derivative Liabilities:
 
 
Gross Amounts of Recognized Liabilities
 
Gross Amounts Offset in the Consolidated Balance Sheets
 
Net Amounts Presented
in the Consolidated Balance Sheets
 
Gross Amounts Not Offset in the Consolidated Balance Sheets
 
 
 
 
 
 
 
Financial Instruments
 
Collateral Pledged (1)
 
Net Amount
March 31, 2018
 
 
 
 
 
 
 
 
 
 
 
 
Repurchase agreements
 
$
3,743,436

 
$

 
$
3,743,436

 
$
(666,306
)
 
$
(3,077,130
)
 
$

Total
 
$
3,743,436

 
$

 
$
3,743,436

 
$
(666,306
)
 
$
(3,077,130
)
 
$

 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2017
 
 
 
 
 
 
 
 
 
 
 
 
TBA
 
$
1,339

 
$

 
$
1,339

 
$
(1,339
)
 
$

 
$

Repurchase agreements
 
3,863,719

 

 
3,863,719

 
(725,319
)
 
(3,138,400
)
 

Total
 
$
3,865,058

 
$

 
$
3,865,058

 
$
(726,658
)
 
$
(3,138,400
)
 
$

————————
(1)
Includes cash and securities received / pledged as collateral, at fair value. Amounts presented are limited to collateral pledged sufficient to reduce the net amount to zero on a counterparty by counterparty basis, as applicable. Refer to Notes 3 and 4 for additional information regarding assets pledged.
(2)  
Reported under derivative assets / liabilities, at fair value in the accompanying consolidated balance sheets. Refer to Note 8 for a reconciliation of derivative assets / liabilities, at fair value to their sub-components.
Note 10. Fair Value Measurements
We have elected the option to account for all of our financial assets at fair value, with changes in fair value reflected in income during the period in which they occur. We have determined that this presentation most appropriately represents our financial results and position. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the assumptions market participants would use when pricing an asset or liability.
We determine the fair value of our agency and non-agency securities, including securities held as collateral, based upon fair value estimates obtained from multiple third-party pricing services and dealers. In determining fair value, third-party pricing sources use various valuation approaches, including market and income approaches. Factors used by third-party sources in estimating the fair value of an instrument may include observable inputs such as recent trading activity, credit data, volatility statistics, and other market data that are current as of the measurement date. The availability of observable inputs can vary by instrument and is affected by a wide variety of factors, including the type of instrument, whether the instrument is new and not yet established in the marketplace and other characteristics particular to the instrument. Third-party pricing sources may also use certain unobservable inputs, such as assumptions of future levels of prepayment, default and loss severity, especially when estimating fair values for securities with lower levels of recent trading activity. When possible, we make inquiries of third-party pricing sources to understand their use of significant inputs and assumptions.
We review the various third-party fair value estimates and perform procedures to validate their reasonableness, including an analysis of the range of third-party estimates for each position, comparison to recent trade activity for similar securities, and our Manager's review for consistency with market conditions observed as of the measurement date. While we do not adjust prices we obtain from third-party pricing sources, we will exclude third-party prices for securities from our determination of fair value if we determine (based on our validation procedures and our Manager's market knowledge and expertise) that the price is significantly different than observable market data would indicate and we cannot obtain a satisfactory understanding from the third party source as to the significant inputs used to determine the price.

We utilize a three-level valuation hierarchy for disclosure of fair value measurement. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the hierarchy is based upon the lowest level of input that is significant to the fair value measurement. We use the results of the validation procedures described above as part of our determination of the appropriate fair value measurement hierarchy classification. The three levels of valuation hierarchy are defined as follows:
Level 1 Inputs - Quoted prices (unadjusted) for identical unrestricted assets and liabilities in active markets that are accessible at the measurement date.

24



Level 2 Inputs - Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
Level 3 Inputs - Significant unobservable market inputs that are supported by little or no market activity. The unobservable inputs represent the assumptions that market participants would use to price the assets and liabilities.
The following tables present our financial instruments carried at fair value as of March 31, 2018 and December 31, 2017 , on the consolidated balance sheets by the valuation hierarchy, as described above (in thousands):
 
 
March 31, 2018
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
 
Agency securities
 
$

 
$
3,660,403

 
$

 
$
3,660,403

Non-agency securities
 

 
833,681

 

 
833,681

U.S. Treasury securities
 
24,924

 

 

 
24,924

Derivative assets
 

 
29,726

 

 
29,726

Total
 
$
24,924

 
$
4,523,810

 
$

 
$
4,548,734

 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
Obligation to return securities borrowed under reverse repurchase agreements
 
824,688

 

 

 
824,688

Total
 
$
824,688

 
$

 
$

 
$
824,688

 
 
December 31, 2017
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets
 
 
 
 
 
 
 
 
Agency securities
 
$

 
$
3,758,181

 
$

 
$
3,758,181

Non-agency securities
 

 
872,084

 

 
872,084

Derivative assets
 

 
14,712

 

 
14,712

Total
 
$

 
$
4,644,977

 
$

 
$
4,644,977

 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
Derivative liabilities
 
$

 
$
4,454

 
$

 
$
4,454

Obligation to return securities borrowed under reverse repurchase agreements
 
830,776

 

 

 
830,776

Total
 
$
830,776

 
$
4,454

 
$

 
$
835,230

Our agency and non-agency securities are valued using the various market data described above, which include inputs determined to be observable or whose significant value drivers are observable. Accordingly, our agency and non-agency securities are classified as Level 2 in the fair value hierarchy as of March 31, 2018 .
For information regarding valuation of our derivative instruments, please refer to the discussion of derivative and other hedging instruments in Note 2. Our interest rate swaps and other derivatives are classified as Level 2 in the fair value hierarchy.
The fair value of our obligation to return securities borrowed under reverse repurchase agreements is based upon the value of the underlying borrowed U.S. Treasury securities as of the reporting date. Both U.S. Treasury securities and our
obligation to return borrowed U.S. Treasury securities are classified as Level 1 in the fair value hierarchy.
Excluded from the table above are financial instruments, including cash and cash equivalents, restricted cash and cash equivalents, receivables, payables, borrowings under repurchase agreements, and debt secured by healthcare real estate investments, which are presented in our consolidated financial statements at cost. The cost basis of financial instruments with initial terms of less than one year are determined to approximate fair value, primarily due to the short duration of these

25



instruments.  The cost basis of floating rate borrowings with initial terms of greater than one year is determined to approximate fair value, primarily as such agreements have floating interest rates based on an index plus or minus a fixed spread and the fixed spread is generally consistent with those demanded in the market. The fair value of fixed rate secured debt is estimated by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. We estimate the fair value of these instruments using Level 2 inputs.
In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis, including those acquired in business combinations. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, and that each of these fair value measurements generally incorporate Level 3 inputs. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value. We estimate the fair value of secured debt assumed in business combinations using current interest rates at which similar borrowings could be obtained on the transaction date.

Note 11. Other Assets
The following table summarizes our other assets as of March 31, 2018 and December 31, 2017 (dollars in thousands):
 
 
March 31, 2018
 
December 31, 2017
Servicing advances
 
$

 
$
324

Prepaid expenses
 
1,595

 
1,993

Accounts receivable
 
2,033

 
5,682

Goodwill
 
5,840

 
5,840

Other
 
6,557

 
9,403

Total other assets
 
$
16,025

 
$
23,242

Note 12. Accounts Payable and Other Accrued Liabilities
The following table summarizes our accounts payable and other accrued liabilities as of March 31, 2018 and December 31, 2017 (dollars in thousands):
 
 
March 31, 2018
 
December 31, 2017
Cash collateral held
 
$
16,992

 
$
5,642

Due to manager
 
1,473

 
1,451

Accrued interest
 
15,181

 
12,547

Other accounts payable and accrued expenses
 
11,258

 
13,952

Total accounts payable and other accrued liabilities
 
$
44,904

 
$
33,592


Risk Mitigation Activities
The Company’s previous investment in MSR exposes us to certain risks, including representation and warranty risk. Representation and warranty risk refers to the representations and warranties we made (or are deemed to have made) to the applicable investor (including, without limitation, the GSEs) regarding, among other things, the origination and servicing of mortgage loans with respect to which we had acquired MSR. We mitigated representation and warranty risk through our due diligence in connection with MSR acquisitions, including counterparty reviews and loan file reviews, as well as negotiated contractual protections from our MSR transaction counterparties with respect to prior origination and servicing. In connection with the sale of its servicing assets and remaining MSR in 2016 and 2017, Residential Credit Solutions, Inc. (“RCS”), the Company’s subsidiary that was previously engaged in mortgage servicing operations, retained certain risk exposure existing prior to the time of such sales, including representation and warranty risk.

26


Note 13. Stockholders’ Equity

Redeemable Preferred Stock

Pursuant to our charter, we are authorized to designate and issue up to 50.0 million shares of preferred stock in one or more classes or series. Our Board of Directors has designated 2.3 million shares as 8.125% Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”). As of March 31, 2018 , we had 47.8 million of authorized but unissued shares of preferred stock. Shares of our Series A Preferred Stock are redeemable at $25.00 per share plus accumulated and unpaid dividends (whether or not declared) exclusively at our option commencing on May 22, 2019, or earlier under certain circumstances intended to preserve our qualification as a REIT for Federal income tax purposes. Dividends are payable quarterly in arrears on the 15th day of each January, April, July and October. As of March 31, 2018 , we had declared all required quarterly dividends on the Series A Preferred Stock.

Our Board of Directors may designate additional series of authorized preferred stock ranking junior to or in parity with the Series A Preferred Stock or designate additional shares of the Series A Preferred Stock and authorize the issuance of such shares. Our Series A Preferred Stock has no stated maturity and is not subject to any sinking fund or mandatory redemption.

Common Stock Repurchase Program

Our Board of Directors adopted a stock repurchase plan pursuant to which the Company is authorized to repurchase up to $100 million of its outstanding shares of common stock through December 31, 2018 . The Company may repurchase shares in the open market or privately negotiated transactions or pursuant to a trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Act of 1934, as amended. The Company intends to repurchase shares under the stock repurchase plan only when the repurchase price is less than its estimate of its then current net asset value per common share. The total amount of $100 million remains authorized and available for common stock repurchases as of March 31, 2018 .

Shares of our common stock may be purchased in the open market, including through block purchases, or through privately negotiated transactions, or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The timing, manner, price and amount of any repurchases will be determined at our discretion and the program may be suspended, terminated or modified at any time for any reason.

Long-Term Incentive Plan

The Company sponsors the American Capital Mortgage Investment Corp. Amended and Restated Equity Incentive Plan (“Incentive Plan” or “plan”), as amended March 4, 2016, to provide for the issuance of equity-based awards, including stock options, restricted stock, restricted stock units (“RSU”) and unrestricted stock to our independent directors. We did not issue any shares of common stock related to the vesting of RSU awards during the three months ended March 31, 2018 , as any awards vested during the period were deferred to future periods. We have made no awards under the plan to our officers or the officers or employees of our Manager, and we no longer intend to issue RSUs to RCS employees.

Net Income per Common Share

Basic net income per common share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share assumes the conversion, exercise or issuance of all potential common stock equivalents unless the effect is to reduce a loss or increase the income per share. Any shares subject to performance conditions that would not be issuable at period end, if that were the end of the contingency period, have been excluded from diluted net income per common share.

Net income used in the numerator to calculate both basic and diluted EPS is the same.  The number of shares used in the denominator of the calculation for basic and diluted EPS is different by an amount equal to the dilutive effect of stock awards issued to employees and directors.

At-the-Market Offering Program

During August 2017, we entered into agreements with sales agents to publicly offer and sell shares of our common stock in privately negotiated and/or at-the-market transactions from time-to-time up to an aggregate amount of $125 million of shares of our common stock. As of March 31, 2018 , we have not issued any shares under this program.


27


Note 14. Subsequent Events
On May 2, 2018, the Company, Annaly Capital Management, Inc., a Maryland corporation (“Annaly”), and Mountain Merger Sub Corporation, a Maryland corporation and a wholly owned subsidiary of Annaly (“Purchaser”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). Pursuant to the Merger Agreement, and upon the terms and conditions thereof, Purchaser will commence an exchange offer (the “Offer”) to purchase all of the Company’s issued and outstanding shares of common stock, par value $0.01 per share (the “Company Common Stock”). In the Offer, holders of Company Common Stock will have the option to elect from among three forms of consideration for each share of Company Common Stock (subject to proration as described below):

$9.82 in cash and 0.9519 shares of Annaly common stock (the “Mixed Consideration Option”);
$19.65 in cash (the “Cash Consideration Option”); or
1.9037 shares of Annaly common stock (the “Stock Consideration Option”).

Holders of Company Common Stock who do not make a valid election will receive the Mixed Consideration Option for their shares of Company Common Stock. Holders who elect to receive the Cash Consideration Option or Stock Consideration Option will be subject to proration to ensure that approximately 50% of the aggregate consideration paid to holders of Company Common Stock in the Offer will be paid in the form of Annaly common stock and approximately 50% of the aggregate consideration paid to holders of Company Common Stock in the Offer will be paid in cash.
Closing of the Offer is subject to the condition that a minimum number of shares be validly tendered and not validly withdrawn. Completion of the Offer is also subject to satisfaction or waiver of a number of other customary closing conditions, including the registration of shares of Annaly common stock to be issued in the transactions and the receipt of certain regulatory approvals. The Company cannot provide any assurance that the proposed transaction will close in a timely manner or at all.
Immediately following the closing of the Offer, the Company will be merged with and into the Purchaser, with the Purchaser surviving the merger. In the merger, holders of Company Common Stock will have the right to receive, at their election, the Mixed Consideration Option, the Cash Consideration Option or the Stock Consideration Option, subject to proration as described above, and each share of the Company’s 8.125% Series A Cumulative Redeemable Preferred Stock, par value $0.01 per share (“Company Preferred Stock”), that is outstanding immediately prior to the merger will be converted into one share of a newly designated series of Annaly preferred stock, par value $0.01 per share, which will have rights, preferences and privileges and voting powers substantially the same as shares of the Company Preferred Stock.
In connection with the execution of the Merger Agreement, the Company and our Manager entered into an amendment (the “Management Agreement Amendment”) to the management agreement, dated July 1, 2016 (the “Management Agreement”).  The Management Agreement Amendment provides that one month following the completion of the transactions contemplated by the Merger Agreement, the Management Agreement will terminate, and as a result of the completion of the transactions contemplated by the Merger Agreement and the subsequent termination of the Management Agreement, the Company will reimburse the Manager for certain unpaid expenses, pay all accrued management fees then owed and pay the Manager a termination fee of approximately $41.7 million as and when specified in the Management Agreement Amendment.


28


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) provides readers of our consolidated financial statements a narrative from the perspective of management, and should be read in conjunction with the consolidated financial statements and accompanying notes included in this Quarterly Report on Form 10-Q for the three months ended March 31, 2018 . Our MD&A is presented in the following sections:
Executive Overview
Financial Condition
Results of Operations
Liquidity and Capital Resources
Off-Balance Sheet Arrangements
Forward-Looking Statements
EXECUTIVE OVERVIEW
Our principal objective is to provide our stockholders with attractive risk-adjusted returns through a combination of monthly dividends and net asset value appreciation. We generate income from the interest earned on our investments, net of associated borrowing and hedging costs, and net realized gains and losses on our investment and hedging activities.
The size and composition of our investment portfolio depend on investment strategies implemented by our Manager, the accessibility of investment capital and overall market conditions, including the availability of attractively priced investments and suitable financing to leverage our investment portfolio appropriately. Market conditions are influenced by, among other things, current levels of and expectations for future levels of interest rates both domestically and globally, mortgage prepayments, market liquidity, housing prices, unemployment rates, general economic conditions, government participation in the mortgage market, and regulations or legal requirements that impact other real estate-related activities.
Trends and Recent Market Impacts
The key market dynamics from 2017, including low volatility, steadily increasing equity valuations, stable longer-term rates, and tighter credit spreads all reversed course dramatically during the first quarter of 2018. The yield on the 10-year U.S. Treasury note rose 33 basis points over the quarter while shorter maturity Treasury and swap rates increased 40 to 50 basis points. Consistent with the increase in rates and wider credit spreads more broadly, spreads on agency RMBS relative to benchmarks widened close to 10 basis points and were the primary driver of our negative economic return of (2.4)% for the quarter, which included a decline of $0.99 per common share in our net book value and dividends declared during the quarter of $0.50 per common share.
Given improving underlying economic fundamentals and a reduction of quantitative easing measures by several key central banks during the second half of 2017, our core view was that interest rates were biased somewhat higher. As such, by the end of 2017, we reduced our exposure to higher rates by increasing our interest rate hedge position to 86% of our repurchase agreement and TBA position. During the first quarter, we increased our interest rate hedge position further to 93% of our repurchase agreement and TBA balance as of March 31, 2018. These actions minimized the impact of the increase in long-term rates during the first quarter on our net book value and should continue to limit our exposure to further rate increases. Our net "duration gap," which is a measure of the risk due to mismatches that can occur between the interest rate sensitivity of our assets and liabilities, inclusive of hedges, was 1.1 years as of March 31, 2018, moderately higher than our net duration gap of 0.6 years as of December 31, 2017. As of March 31, 2018, our sensitivity to an instantaneous parallel increase in rates of 50 and 100 basis points, and assuming no portfolio rebalancing actions, was an estimated decline of (4.6)% and (10.4)%, respectively, of our net book value.
The continued favorable U.S. residential housing market fundamentals led to a slight net fair value gain on our non-agency securities during the first quarter. In response to the favorable market valuations and the corresponding reduced projected returns, we continued to sell a subset of our non-agency securities and re-allocated the capital to more attractive investment opportunities in the agency RMBS and healthcare real estate sectors.
The average cost of our repo funding increased by 25 basis points during the first quarter, consistent with the increase in the federal funds rate, as the Federal Reserve continued to gradually increase short-term interest rates. Over the same period, three-month LIBOR, which determines the receive leg of our pay fixed interest rate swaps, increased 62 basis points, and ended the quarter 35 bps higher than our average repo rate. Despite this favorable spread differential, our average total cost of funds for the first quarter, which includes repurchase agreements, the implied funding costs of our TBA securities and interest rate swaps, increased by 16 basis points to 1.72% for the quarter, as the receive legs of our interest rate swaps had not yet fully reset to the higher prevailing 3-month LIBOR rates. Our average net interest margin (including our TBA dollar roll funded assets

29



and interest rate swap hedges and excluding "catch-up" premium amortization cost due to changes in CPR forecasts) for the first quarter decreased to 1.64%, compared to 1.74% for the fourth quarter, largely due to higher funding costs.
Within the healthcare sector, skilled nursing and senior living facilities continue to benefit from favorable demographic trends, including the substantial growth in the U.S. population aged 75 and older. This growth in the elderly population, coupled with the already high utilization rates at these facilities, provides a strong foundation for this sector. In addition, investments in these facilities benefit from a stable supply of long term, fixed rate funding from GSEs and HUD. Our wholly-owned subsidiary, Capital Healthcare Investments, LLC (“CHI”) has completed healthcare real estate acquisitions with a combined asset value of $299.2 million as of March 31, 2018.
The table below summarizes interest rates and prices for generic agency RMBS as of the end of each respective quarter since March 31, 2017 :
Interest Rate / Security (1)
 
March
31, 2018
 
December 31, 2017
 
September 30, 2017
 
June 30, 2017
 
March 31, 2017
LIBOR:
 
 
 
 
 
 
 
 
 
 
1-Month
 
1.88
%
 
1.56
%
 
1.23
%
 
1.22
%
 
0.98
%
3-Month
 
2.31
%
 
1.69
%
 
1.33
%
 
1.30
%
 
1.15
%
U.S. Treasury Securities:
 
 
 
 
 
 
 
 
 
 
2-Year U.S. Treasury
 
2.27
%
 
1.89
%
 
1.48
%
 
1.38
%
 
1.26
%
5-Year U.S. Treasury
 
2.57
%
 
2.21
%
 
1.93
%
 
1.89
%
 
1.93
%
10-Year U.S. Treasury
 
2.74
%
 
2.41
%
 
2.33
%
 
2.30
%
 
2.39
%
Interest Rate Swap Rates:
 
 
 
 
 
 
 
 
 
 
2-Year Swap Rate
 
2.58
%
 
2.08
%
 
1.73
%
 
1.61
%
 
1.62
%
5-Year Swap Rate
 
2.71
%
 
2.24
%
 
2.00
%
 
1.95
%
 
2.06
%
10-Year Swap Rate
 
2.78
%
 
2.4
%
 
2.28
%
 
2.27
%
 
2.39
%
30-Year Fixed Rate Agency Price:
 
 
 
 
 
 
 
 
 
 
3.5%
 
$
100.20

 
$
102.70

 
$
103.09

 
$
102.70

 
$
102.29

4.0%
 
$
102.61

 
$
104.59

 
$
105.27

 
$
105.12

 
$
104.90

4.5%
 
$
104.70

 
$
106.40

 
$
107.33

 
$
107.27

 
$
107.24

15-Year Fixed Rate Agency Price:
 
 
 
 
 
 
 
 
 
 
2.5%
 
$
97.98

 
$
99.88

 
$
100.69

 
$
100.53

 
$
100.03

3.0%
 
$
99.88

 
$
101.88

 
$
102.75

 
$
102.64

 
$
102.51

3.5%
 
$
101.94

 
$
103.23

 
$
104.14

 
$
104.06

 
$
104.06

 ________________________
(1)  
Price information is for generic instruments only and is not reflective of our specific portfolio holdings. Price information can vary by source. Prices in the table above were obtained from a combination of Bloomberg and dealer indications. Interest rates were obtained from Bloomberg.
For the estimated impact of changes in interest rates and mortgage spreads on our net asset value please refer to “Quantitative and Qualitative Disclosures about Market Risk” under Item 3 of this Quarterly Report on Form 10-Q.

30




The table below summarizes pay-ups on specified pools over the corresponding generic agency RMBS as of the end of each respective quarter for a select sample of specified securities. Price information provided in the table below is for illustrative purposes only and is not meant to be reflective of our specific portfolio holdings. Actual pay-ups are dependent on specific securities held in our portfolio and prices can vary depending on the source.
Specified Mortgage Pool Pay-ups over Generic TBA Price  (1)(2)
 
March 31,
2018
 
December 31, 2017
 
September 30, 2017
 
June 30, 2017
 
March 31, 2017
30-Year Lower Loan Balance (3) :
 
 
 
 
 
 
 
 
 
 
3.0%
 
$
0.41

 
$
0.41

 
$
0.45

 
$
0.41

 
$
0.38

3.5%
 
$
0.56

 
$
0.81

 
$
0.89

 
$
0.83

 
$
0.72

4.0%
 
$
1.03

 
$
1.69

 
$
1.69

 
$
1.47

 
$
1.20

30-Year HARP (4) :
 
 
 
 
 
 
 
 
 
 
3.5%
 
$

 
$
0.03

 
$
0.16

 
$
0.16

 
$
0.16

4.0%
 
$
0.05

 
$
0.17

 
$
0.50

 
$
0.50

 
$
0.47

 ________________________  
(1)  
Source: Bloomberg and dealer indications.
(2)  
“Pay-ups” represent the value of the price premium of specified securities over generic TBA pools. The table above includes pay-ups for newly originated specified pools. Price information is provided for information only and is not meant to be reflective of our specific portfolio holdings. Prices can vary materially depending on the source.
(3)  
Lower loan balance pay-ups for pools with original loan balances from $85,000 to $110,000.
(4)  
HARP pay-ups for pools backed by 100% refinance loans with original loan-to-value ratios between 95% and 100%.

Share Repurchases
Under our stock repurchase plan, the Company is authorized to repurchase up to $100 million of its outstanding shares of common stock through December 31, 2018. The Company may repurchase shares in the open market or privately negotiated transactions or pursuant to a trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Act of 1934, as amended. The Company intends to only repurchase shares under the stock repurchase plan when the repurchase price is less than its estimate of its then current net asset value per common share.

At-the-Market Offering Program

During August 2017, we entered into agreements with sales agents to publicly offer and sell shares of our common stock in privately negotiated and/or at-the-market transactions from time-to-time up to an aggregate amount of $125 million of shares of our common stock.
Summary of Critical Accounting Estimates

Our critical accounting estimates relate to the fair value of our investments and derivatives and the recognition of interest income. Certain of these items involve estimates that require management to make judgments that are subjective in nature. We rely on our Manager's experience and analysis of historical and current market data in order to arrive at what we believe to be reasonable estimates. Under different conditions, we could report materially different amounts based on such estimates. Our significant accounting policies are described in Note 3 to the consolidated financial statements included under Item 1 of this Quarterly Report on Form 10-Q.

We have not designated any derivatives as hedging instruments and therefore all changes in fair value are reflected in income during the period in which they occur. We also have elected the option to account for all of our financial assets at fair value, with changes in fair value reflected in income during the period in which they occur. In management's view, this election more appropriately reflects the results of our operations, as financial asset fair value changes are presented in a manner consistent with the presentation and timing of the fair value changes of economic hedging instruments.


31



FINANCIAL CONDITION
As of March 31, 2018 , our investment portfolio with a notional fair value of $6.4 billion was comprised of $3.7 billion of agency RMBS, $1.6 billion of net long TBA securities, $0.8 billion of non-agency securities and $0.3 billion of healthcare real estate investments.
 
 
March 31, 2018
 
December 31, 2017
Notional fair value of securities investments:
 
 
 
 
Agency RMBS, at fair value
 
$
3,660,403

 
$
3,758,181

Non-agency securities, at fair value
 
833,681

 
872,084

Subtotal
 
4,494,084

 
4,630,265

TBA notional fair value
 
1,582,747

 
1,733,152

Total securities investments notional fair value
 
$
6,076,831

 
$
6,363,417

Agency and non-agency securities funding
 
$
3,743,436

 
$
3,863,719

At risk securities leverage
 
6.2x

 
6.2x

 
 
 
 
 
Healthcare investments:
 
 
 
 
Real estate related assets, including net working capital
 
$
299,185

 
$
281,827

Notes payable, net of deferred financing costs
 
$
201,986

 
$
186,500

Healthcare leverage
 
2.1x

 
2.0x

 
 
 
 
 
Total assets
 
$
5,857,808

 
$
5,953,036

Total liabilities
 
$
4,897,212

 
$
4,947,414

Total stockholders' equity
 
$
959,797

 
$
1,005,107

Net asset value per common share
 
$
19.76

 
$
20.75

The following tables summarize certain characteristics of our mortgage securities portfolio by issuer and investment category as of March 31, 2018 and December 31, 2017 (dollars in thousands):

 
March 31, 2018
  
 
Fair Value
 
Amortized Cost Basis
 
Par Value
 
Weighted Average
Coupon
 
Yield (1)
Fannie Mae

$
2,436,815


$
2,511,459


$
2,393,236


3.61
%

2.82
%
Freddie Mac

1,223,588


1,260,013


1,196,372


3.73
%

2.96
%
Agency RMBS total

3,660,403


3,771,472


3,589,608


3.65
%

2.87
%
Non-agency securities

833,681


744,562


874,844


3.91
%

6.92
%
Total

$
4,494,084


$
4,516,034


$
4,464,452


3.70
%

3.54
%
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2017
 
 
Fair Value
 
Amortized Cost Basis
 
Par Value
 
Weighted Average
 
 
Coupon
 
Yield  (1)
Fannie Mae
 
$
2,587,575

 
$
2,612,063

 
$
2,485,055

 
3.63
%
 
2.78
%
Freddie Mac
 
1,170,606

 
1,181,017

 
1,117,551

 
3.75
%
 
2.89
%
Agency RMBS total
 
3,758,181

 
3,793,080

 
3,602,606

 
3.67
%
 
2.82
%
Non-agency securities
 
872,084

 
779,629

 
911,707

 
3.73
%
 
6.59
%
Total
 
$
4,630,265

 
$
4,572,709

 
$
4,514,313

 
3.67
%
 
3.44
%
 
————————

32



(1)  
The weighted average agency security yield incorporates an average future CPR assumption of 7.6% and 8.4% as of March 31, 2018 and December 31, 2017 , respectively, based on forward rates. For non-agency securities, the weighted average yield is based on estimated cash flows that incorporate expected credit losses.

Agency RMBS
As detailed in the tables below, the weighted average agency RMBS portfolio yield increased 5 basis points from December 31, 2017 to March 31, 2018 .
The following table summarizes certain characteristics of our agency RMBS portfolio by term and coupon as of March 31, 2018 (dollars in thousands):
 
 
March 31, 2018
 
 
Fair Value
 
Amortized Cost Basis
 
Par Value
 
Weighted Average
 
 
Yield
 
Projected CPR
Fixed rate
 
 
 
 
 
 
 
 
 
 
≤ 15-year
 
 
 
 
 
 
 
 
 
 
2.5%
 
$
29,360

 
$
29,844

 
$
29,832

 
2.44
%
 
8.8
%
3.0%
 
189,049

 
192,738

 
188,392

 
2.31
%
 
9.1
%
3.5%
 
111,090

 
113,567

 
108,737

 
2.25
%
 
9.8
%
4.0%
 
87,135

 
88,657

 
84,160

 
2.17
%
 
11.3
%
4.5%
 
7,275

 
7,377

 
6,985

 
2.58
%
 
10.6
%
≤ 15-year total
 
423,909

 
432,183

 
418,106

 
2.28
%
 
9.7
%
20-year
 
 
 
 
 
 
 
 
 
 
3.0%
 
52,079

 
53,829

 
52,370

 
2.35
%
 
10.6
%
3.5%
 
62,984

 
63,651

 
61,829

 
2.82
%
 
9.8
%
5.0%
 
823

 
850

 
771

 
2.13
%
 
14.8
%
20-year total
 
115,886

 
118,330

 
114,970

 
2.60
%
 
10.2
%
30-year
 
 
 
 
 
 
 
 
 
 
3.0%
 
10,737

 
10,894

 
10,997

 
3.12
%
 
6.7
%
3.5%
 
1,493,207

 
1,546,813

 
1,479,889

 
2.86
%
 
6.7
%
4.0%
 
144,377

 
1,488,287

 
1,395,828

 
3.07
%
 
7.2
%
4.5%
 
49,490

 
51,009

 
46,653

 
3.10
%
 
7.6
%
30-year total
 
2,997,811

 
3,097,003

 
2,933,367

 
2.96
%
 
6.9
%
Pass through agency RMBS
 
3,537,606

 
3,647,516

 
3,466,443

 
2.87
%
 
7.4
%
Agency CMO and other
 
49,722

 
51,029

 
49,569

 
2.81
%
 
1.9
%
Total fixed-rate agency RMBS
 
3,587,328

 
3,698,545

 
3,516,012

 
2.87
%
 
7.3
%
Adjustable rate agency RMBS
 
73,075

 
72,927

 
73,596

 
2.87
%
 
20.2
%
Total agency RMBS
 
$
3,660,403

 
$
3,771,472

 
$
3,589,608

 
2.87
%
 
7.6
%

33



The following table summarizes certain characteristics of our agency RMBS portfolio by term and coupon as of December 31, 2017 (dollars in thousands):
 
 
December 31, 2017
 
 
Fair Value
 
Amortized Cost Basis
 
Par Value
 
Weighted Average
 
 
Yield
 
Projected CPR
Fixed rate
 
 
 
 
 
 
 
 
 
 
≤ 15-year
 
 
 
 
 
 
 
 
 
 
2.5%
 
$
31,438

 
$
31,421

 
$
31,405

 
2.44
%
 
8.8
%
3.0%
 
169,991

 
171,384

 
166,572

 
2.17
%
 
9.4
%
3.5%
 
141,410

 
142,448

 
136,503

 
2.30
%
 
10.4
%
4.0%
 
93,679

 
94,528

 
89,635

 
2.17
%
 
11.4
%
4.5%
 
7,841

 
7,883

 
7,457

 
2.58
%
 
10.8
%
≤ 15-year total
 
444,359

 
447,664

 
431,572

 
2.24
%
 
10.1
%
20-year
 
 
 
 
 
 
 
 
 
 
3.0%
 
55,360

 
55,876

 
54,349

 
2.34
%
 
10.8
%
3.5%
 
67,410

 
66,699

 
64,799

 
2.82
%
 
10.2
%
5.0%
 
1,116

 
1,135

 
1,038

 
2.20
%
 
16.7
%
20-year total
 
123,886

 
123,710

 
120,186

 
2.60
%
 
10.5
%
30-year
 
 
 
 
 
 
 
 
 
 
3.0%
 
11,077

 
10,966

 
11,071

 
3.12
%
 
7.1
%
3.5%
 
1,396,687

 
1,417,768

 
1,350,308

 
2.78
%
 
7.2
%
4.0%
 
1,601,321

 
1,612,878

 
1,514,426

 
3.02
%
 
8.4
%
4.5%
 
52,203

 
52,637

 
48,208

 
3.07
%
 
8.2
%
30-year total
 
3,061,288

 
3,094,249

 
2,924,013

 
2.91
%
 
7.9
%
Pass through agency RMBS
 
3,629,533

 
3,665,623

 
3,475,771

 
2.82
%
 
8.2
%
Agency CMO
 
51,535

 
51,662

 
50,115

 
2.81
%
 
2.1
%
Total fixed-rate agency RMBS
 
3,681,068

 
3,717,285

 
3,525,886

 
2.82
%
 
8.1
%
Adjustable rate agency RMBS
 
77,113

 
75,795

 
76,720

 
2.86
%
 
20.6
%
Total agency RMBS
 
$
3,758,181

 
$
3,793,080

 
$
3,602,606

 
2.82
%
 
8.4
%

    

34



The percentage of our fixed-rate agency RMBS portfolio allocated to HARP and lower loan balance securities was 83% (not including our net long TBA position) as of March 31, 2018 as detailed in the following table (dollars in thousands):
 
 
March 31, 2018
  
 
Fair Value
 
Amortized Cost Basis
 
Par Value
 
Weighted Average
Coupon
 
Yield
 
Projected CPR
HARP (1)
 
$
553,837

 
$
572,577

 
$
546,374

 
3.56
%
 
2.82
%
 
7.3
%
Lower loan balance (2)
 
2,436,299

 
2,512,793

 
2,382,809

 
3.70
%
 
2.83
%
 
7.6
%
Other
 
547,470

 
562,146

 
537,260

 
374.00
%
 
3.09
%
 
6.3
%
Pass through agency RMBS
 
3,537,606

 
3,647,516

 
3,466,443

 
3.68
%
 
2.87
%
 
7.4
%
Agency CMO and other
 
49,722

 
51,029

 
49,569

 
3.01
%
 
2.81
%
 
1.9
%
Total fixed-rate agency RMBS
 
3,587,328

 
3,698,545

 
3,516,012

 
3.67
%
 
2.87
%
 
7.3
%
Adjustable rate agency RMBS
 
73,075

 
72,927

 
73,596

 
2.54
%
 
2.87
%
 
20.2
%
Total agency RMBS
 
$
3,660,403

 
$
3,771,472

 
$
3,589,608

 
3.65
%
 
2.87
%
 
7.6
%
————————
(1)
HARP securities are defined as pools backed by 100% refinance loans with LTVs greater than or equal to 80%. Our HARP securities had a weighted average LTV of 124% and 128% for 15-year and 30-year securities, respectively, as of March 31, 2018 . Includes $333.6 million of >105% LTV pools which are not deliverable into TBA securities.
(2)
Lower loan balance securities represent pools with maximum original loan balances less than or equal to $150,000. Our lower loan balance securities had a weighted average original loan balance of $101,655 and $106,829 for 15-year and 30-year securities, respectively, as of March 31, 2018 .

The percentage of our fixed-rate agency RMBS portfolio allocated to HARP and lower loan balance securities was 79% (not including our net long TBA position) as of December 31, 2017 , as detailed in the following table (dollars in thousands):
 
 
December 31, 2017
  
 
Fair Value
 
Amortized Cost Basis
 
Par Value
 
Weighted Average
Coupon
 
Yield
 
Projected CPR
HARP  (1)
 
$
588,217

 
$
594,839

 
$
568,348

 
3.56
%
 
2.81
%
 
8.0
%
Lower loan balance  (2)
 
2,303,047

 
2,330,173

 
2,200,991

 
3.72
%
 
2.76
%
 
8.1
%
Other
 
738,269

 
740,611

 
706,432

 
3.79
%
 
2.99
%
 
8.9
%
Pass through agency RMBS
 
3,629,533

 
3,665,623

 
3,475,771

 
3.70
%
 
2.82
%
 
8.2
%
Agency CMO
 
51,535

 
51,662

 
50,115

 
3.01
%
 
2.81
%
 
2.1
%
Total fixed-rate agency RMBS
 
3,681,068

 
3,717,285

 
3,525,886

 
3.69
%
 
2.82
%
 
8.1
%
Adjustable rate agency RMBS
 
77,113

 
75,795

 
76,720

 
2.55
%
 
2.86
%
 
20.6
%
Total agency RMBS
 
$
3,758,181

 
$
3,793,080

 
$
3,602,606

 
3.67
%
 
2.82
%
 
8.4
%
————————
(1)  
Our HARP securities had a weighted average LTV of 123% and 128% for 15-year and 30-year securities, respectively, as of December 31, 2017 . Includes $355.0 million of >105% LTV pools which are not deliverable into TBA securities.
(2)  
Our lower loan balance securities had a weighted average original loan balance of $98,996 and $106,244 for 15-year and 30-year securities, respectively, as of December 31, 2017 .


35



TBA Investments

Our TBA positions are recorded as derivative instruments in our accompanying consolidated financial statements, with the TBA dollar roll transactions representing a form of off-balance sheet financing. As of March 31, 2018 , our net long TBA position had a notional market value of $1.6 billion and a net carrying value of $9.7 million reported in derivative assets/(liabilities) on our consolidated balance sheets.

The following tables summarize our net long and (short) TBA positions as of March 31, 2018 and December 31, 2017 (dollars in thousands):
 
 
March 31, 2018
 
 
Notional Amount  (1)
 
Cost Basis  (2)
 
Notional Market
Value
(3)
 
Net Carrying Value  (4)
 
 
 
15- Year
 
 
 
 
 
 
 
 
2.5%
 
$
47,500

 
$
46,029

 
$
46,519

 
$
490

3.0%
 
176,223

 
175,161

 
175,858

 
697

3.5%
 
19,200

 
19,459

 
19,540

 
81

Subtotal
 
242,923

 
240,649

 
241,917

 
1,268

30-Year
 
 
 
 
 
 
 
 
3.0%
 
470,660

 
454,464

 
458,784

 
4,320

3.5%
 
588,406

 
586,186

 
589,301

 
3,115

4.0%
 
263,009

 
268,923

 
269,872

 
949

4.5%
 
21,846

 
22,814

 
22,873

 
59

Subtotal
 
1,343,921

 
1,332,387

 
1,340,830

 
8,443

Portfolio total
 
$
1,586,844

 
$
1,573,036

 
$
1,582,747

 
$
9,711

 
 
December 31, 2017
 
 
Notional Amount  (1)
 
Cost Basis  (2)
 
Notional Market
Value
(3)
 
Net Carrying Value (4)
 
 
 
15- Year
 
 
 
 
 
 
 
 
2.5%
 
$
152,500

 
$
152,342

 
$
152,135

 
$
(207
)
3.0%
 
164,329

 
167,678

 
167,266

 
(412
)
3.5%
 
(1,200
)
 
(1,240
)
 
(1,239
)
 
1

Subtotal
 
315,629

 
318,780

 
318,162

 
(618
)
30-Year
 
 
 
 
 


 
 
3.0%
 
525,660

 
523,815

 
525,057

 
1,242

3.5%
 
659,506

 
675,182

 
676,598

 
1,416

4.0%
 
181,745

 
190,334

 
190,093

 
(241
)
4.5%
 
21,846

 
23,290

 
23,242

 
(48
)
Subtotal
 
1,388,757

 
1,412,621

 
1,414,990

 
2,369

Portfolio total
 
$
1,704,386

 
$
1,731,401

 
$
1,733,152

 
$
1,751

————————
(1)  
Notional amount represents the par value or principal balance of the underlying agency RMBS.
(2)  
Cost basis represents the forward price to be paid for the underlying agency RMBS.
(3)  
Notional market value represents the current market value of the agency RMBS underlying the TBA contracts as of period end.
(4)  
Net carrying value represents the difference between the market value of the TBA contract as of period end and the cost basis and is reported in derivative assets / (liabilities), at fair value in our consolidated balance sheets.


36



Non-Agency Investments
Non-agency security yields are based on our estimates of the timing and amount of future cash flows and our amortized cost basis. Our cash flow estimates for these investments are based on our observations of current information and events and include assumptions related to interest rates, prepayment rates and the timing and amount of credit losses and other factors.
The following tables summarize our non-agency securities portfolio as of March 31, 2018 and December 31, 2017 (dollars in thousands):
March 31, 2018
 
 
Fair
  Value
 
Gross Unrealized
 
Amortized Cost
 
Premium (Discount)
 
Par/ Current Face
 
Weighted Average
Category
 
 
Gains
 
Losses
 
 
 
 
Coupon (1)
 
Yield
Prime
 
$
139,841

 
$
9,529

 
$
(77
)
 
$
130,389

 
$
(13,262
)
 
$
143,651

 
3.86
%
 
5.89
%
CRT
 
300,338

 
16,465

 
(81
)
 
283,954

 
13,258

 
270,696

 
5.50
%
 
5.68
%
Alt-A
 
277,083

 
50,162

 
(628
)
 
227,549

 
(109,122
)
 
336,671

 
2.94
%
 
9.21
%
Option-ARM
 
84,683

 
12,790

 

 
71,893

 
(20,305
)
 
92,198

 
2.11
%
 
6.79
%
Subprime
 
13,337

 
873

 

 
12,464

 
(664
)
 
13,128

 
5.20
%
 
5.92
%
CMBS
 
18,399

 
171

 
(85
)
 
18,313

 
(187
)
 
18,500

 
5.68
%
 
6.04
%
Total
 
$
833,681

 
$
89,990

 
$
(871
)
 
$
744,562

 
$
(130,282
)
 
$
874,844

 
3.91
%
 
6.92
%
————————
(1)
Coupon rates are floating, except for $11.4 million , $5.6 million , $12.0 million , $13.3 million , $18.4 million fair value of fixed-rate prime, CRT, Alt-A, subprime and CMBS non-agency securities, respectively, as of March 31, 2018 .
December 31, 2017
 
 
Fair
  Value
 
Gross Unrealized
 
Amortized Cost
 
Discount
 
Par/ Current Face
 
Weighted Average
Category
 
 
Gains
 
Losses
 
 
 
 
Coupon (1)
 
Yield
Prime
 
$
143,329

 
$
9,342

 
$
(12
)
 
$
133,999

 
$
(13,893
)
 
$
147,892

 
3.77
%
 
5.66
%
CRT
 
322,819

 
18,346

 

 
304,473

 
16,011

 
288,462

 
5.34
%
 
5.23
%
Alt-A
 
286,953

 
51,123

 
(774
)
 
236,604

 
(112,305
)
 
348,909

 
2.69
%
 
8.93
%
Option-ARM
 
86,886

 
13,114

 

 
73,772

 
(21,044
)
 
94,816

 
1.79
%
 
6.58
%
Subprime
 
13,374

 
929

 

 
12,445

 
(683
)
 
13,128

 
5.20
%
 
5.97
%
CMBS
 
18,723

 
387

 

 
18,336

 
(164
)
 
18,500

 
5.68
%
 
6.03
%
Total
 
$
872,084

 
$
93,241

 
$
(786
)
 
$
779,629

 
$
(132,078
)
 
$
911,707

 
3.73
%
 
6.59
%
————————
(1)  
Coupon rates are floating, except for $11.8 million , $0.9 million , $12.2 million , $13.4 million and $18.7 million fair value of fixed-rate prime, CRT, Alt-A, subprime and CMBS non-agency securities, respectively, as of December 31, 2017 .

The following table summarizes our non-agency securities by their estimated weighted average life classifications as of March 31, 2018 and December 31, 2017 (dollars in thousands): 
 
 
March 31, 2018
 
December 31, 2017
 
 
 
 
 
 
Weighted Average
 
 
 
 
 
Weighted Average
Estimated Weighted
Average Life
 
Fair Value
 
Amortized
Cost
 
Coupon
 
Yield
 
Fair Value
 
Amortized
Cost
 
Coupon
 
Yield
≤ 5 years
 
$
285,566

 
$
244,884

 
3.33
%
 
8.44
%
 
$
302,797

 
$
258,501

 
3.11
%
 
8.31
%
> 5 to ≤ 7 years
 
258,753

 
226,721

 
4.17
%
 
7.05
%
 
398,712

 
361,649

 
4.33
%
 
5.97
%
> 7 years
 
289,362

 
272,957

 
4.35
%
 
5.43
%
 
170,575

 
159,479

 
3.61
%
 
5.18
%
Total
 
$
833,681

 
$
744,562

 
3.91
%
 
6.92
%
 
$
872,084

 
$
779,629

 
3.73
%
 
6.59
%

37



Our non-agency securities are subject to risk of loss of principal and interest payments. As of March 31, 2018 , our non-agency securities were generally either assigned below investment grade ratings by rating agencies, or were not rated. The following table summarizes the credit ratings of our non-agency securities as of March 31, 2018 and December 31, 2017 :
 
March 31, 2018
 
December 31, 2017
Credit Rating (1)
 
 
 
AA
1
%
 
1
%
A
1
%
 
1
%
BBB
10
%
 
7
%
BB
12
%
 
14
%
B
19
%
 
17
%
Below B
24
%
 
30
%
Not Rated
33
%
 
30
%
Total
100
%
 
100
%
————————
(1)
Represents the lowest of Standard and Poor's, Moody's and Fitch credit ratings, stated in terms of the S&P equivalent, as of each respective balance sheet date.
We evaluate each investment based on the characteristics of the underlying collateral and securitization structure. Our legacy non-agency RMBS were collateralized by mortgages with original weighted average amortized loan to value ratios (“LTV”) of 76% and 75% as of March 31, 2018 and December 31, 2017 , respectively. However, as the home values associated with these mortgages may have experienced significant price declines since origination and LTV is calculated based on the original home values, we believe that current market-based LTV could be significantly higher. Additionally, as of both March 31, 2018 and December 31, 2017 , 7% of the mortgages underlying these legacy non-agency RMBS were either 60 or more days delinquent, undergoing foreclosure or bankruptcy processes, or held as real estate owned by the trusts. Credit enhancement, or protection provided at the security level to absorb future credit losses due to defaults on underlying collateral, is another important component of this evaluation. Our non-agency securities had weighted average credit enhancements of 3% as of both March 31, 2018 and December 31, 2017 .

38



The following tables present the fair value and weighted average purchase price for each of our non-agency securities categories, together with certain of their respective underlying loan collateral attributes and current performance metrics as of March 31, 2018 and December 31, 2017 (fair value dollars in thousands):
March 31, 2018
 
 
Fair
  Value
 
Weighted Average Purchase Price
 
Weighted Average
Collateral Attributes
 
Weighted Average
Current Performance
Category
 
 
 
Loan Age (months)
 
Original LTV
 
Original FICO (1)
 
60+ Day Delinquent (2)
 
3-Month CPR (3)
Prime
 
$
139,841

 
$
85.51

 
139
 
71
%
 
738
 
7
%
 
15
%
CRT
 
300,338

 
101.62

 
27
 
79
%
 
751
 
%
 
9
%
Alt-A
 
277,083

 
64.36

 
148
 
76
%
 
708
 
12
%
 
13
%
Option-ARM
 
84,683

 
71.98

 
141
 
76
%
 
704
 
15
%
 
11
%
Subprime
 
13,337

 
93.28

 
156
 
77
%
 
604
 
17
%
 
9
%
CMBS
 
18,399

 
98.92

 
17
 
55
%
 
NA
 
%
 
%
Total
 
$
833,681

 
$
83.38

 
99
 
76
%
 
711
 
7
%
 
11
%
December 31, 2017
 
 
Fair
  Value
 
Weighted Average Purchase Price
 
Weighted Average
Collateral Attributes
 
Weighted Average
Current Performance
Category
 
 
 
Loan Age (months)
 
Original LTV
 
Original FICO (1)
 
60+ Day Delinquent (2)
 
3-Month CPR (3)
Prime
 
$
143,329

 
$
85.51

 
136
 
71
%
 
738
 
8
%
 
18
%
CRT
 
322,819

 
101.63

 
32
 
76
%
 
754
 
%
 
11
%
Alt-A
 
286,953

 
64.36

 
145
 
76
%
 
708
 
12
%
 
15
%
Option-ARM
 
86,886

 
71.96

 
139
 
76
%
 
704
 
15
%
 
11
%
Subprime
 
13,374

 
93.28

 
153
 
77
%
 
604
 
18
%
 
12
%
CMBS
 
18,723

 
98.92

 
14
 
55
%
 
NA
 
%
 
%
Total
 
$
872,084

 
$
83.06

 
98
 
75
%
 
713
 
7
%
 
13
%
————————
(1)
FICO represents a mortgage industry accepted credit score of a borrower based on a scale of 300 to 850 with a score of 850 being the highest quality rating.
(2)  
60+ day delinquent represents the percentage of mortgage loans underlying each category of non-agency securities that were delinquent for at least 60 days.
(3)  
Three-month CPR is reflective of the prepayment and default rate on the underlying securitization; however, it does not necessarily indicate the proceeds received on our non-agency securities. Proceeds received for each security are dependent on the position of the individual security within the structure of each deal.    
The mortgage loans underlying our non-agency securities are located throughout the United States. The following table presents the six states with the largest geographic concentrations of underlying mortgages as of March 31, 2018 and December 31, 2017 :
 
 
March 31, 2018
 
December 31, 2017
California
 
33
%
 
34
%
Florida
 
7
%
 
7
%
New York
 
5
%
 
4
%
Virginia
 
4
%
 
5
%
Texas
 
4
%
 
3
%
Maryland
 
4
%
 
4
%
Total
 
57
%
 
57
%

39




Investments in Real Property
    
During March 2018, CHI acquired a senior living facility located in Kansas for total consideration of $21.5 million through an existing joint venture structured in a manner intended to comply with the REIT Income Diversification and Empowerment Act (“RIDEA”).

As of March 31, 2018 , CHI had real estate investments net of accumulated depreciation of $299.2 million which are financed through secured debt. As of March 31, 2018 , CHI had fixed rate debt with a principal amount of $138.3 million , a weighted average maturity of 25.3 years and a weighted average interest rate of 3.81% and floating rate debt with a principal amount of $66.4 million , a weighted average maturity of 0.9 years and a weighted average interest rate of 4.63% .
 
Securities Financing and Hedging
As of March 31, 2018 and December 31, 2017 , our borrowings under repurchase agreements had the following characteristics (dollars in thousands):
 
 
March 31, 2018
 
December 31, 2017
 
 
 
 
Weighted Average
 
 
 
Weighted Average
Collateral Type
 
Borrowings
Outstanding
 
Interest Rate
 
Days
to Maturity
 
Borrowings
Outstanding
 
Interest Rate
 
Days
to Maturity
Agency securities
 
$
3,170,784

 
1.78
%
 
106
 
$
3,307,662

 
1.54
%
 
114
Non-agency securities
 
569,380

 
2.93
%
 
18
 
556,057

 
2.72
%
 
24
U.S. Treasury securities
 
3,272

 
1.65
%
 
1
 

 
N/A

 
N/A
Total repurchase agreements
 
$
3,743,436

 
1.96
%
 
92
 
$
3,863,719

 
1.71
%
 
101

The following table summarizes our borrowings under repurchase arrangements as of March 31, 2018 and December 31, 2017 (dollars in thousands):  
 
 
March 31, 2018
 
December 31, 2017
 
 
 
 
Weighted Average
 
 
 
Weighted Average
 
 
Borrowings
Outstanding
 
Interest Rate
 
Days to Maturity
 
Borrowings
Outstanding
 
Interest Rate
 
Days to Maturity
≤ 1 month
 
$
1,584,501

 
2.09
%
 
14
 
$
1,341,712

 
1.91
%
 
17
> 1 to ≤ 2 months
 
955,061

 
1.80
%
 
43
 
1,334,493

 
1.55
%
 
40
> 2 to ≤ 3 months
 
342,533

 
1.95
%
 
78
 
295,204

 
1.76
%
 
76
> 3 to ≤ 6 months
 
510,378

 
1.71
%
 
155
 
334,372

 
1.51
%
 
123
> 6 to ≤ 12 months
 
85,963

 
2.04
%
 
301
 
292,938

 
1.57
%
 
256
> 12 months
 
265,000

 
2.18
%
 
568
 
265,000

 
1.80
%
 
658
Total repurchase agreements
 
$
3,743,436

 
1.96
%
 
92
 
$
3,863,719

 
1.71
%
 
101


40



The following table summarizes our interest rate swap agreements outstanding as of March 31, 2018 and December 31, 2017 , (dollars in thousands):
Current Maturity Date (1)
 
March 31, 2018
 
December 31, 2017
 
Notional
Amount
 
Weighted Average
 
Notional
Amount
 
Weighted Average
 
 
Fixed
Pay Rate
(2)
 
Receive 
Rate
(3)
 
Maturity
(Years)
 
 
Fixed Pay Rate (2)
 
Receive 
Rate
(3)
 
Maturity
(Years)
 ≤ 3 years
 
$
1,600,000

 
1.31
%
 
1.90
%
 
1.2
 
$
1,500,000

 
1.26
%
 
1.46
%
 
1.3
> 3 to ≤ 5 years
 
935,000

 
1.77
%
 
1.94
%
 
3.9
 
985,000

 
1.79
%
 
1.47
%
 
4.0
> 5 to ≤ 7 years
 
400,000

 
1.98
%
 
1.79
%
 
5.4
 
350,000

 
1.78
%
 
1.40
%
 
5.7
> 7 years
 
695,000

 
2.26
%
 
1.96
%
 
9.6
 
695,000

 
2.26
%
 
1.47
%
 
9.9
Total
 
$
3,630,000

 
1.68
%
 
1.91
%
 
4.0
 
$
3,530,000

 
1.65
%
 
1.46
%
 
4.2
————————
(1)  
Includes swaps with an aggregate notional of $0.2 billion and $0.4 billion with deferred start dates averaging 0.0 years and 0.1 years from March 31, 2018 and December 31, 2017 , respectively.
(2)  
Excluding forward starting swaps, the weighted average pay rate was 1.64% and 1.58% as of March 31, 2018 and December 31, 2017 , respectively.
(3)  
Weighted average receive rate excludes impact of forward starting interest rate swaps.
The following tables present certain information about our interest rate swaption agreements as of March 31, 2018 and December 31, 2017 (dollars in thousands):
March 31, 2018
 
 
Option
 
Underlying Swap
Current Option Expiration Date
 
Cost
 
Fair Value
 
Weighted Average Years to Expiration
 
Notional Amount
 
Pay Rate
 
Weighted Average Term (Years)
 
 
 
 
 
 
≤ 12 months
 
$
2,341

 
$
3,979

 
0.7
 
$
200,000

 
2.73
%
 
8.4
>12 to ≤ 24 months
 
2,623

 
3,077

 
1.2
 
125,000

 
2.86
%
 
8.4
> 24 months
 
7,951

 
5,764

 
3.2
 
175,000

 
2.87
%
 
8.7
Total / weighted average
 
$
12,915

 
$
12,820

 
1.7
 
$
500,000

 
2.81
%
 
8.5
December 31, 2017
 
 
Option
 
Underlying Swap
Current Option Expiration Date
 
Cost
 
Fair Value
 
Weighted Average Years to Expiration
 
Notional Amount
 
Pay Rate
 
Weighted Average Term (Years)
 
 
 
 
 
 
< 12 months
 
$
2,111

 
$
1,621

 
0.9
 
$
175,000

 
2.71
%
 
8.6
>12 to ≤ 24 months
 
2,083

 
1,400

 
1.5
 
75,000

 
2.73
%
 
10.0
> 24 months
 
7,951

 
3,707

 
3.4
 
175,000

 
2.87
%
 
8.9
Total / weighted average
 
$
12,145

 
$
6,728

 
2.0
 
$
425,000

 
2.78
%
 
8.9


41


RESULTS OF OPERATIONS
The table below presents our consolidated statements of operations during three months ended March 31, 2018 and 2017 (dollars in thousands, except per share amounts):
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Interest income:
 
 
 
 
Agency securities
 
$
27,511

 
$
17,901

Non-agency securities
 
11,994

 
15,696

Other
 
125

 
160

Interest expense
 
(17,053
)
 
(10,165
)
Net interest income
 
22,577

 
23,592

 
 
 
 
 
Healthcare real estate:
 
 
 
 
Healthcare real estate income
 
7,760

 
3,315

Healthcare real estate expense
 
(5,795
)
 
(2,653
)
Net healthcare investment income
 
1,965

 
662

 
 
 
 
 
Other gains (losses):
 
 
 
 
Realized loss on agency securities, net
 
(1,940
)
 
(212
)
Realized gain on non-agency securities, net
 
4,154

 
12,714

Realized gain (loss) on periodic settlements of interest rate swaps, net
 
358

 
(2,660
)
Realized gain on other derivatives and securities, net
 
2,736

 
2,167

Unrealized loss on agency securities, net
 
(76,170
)
 
(115
)
Unrealized gain (loss) on non-agency securities, net
 
(3,337
)
 
13,014

Unrealized gain (loss) on other derivatives and securities, net
 
33,457

 
(2,839
)
Servicing income
 
50

 
2,558

Servicing expense
 
(250
)
 
(4,985
)
Total other gains (losses), net
 
(40,942
)
 
19,642

Expenses:
 
 
 
 
Management fees
 
3,389

 
3,376

General and administrative expenses
 
1,578

 
1,719

Total expenses
 
4,967

 
5,095

Net income (loss)
 
(21,367
)
 
38,801

Dividend on preferred stock
 
(1,117
)
 
(1,117
)
Noncontrolling interest in net loss (income)
 
5

 
(2
)
Net income (loss) available to common stockholders
 
$
(22,479
)
 
$
37,682

 
 
 
 
 
Net income (loss) per common share — basic and diluted
 
$
(0.49
)
 
$
0.82

 
 
 
 
 
Weighted average common shares — basic
 
45,810

 
45,798

Weighted average common shares — diluted
 
45,822

 
45,806

 
 
 
 
 
Dividend declared per common share
 
$
0.50

 
$
0.45





42




Interest Income and Asset Yields
The tables below present the interest income and weighted average yield for our agency and non-agency securities during the three months ended March 31, 2018 and 2017 (dollars in thousands):
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
 
 
Average Amortized Cost
 
Weighted Average Yield
 
Interest Income
 
Average Amortized Cost
 
Weighted Average Yield
 
Interest Income
Agency RMBS  (1)
 
$
3,672,651

 
3.00
%
 
$
27,511

 
$
2,762,718

 
2.59
%
 
$
17,901

Non-agency securities
 
738,842

 
6.49
%
 
11,994

 
1,009,041

 
6.22
%
 
15,696

Total
 
$
4,411,493

 
3.58
%
 
$
39,505

 
$
3,771,759

 
3.56
%
 
$
33,597

—————— 
(1)  
Does not include TBA dollar roll income reported in realized gain (loss) on other derivatives and securities, net in our consolidated statements of operations.
The following is a summary of the estimated impact of changes in the principal elements of interest income during the three months ended March 31, 2018 and 2017 (in thousands):
 
 
For the Three Months Ended March 31, 2018 vs. 2017
 
 
Increase / (Decrease)
 
Due to Change in Average  (1)
 
 
 
Volume
 
Yield
Agency RMBS
 
$
9,610

 
$
6,490

 
$
3,120

Non-agency securities
 
(3,702
)
 
(4,418
)
 
716

Total
 
$
5,908

 
$
2,072

 
$
3,836

—————— 
(1)  
Variances that are the combined effect of volume and yield, but cannot be separately identified, are allocated to the volume and yield variances based on their respective relative amounts.
Interest income on agency RMBS increased by $9.6 million during the three months ended March 31, 2018 compared to the three months ended March 31, 2017 , due to a 41 basis point increase in average yields combined with a 33% increase in average balances. Interest income on non-agency securities decreased by $(3.7) million during the three months ended March 31, 2018 compared to the three months ended March 31, 2017 , due to a 27% decrease in average balances related to net sales activity, partially offset by an 27 basis point increase in average yields.
We amortize or accrete premiums and discounts associated with agency RMBS and non-agency securities of high credit quality into interest income over the life of such securities using the effective yield method. The effective yield (or asset yield) on these securities is based on actual CPRs realized for individual securities in our investment portfolio through the reporting date and assumes a CPR over the remaining projected life of our aggregate investment portfolio. We estimate projected CPRs on these securities using a third-party service and market data. We update our estimates on at least a quarterly basis, and more frequently when economic or market conditions warrant. The effective yield on these securities is adjusted retrospectively for differences between actual and projected CPR estimates or for changes in our projected CPR estimates. Our projected CPR estimate for our agency RMBS was 7.6% and 8.4% as of March 31, 2018 and December 31, 2017 , respectively. The actual CPR realized for individual agency RMBS in our investment portfolio was approximately 8.9% and 9.2% for the three months ended March 31, 2018 and 2017 , respectively.
Interest income from our agency RMBS is net of premium amortization expense of $4.5 million and $5.5 million for the three months ended March 31, 2018 and 2017 , respectively. The change in our weighted average CPR estimates resulted in the recognition of “catch up” premium amortization benefit (expense) of approximately $1.6 million and $(0.6) million for the three months ended March 31, 2018 and 2017 , respectively. The amortized cost basis of our agency RMBS portfolio was 105.1% and 105.3% of par value as of March 31, 2018 and December 31, 2017 , respectively. The net unamortized premium

43



balance of our aggregate agency RMBS portfolio was $181.9 million and $190.5 million as of March 31, 2018 and December 31, 2017 , respectively.
At the time we purchase non-agency securities that are not of high credit quality, we determine an effective yield based on our estimate of the timing and amount of future cash flows and our cost basis. On at least a quarterly basis, we review the estimated cash flows and make appropriate adjustments with any changes in effective yield recognized prospectively based on the current amortized cost of the investment as adjusted for credit impairment, if any. Our estimates of future cash flows are based on input and analysis received from external sources, internal models and judgment about interest rates, prepayment rates, the timing and amount of credit losses and other factors. Interest income from our non-agency securities includes discount accretion of $3.8 million and $6.8 million for the three months ended March 31, 2018 and 2017 , respectively. The weighted average cost basis of the non-agency portfolio was 85.1% and 85.5% of par as of both March 31, 2018 and December 31, 2017 , respectively. The total net discount remaining was $130.3 million and $132.1 million , with $83.7 million and $85.1 million designated as credit reserves as of March 31, 2018 and December 31, 2017 , respectively.
Leverage
Our leverage, when adjusted for the net payables and receivables for unsettled securities and our net TBA position, was 6.2x our stockholders' equity, excluding investments in RCS and real property as of both March 31, 2018 and December 31, 2017 , respectively. Our leverage will vary from time to time based on various factors, including our Manager’s opinion of the level of risk of our assets and liabilities, our view of the attractiveness of the return environment, composition of our investment portfolio, our liquidity position, our level of unused borrowing capacity, over-collateralization levels required by lenders when we pledge securities to secure our borrowings and the current market value of our investment portfolio. In addition, certain of our master repurchase agreements and master swap agreements contain a restriction that prohibits our leverage from exceeding certain levels. We do not expect these restrictions to adversely impact our operations.
The table below presents our quarterly average and quarter end mortgage securities funding balances outstanding and average leverage ratios for the quarterly periods since March 31, 2016 (dollars in thousands):  
 
 
Repurchase Agreements and Advances (1)
 
Average
Interest
Rate as of Period End (1)
 
Average Leverage During the Period (2)
 
Leverage as of Period End (3)
 
Adjusted Leverage as of Period End (4)
Quarter Ended
 
Average Daily Amount Outstanding
 
Maximum Daily Amount Outstanding
 
Ending Amount Outstanding
 
March 31, 2018
 
$
3,717,094

 
$
3,883,304

 
$
3,743,436

 
1.96
%
 
4.2x
 
4.4x
 
6.2x
December 31, 2017
 
$
3,784,846

 
$
3,873,054

 
$
3,863,719

 
1.71
%
 
4.2x
 
4.2x
 
6.2x
September 30, 2017
 
$
3,650,206

 
$
3,893,263

 
$
3,807,880

 
1.58
%
 
4.1x
 
4.2x
 
6.3x
June 30, 2017
 
$
3,538,006

 
$
3,836,940

 
$
3,805,778

 
1.47
%
 
4.0x
 
4.4x
 
6.3x
March 31, 2017
 
$
3,117,397

 
$
3,272,548

 
$
3,185,134

 
1.31
%
 
3.5x
 
3.6x
 
5.9x
December 31, 2016
 
$
3,677,854

 
$
3,554,251

 
$
3,244,516

 
1.26
%
 
3.8x
 
3.7x
 
4.8x
September 30, 2016
 
$
3,682,233

 
$
3,781,117

 
$
3,553,666

 
1.11
%
 
4.0x
 
3.7x
 
5.0x
June 30, 2016
 
$
3,692,354

 
$
4,306,868

 
$
3,555,883

 
1.04
%
 
4.2x
 
4.5x
 
4.9x
March 31, 2016
 
$
3,933,580

 
$
4,291,269

 
$
3,844,759

 
1.00
%
 
4.4x
 
4.4x
 
4.6x
————————
(1)  
Excludes repurchase agreements collateralized by U.S. Treasury securities and borrowings related to our healthcare investments, but includes advances from the Federal Home Loan Bank collateralized by agency and non-agency securities.
(2)  
Average leverage during the period was calculated by dividing our daily weighted average agency and non-agency financing balance by our average month-end stockholders’ equity for the period, less investments in RCS and healthcare real estate.
(3)  
Leverage as of period end was calculated by dividing the amount outstanding under our agency and non-agency financing agreements and net payables and receivables for unsettled agency and non-agency securities by our total stockholders' equity at period end, less our investments in RCS and healthcare real estate.
(4)  
Adjusted leverage as of period end was calculated by dividing the sum of the amounts outstanding under our agency and non-agency financing agreements, the cost basis (or contract price) of our net TBA position, and net payables and receivables for unsettled agency and non-agency securities by our total stockholders’ equity at period end, less our investments in RCS and healthcare real estate.
    
Adjusted leverage presented in the table above includes the impact of TBA positions, which have the effect of increasing or decreasing our “at risk” leverage. A net long position increases our at risk leverage, while a net short position reduces our at risk leverage. As of March 31, 2018 , we had a net long TBA position with a notional market value and underlying costs basis of $1.6 billion .

44



Interest Expense and Cost of Funds
Interest expense on our mortgage securities portfolio of $17.1 million and $10.2 million for the three months ended March 31, 2018 and 2017 , respectively was comprised primarily of interest expense on our repurchase agreements. We recognized net periodic interest settlements related to our interest rate swaps of $(0.4) million and $2.7 million for the three months ended March 31, 2018 and 2017 , respectively, which is included in realized loss on periodic settlements of interest rate swaps, net, on our consolidated statements of operations.

The tables below present our adjusted cost of funds on our mortgage securities portfolio during the three months ended March 31, 2018 and 2017 (dollars in thousands):
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
 
 
Average
Balance / Effective Notional
 
Rate
 
Adjusted Cost of Funds (1)
 
Average
Balance / Effective Notional
 
Rate
 
Adjusted Cost of Funds (1)
Repurchase agreements
 
$
3,717,094

 
1.86%
 
$
17,053

 
$
3,117,397

 
1.32%
 
$
10,165

Interest rate swaps
 
3,362,500

 
(0.04)%
 
(358
)
 
2,887,500

 
0.37%
 
2,660

Total adjusted cost of funds
 
 
 
1.82%
 
$
16,695

 
 
 
1.67%
 
$
12,825

————————
(1)  
Our adjusted cost of funds excludes any impacts from other supplemental hedges such as U.S. Treasury securities and swaptions, and the implied financing cost or benefit of our net TBA dollar roll position reported in gain (loss) on other derivatives and securities, net in our consolidated statements of operations.
The following is a summary of the impact of changes in the principal elements of our adjusted cost of funds during the three months ended March 31, 2018 and 2017 (in thousands):
 
 
For the Three Months Ended March 31, 2018 vs. 2017
 
 
Increase / (Decrease)
 
Due to Change in Average  (1)
 
 
 
Volume
 
Rate
Repurchase agreements
 
$
6,888

 
$
2,201

 
$
4,687

Interest rate swaps
 
(3,018
)
 
(365
)
 
(2,653
)
Total adjusted cost of funds
 
$
3,870

 
$
1,836

 
$
2,034

—————— 
(1)  
Variances that are the combined effect of volume and yield, but cannot be separately identified, are allocated to the volume and yield variances based on their respective relative amounts.
The increase in our adjusted cost of funds on our mortgage securities portfolio of $3.9 million for the three months ended March 31, 2018 compared to the three months ended March 31, 2017 , respectively, was primarily attributable to higher average rates on our repurchase agreements, partially offset by improved average net pay/receive rates on our interest rate swaps.

45



Healthcare Real Estate Income and Expense
The following table presents the components of net income and expense from our healthcare real estate investments for the three months ended March 31, 2018 and 2017 (dollars in thousands):
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Lease income
 
$
5,706

 
$
2,253

Rental income
 
2,054

 
1,062

Healthcare real estate income
 
7,760

 
3,315

 
 
 
 
 
Interest expense
 
2,089

 
1,173

Depreciation
 
2,001

 
771

Tenant expenses
 
1,425

 
709

Other
 
280

 

Healthcare real estate expense
 
5,795

 
2,653

Net healthcare investment income
 
$
1,965

 
$
662


The increase in healthcare real estate income and expense amounts during 2018 compared to 2017 result from investment activity beginning in the second quarter of 2017.
Realized and Unrealized Gain (Loss) on Securities, Net
Sales of securities for the three months ended March 31, 2018 and 2017 were largely driven by rebalancing of our agency and non-agency securities portfolios. The changes in portfolio composition were based upon our Manager's expectations concerning interest rates, Federal government actions, general economic conditions and other factors.
The following table is a summary of our net realized gains on agency RMBS during the three months ended March 31, 2018 and 2017 (dollars in thousands):  
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Proceeds from agency securities sold
 
$
220,435

 
$
208,457

Less agency securities sold, at cost
 
(222,375
)
 
(208,669
)
Realized loss on agency securities, net
 
$
(1,940
)
 
$
(212
)
 
 
 
 
 
Gross realized gains on sale of agency securities
 
$
14

 
$
1,270

Gross realized losses on sale of agency securities
 
(1,954
)
 
(1,482
)
Realized loss on agency securities, net
 
$
(1,940
)
 
$
(212
)

46



The following table summarizes our net realized gains and losses on non-agency securities incurred during the three months ended March 31, 2018 and 2017 (dollars in thousands):  
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Proceeds from non-agency securities sold
 
$
89,901

 
$
260,473

Increase in receivable for securities sold
 

 
5,748

Less: non-agency securities sold, at cost
 
(85,747
)
 
(253,507
)
Realized gain on non-agency securities, net
 
$
4,154

 
$
12,714

 
 
 
 
 
Gross realized gain on sale of non-agency securities
 
$
4,155

 
$
12,864

Gross realized loss on sale of non-agency securities
 
(1
)
 
(150
)
Realized gain on non-agency securities, net
 
$
4,154

 
$
12,714


Unrealized net losses of $(76.2) million on agency RMBS and unrealized net gains of $(3.3) million on non-agency securities for the three months ended March 31, 2018 were attributable to the changes in market pricing on the underlying instruments as described above in Trends and Recent Market Impacts , as well as the impact of realized gains and losses on sales of securities.
Gain (Loss) on Other Derivatives and Securities, Net
The following table is a summary of our realized and unrealized gain (loss) on other derivatives and securities, net, during the three months ended March 31, 2018 and 2017 (dollars in thousands): 
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Realized gain (loss) on periodic settlements of interest rate swaps, net
 
$
358


$
(2,660
)
Realized gain on other derivatives and securities:
 
 
 
 
Interest rate swaps
 
$
47,929


$
26,021

TBA securities
 
(43,145
)

(24,290
)
Short sales of U.S. Treasury securities
 
(389
)

251

Credit default swaps
 
(1,648
)
 
(43
)
Other, net
 
(11
)
 
228

Total realized gain on other derivatives and securities, net
 
$
2,736


$
2,167

Unrealized gain (loss) on other derivatives and securities:
 
 
 
 
Interest rate swaps
 
$
2,120


$
(21,830
)
Interest rate swaptions
 
5,322


(428
)
TBA securities
 
7,959


29,510

Short sales of U.S. Treasury securities
 
16,503


(9,641
)
Credit default swaps
 
1,528

 
(457
)
Other, net
 
25

 
7

Total unrealized gain (loss) on other derivatives and securities, net
 
$
33,457


$
(2,839
)

Net gains on pay-fixed interest rate swaps during the three months ended March 31, 2018 and 2017 were due primarily to an increase in shorter-term swap interest rates during those quarters.
Net gains on short positions in U.S. Treasury securities during the three months ended March 31, 2018 were due primarily to an increase in longer term Treasury interest rates during the quarter.
Net losses on TBA securities during the three months ended March 31, 2018 were due primarily due to an increase in longer-term Treasury interest rates during the quarter and wider spreads on agency RMBS.  

47



For further details regarding our derivatives and related hedging activity please refer to Notes 3 and 8 to our consolidated financial statements in this Quarterly Report on Form 10-Q.
Management Fees and General and Administrative Expenses
We pay our Manager a management fee payable monthly in arrears in an amount equal to one twelfth of 1.50% of our month-end GAAP stockholders’ equity, adjusted to exclude the effect of any unrealized gains or losses included in retained earnings as computed in accordance with GAAP. There is no incentive compensation payable to our Manager pursuant to the management agreement. We incurred management fees of $3.4 million during both the three months ended March 31, 2018 and 2017 , respectively.
General and administrative expenses, primarily consisting of prime brokerage fees, information technology costs, research and data service fees, audit fees, Board of Directors fees and insurance expenses, were $1.6 million and $1.7 million during the three months ended March 31, 2018 and 2017 , respectively.
Our management fees and general and administrative expenses as a percentage of our average stockholders’ equity on an annualized basis were 2.0% and 2.2% for the three months ended March 31, 2018 and 2017 , respectively.

48



Dividends and Income Taxes

We had estimated taxable income available to common shareholders of $8.6 million and $5.3 million (or $0.19 and $0.12 per common share) for the three months ended March 31, 2018 and 2017 .

The following is a reconciliation of our GAAP net income to our estimated taxable income during the three months ended March 31, 2018 and 2017 (dollars in thousands, except per share amounts).
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Net income
 
$
(21,367
)
 
$
38,801

Book to tax differences:
 
 
 
 
Unrealized (gains) and losses, net
 
 
 
 
Agency RMBS
 
76,170

 
115

Non-agency securities
 
3,337

 
(13,014
)
Derivatives, MSR and other securities
 
(33,457
)
 
2,839

Amortization / accretion
 
(1,094
)
 
(1,174
)
Capital gains (1)
 
40,859

 
13,716

Realized losses (gains), net (1)
 
(54,952
)
 
(37,324
)
Taxable REIT subsidiary loss and other
 
200

 
2,427

Total book to tax difference
 
31,063

 
(32,415
)
Estimated taxable income
 
9,696

 
6,386

Dividend on preferred stock
 
(1,117
)
 
(1,117
)
Estimated taxable income available to common stockholders
 
$
8,579

 
$
5,269

 
 
 
 
 
Weighted average common shares — basic
 
45,810

 
45,798

Weighted average common shares — diluted
 
45,822

 
45,806

 
 
 
 
 
Estimated taxable income per common share - basic and diluted
 
$
0.19

 
$
0.12

Ending cumulative (overdistribution) of estimated taxable income per common share
 
$
(1.93
)
 
$
(0.82
)
 
 
 
 
 
Beginning cumulative non-deductible capital losses
 
$
73,252

 
$
118,347

Current period net capital gain
 
40,859

 
13,716

Ending cumulative non-deductible capital losses
 
$
114,111

 
$
132,063

Ending cumulative non-deductible capital losses per common share
 
$
2.49

 
$
2.88

—————— 
(1)  
Estimated taxable income excludes estimated net capital losses of $(0.89) per common share for the three months ended March 31, 2018 , respectively, which increase our net capital loss carryforwards from prior periods.

The increase in our estimated taxable income per common share is primarily due to lower net interest income, driven mainly by increased repurchase agreement interest rates.
We believe that providing investors with estimated taxable income and certain financial metrics derived from such non-GAAP financial information, in addition to the related GAAP measures, gives investors greater transparency to the information used by management in its financial and operational decision-making. In the case of estimated taxable income, we believe it is meaningful information as it is directly related to the amount of dividends we are required to distribute in order to maintain our REIT qualification status. However, because estimated taxable income is an incomplete measure of our financial performance and involves differences from net income computed in accordance with GAAP, this non-GAAP financial information should be considered supplementary to, and not a substitute for, our net income computed in accordance with GAAP as a measure of our financial performance. In addition, because not all companies use identical calculations, our presentation of estimated taxable income may not be comparable to other similarly-titled measures of other companies. Furthermore, estimated taxable income

49



can include certain information that is subject to potential adjustments up to the time of filing our income tax returns, which occurs after the end of our fiscal year.
We declared dividends of $0.50 and $0.45 per common share for the three months ended March 31, 2018 and 2017 , respectively. As of March 31, 2018 , we have distributed all of our 2017 taxable income within the allowable time frame, including the available spill-back provision, so that we will not be subject to Federal or state corporate income tax for 2017.

RCS is taxable as a corporation under Subchapter C of the Internal Revenue Code, with which we filed a joint TRS election. As of March 31, 2018 , RCS had Federal net operating loss (“NOL”) carryforwards of approximately $119 million . The utilization of approximately $50 million of the NOL is subject to limitations imposed by the Internal Revenue Code. RCS sold its MSR holdings during the first quarter of 2017 and incurred approximately $14 million of capital loss, which can be carried forward for up to five years.

The Tax Cuts and Jobs Act (“TCJA”) signed into law during the fourth quarter of 2017 reduces the Corporate tax rate to 21% for tax years starting after December 31, 2017. As of December 31, 2017, RCS’s gross deferred tax assets associated with the NOL and temporary differences, as reevaluated based on the new corporate tax rate and estimated state effective rate, were approximately $31 million , with respect to which RCS has provided a full valuation allowance.


50



Key Statistics
The table below presents key statistics for the three months ended March 31, 2018 and 2017 (dollars in thousands, except per share amounts):

 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Ending agency securities, at fair value
 
$
3,660,403

 
$
2,997,725

Ending agency securities, at cost
 
$
3,771,472

 
$
3,031,237

Ending agency securities, at par
 
$
3,589,608

 
$
2,881,851

Average agency securities, at cost
 
$
3,672,651

 
$
2,762,718

Average agency securities, at par
 
$
3,491,456

 
$
2,629,607

 
 
 
 
 
Ending non-agency securities, at fair value
 
$
833,681

 
$
948,495

Ending non-agency securities, at cost
 
$
744,562

 
$
880,376

Ending non-agency securities, at par
 
$
874,844

 
$
1,039,185

Average non-agency securities, at cost
 
$
738,842

 
$
1,009,041

Average non-agency securities, at par
 
$
870,646

 
$
1,187,097

 
 
 
 
 
Net TBA portfolio - as of period end, at fair value
 
$
1,582,747

 
$
2,081,093

Net TBA portfolio - as of period end, at cost
 
$
1,573,036

 
$
2,070,072

Average net TBA portfolio, at cost
 
$
1,791,969

 
$
1,366,814

 
 
 
 
 
Average total assets, at fair value
 
$
5,773,121

 
$
5,044,712

Average agency and non-agency repurchase agreements and advances
 
$
3,717,094

 
$
3,117,397

Average stockholders' equity
 
$
985,289

 
$
946,266

 
 
 
 
 
Average coupon
 
3.69
 %
 
3.38
%
Average asset yield
 
3.58
 %
 
3.56
%
Average asset yield excluding “catch-up” premium amortization
 
3.44
 %
 
3.63
%
Average cost of funds (1)
 
1.82
 %
 
1.67
%
Average net interest rate spread
 
1.76
 %
 
1.89
%
Average net interest rate spread, excluding “catch-up” premium amortization
 
1.62
 %
 
1.96
%
Average net interest rate spread, including TBA dollar roll, excluding “catch-up” premium amortization
 
1.64
 %
 
2.05
%
Average coupon as of period end
 
3.70
 %
 
3.54
%
Average asset yield as of period end
 
3.54
 %
 
3.60
%
Average repurchase agreement/ FHLB funding rate as of period end
 
1.96
 %
 
1.31
%
Effective swap net pay rate as of period end
 
(0.27
)%
 
0.31
%

51



 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Average actual CPR for agency securities held during the period
 
8.9
 %
 
9.2
%
Average projected life CPR for agency securities as of period end
 
7.6
 %
 
8.5
%
 
 
 
 
 
Leverage - average during the period (2)
 
4.2x

 
3.5x

Leverage - average during the period, including net TBA position
 
6.2x

 
5.1x

Leverage - as of period end (3)
 
4.4x

 
3.6x

Leverage - as of period end, including net TBA position
 
6.2x

 
5.9x

 
 
 
 
 
Expenses % of average total assets - annualized
 
0.3
 %
 
0.4
%
Expenses % of average stockholders' equity - annualized
 
2.0
 %
 
2.2
%
Net asset value per common share as of period end
 
$
19.76

 
$
19.54

Dividends declared per common share
 
$
0.50

 
$
0.45

Economic return (loss) on common equity - annualized
 
(9.4
)%
 
17.2
%
————————   
(1)  
Average cost of funds includes periodic settlements of interest rate swaps and excludes U.S. Treasury repurchase agreements and healthcare real estate financing.
(2)  
Leverage during the period was calculated by dividing the Company's daily weighted average agency and non-agency financing agreements for the period by the Company's average month-ended stockholders' equity for the period less investments in RCS and healthcare real estate. Leverage excludes U.S. Treasury repurchase agreements.
(3)  
Leverage at period end was calculated by dividing the sum of the amount outstanding under the Company's agency and non-agency financing agreements, and the net receivable/payable for unsettled securities at period end by the Company's stockholders' equity at period end less investments in RCS and healthcare real estate. Leverage excludes U.S. Treasury repurchase agreements.

Non-GAAP Financial Measures

In addition to the results presented in accordance with GAAP, the Company presents certain non-GAAP financial information, including the total notional fair value of its investment portfolio, “net spread and dollar roll income,” “net spread and dollar roll income, excluding ‘catch-up’ premium amortization,” “estimated taxable income” and the related per common share measures and certain financial metrics derived from such non-GAAP information, such as “cost of funds” and “net interest rate spread.”

“Net spread and dollar roll income” is measured as (i) net interest income (GAAP measure) adjusted to include other interest rate swap periodic costs and TBA dollar roll income, less (ii) total operating expenses (GAAP measure). “Net spread and dollar roll income, excluding “catch-up” premium amortization,” further excludes retrospective “catch-up” adjustments to premium amortization cost or benefit due to changes in projected CPR estimates.

By providing users of the Company's financial information with such measures in addition to the related GAAP measures, the Company believes users will have greater transparency into the information used by the Company's management in its financial and operational decision-making. The Company also believes it is important for users of its financial information to consider information related to its current financial performance without the effects of certain measures that are not necessarily indicative of its current or expected investment portfolio performance and operations.

While TBAs are economically equivalent to holding and financing generic agency MBS using short-term repurchase agreements, they are accounted for under GAAP as derivative instruments with gains and losses recognized in other gain (loss) in the Company’s statements of operations. As such, the Company includes TBAs in the total notional fair value of its investment portfolio and TBA dollar roll income in “net spread and dollar roll income.” Similarly, the Company believes that the inclusion of periodic settlements on interest rate swaps, which are recognized under GAAP in other gain (loss), is meaningful as interest rate swaps are the primary instrument used to economically hedge against fluctuations in the Company’s borrowing costs. As such, the inclusion of periodic interest rate swap settlement costs is more indicative of the Company’s total cost of funds than interest expense alone. In the case of “net spread and dollar roll income, excluding ‘catch-up’ premium amortization,” the Company believes the exclusion of “catch-up” adjustments to premium amortization cost or benefit is meaningful as it excludes the cumulative effect from prior reporting periods due to current changes in future prepayment expectations and, therefore, exclusion of such cost or benefit is more indicative of the current and expected earnings potential of

52



the Company’s investment portfolio. In the case of estimated taxable income, the Company believes it is meaningful information as it is directly related to the amount of dividends the Company is required to distribute in order to maintain its REIT qualification status.

However, because such measures are incomplete measures of the Company's financial performance and involve differences from results computed in accordance with GAAP, they should be considered as supplementary to, and not as a substitute for, results computed in accordance with GAAP. In addition, because not all companies use identical calculations, the Company's presentation of such non-GAAP measures may not be comparable to similarly-titled measures of other companies. Furthermore, estimated taxable income can include certain information that is subject to potential adjustments up to the time of filing the Company's income tax returns, which occurs after the end of its fiscal year.
Net Spread and Dollar Roll Income
The table below presents a reconciliation from GAAP net interest income to net spread and dollar roll income, excluding “catch-up” premium amortization, available to common stockholders during the three months ended March 31, 2018 and 2017 (dollars in thousands, except per share amounts):
 
 
For the Three Months Ended March 31,
 
 
2018
 
2017
Interest income:
 
 
 
 
Agency securities
 
$
27,511

 
$
17,901

Non-agency securities and other
 
12,119

 
15,856

Interest expense
 
(17,053
)
 
(10,165
)
Net interest income
 
22,577

 
23,592

Realized gain (loss) on periodic settlements of interest rate swaps, net
 
358

 
(2,660
)
Dollar roll income
 
7,465

 
7,271

Adjusted net interest and dollar roll income
 
30,400

 
28,203

Operating expenses
 
(4,967
)
 
(5,095
)
Net spread and dollar roll income
 
25,433

 
23,108

Dividend on preferred stock
 
(1,117
)
 
(1,117
)
Net spread and dollar roll income available to common stockholders
 
24,316

 
21,991

Estimated “catch-up” premium amortization cost due to change in CPR forecast
 
(1,563
)
 
645

Net spread and dollar roll income, excluding “catch-up” premium amortization, available to common stockholders
 
$
22,753

 
$
22,636

 
 
 
 
 
Weighted average common shares — basic
 
45,810

 
45,798

Weighted average common shares — diluted
 
45,822

 
45,806

 
 
 
 
 
Net spread and dollar roll income per common share- basic and diluted
 
$
0.53

 
$
0.48

Net spread and dollar roll income, excluding “catch up” amortization per common share - basic and diluted
 
$
0.50

 
$
0.49

LIQUIDITY AND CAPITAL RESOURCES
Our primary sources of funds are borrowings under master repurchase agreements, equity offerings, asset sales and monthly principal and interest payments on our investment portfolio. Because the level of our borrowings can be adjusted on a daily basis, the level of cash and cash equivalents carried on our balance sheets is significantly less important than the potential liquidity available under our borrowing arrangements. We currently believe that we have sufficient liquidity and capital resources available for the acquisition of additional investments, repayments on borrowings, maintenance of any margin requirements and the payment of cash dividends as required for our continued qualification as a REIT. To qualify as a REIT, we must distribute annually at least 90% of our taxable income. To the extent that we annually distribute all of our taxable income in a timely manner, we will generally not be subject to Federal and state income taxes. We currently expect to distribute all of our taxable income in a timely manner so that we are not subject to Federal and state income taxes. This distribution requirement limits our ability to retain earnings and thereby replenish or increase capital from operations.

53



Equity Capital

Common Stock Repurchase Program

Our Board of Directors adopted a stock repurchase plan under which, the Company is authorized to repurchase up to $100 million of its outstanding shares of common stock through December 31, 2018. The Company may repurchase shares in the open market or privately negotiated transactions or pursuant to a trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities and Exchange Act of 1934, as amended. The Company intends to repurchase shares under the stock repurchase plan only when the repurchase price is less than its estimate of its then current net asset value per common share. As of March 31, 2018 , the total remaining amount authorized by our Board of Directors for repurchases of our common stock was $100 million .

Shares of our common stock may be purchased in the open market, including through block purchases, or through privately negotiated transactions, or pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The timing, manner, price and amount of any repurchases will be determined at our discretion and the program may be suspended, terminated or modified at any time for any reason.

At-the-Market Offering Program

During August 2017, we entered into agreements with sales agents to publicly offer and sell shares of our common stock in privately negotiated and/or at-the-market transactions from time-to-time up to an aggregate amount of $125 million of shares of our common stock. As of March 31, 2018 , we have not issued any shares under this program.

Debt Capital

Repurchase Agreements
As part of our investment strategy, we borrow against our agency and non-agency securities pursuant to master repurchase agreements. We expect that our borrowings pursuant to repurchase transactions under such master repurchase agreements generally will have maturities of less than one year. When adjusted for net payables and receivables for unsettled agency and non-agency securities, our leverage ratio was 4.4x and 4.2x the amount of our stockholders’ equity less our investments in RCS and real property as of March 31, 2018 and December 31, 2017 , respectively.
To limit our exposure to counterparty credit risk, we diversify our funding across multiple counterparties and by counterparty region. We had repurchase agreements with 36 financial institutions as of March 31, 2018 , located throughout North America, Europe and Asia. In addition, less than 4% of our equity was at risk with any one repurchase agreement counterparty, with the top five counterparties representing approximately 17% of our equity at risk as of March 31, 2018 .
As of March 31, 2018 , borrowings under repurchase agreements of $3.2 billion and $0.6 billion , with weighted average remaining days to maturity of 106 days and 18 days , were secured by agency and non-agency securities, respectively.
The table below includes a summary of our repurchase agreement funding and number of counterparties by region as of March 31, 2018 . Please refer to Note 7 to our consolidated financial statements in this Quarterly Report on Form 10-Q for further details regarding our borrowings under repurchase agreements and weighted average interest rates as of March 31, 2018 .
 
 
March 31, 2018
Counterparty Region
 
Number of Counterparties
 
Percentage of Repurchase Agreement Funding
North America
 
18
 
67%
Asia
 
6
 
10%
Europe
 
12
 
23%
Total
 
36
 
100%
Amounts available to be borrowed under our repurchase agreements are dependent upon lender collateral requirements and the lender's determination of the fair value of the securities pledged as collateral, based on recognized pricing sources agreed to by both parties to the agreement. Collateral fair value can fluctuate with changes in interest rates, credit quality and liquidity conditions within the investment banking, mortgage finance and real estate industries. Our counterparties also apply a “haircut” to the fair value of our pledged collateral, which reflects the underlying risk of the specific collateral and protects our

54



counterparties against a decrease in collateral value, but conversely subjects us to counterparty risk and limits the amount we can borrow against our investment securities. Our master repurchase agreements do not specify the haircut, rather haircuts are determined on an individual repurchase transaction basis. Throughout 2017, haircuts on our pledged collateral remained stable and, as of March 31, 2018 , our weighted average haircut on agency and non-agency securities held as collateral were approximately 5% and 25% , respectively.
We may be required to pledge additional assets to repurchase agreement counterparties in the event the estimated fair value of the existing pledged collateral under such agreements declines and such counterparties demand additional collateral (a margin call), which may take the form of additional securities or cash. Specifically, margin calls would result from a decline in the value of our securities securing our repurchase agreements and prepayments on the mortgages securing such securities. Similarly, if the estimated fair value of our investment securities increases due to changes in interest rates or other factors, counterparties may release collateral back to us. Our repurchase agreements generally provide that the valuations for the securities securing our repurchase agreements are to be obtained from a generally recognized source agreed to by the parties. However, in certain circumstances our lenders have the sole discretion to determine the value of the securities securing our repurchase agreements. In such instances, our lenders are required to act in good faith in making determinations of value. Our repurchase agreements generally provide that in the event of a margin call we must provide additional securities or cash on the same business day that a margin call is made if the lender provides us notice prior to the margin notice deadline on such day.
As of March 31, 2018 , we had met all margin requirements and had unrestricted cash and cash equivalents of $123.4 million and unpledged securities of approximately $267.7 million , excluding unsettled purchases of securities, available to meet margin calls on our repurchase agreements and derivative instruments as of March 31, 2018 .
Although we believe that we will have adequate sources of liquidity available to us through repurchase agreement financing to execute our business strategy, there can be no assurances that repurchase agreement financing will be available to us upon the maturity of our current repurchase agreements to allow us to renew or replace our repurchase agreement financing on favorable terms or at all. If our repurchase agreement lenders default on their obligations to resell the underlying securities back to us at the end of the term, we could incur a loss equal to the difference between the value of the securities and the cash we originally received.
We maintain an interest rate risk management strategy under which we use derivative financial instruments to help manage the adverse impact of interest rate changes on the value of our investment portfolio as well as our cash flows. In particular, we attempt to mitigate the risk of the cost of our short-term variable rate liabilities increasing at a faster rate than the earnings of our long-term assets during a period of rising interest rates. The principal derivative instruments that we use are interest rate swaps, swaptions and short Treasury positions. We may also supplement our hedge portfolio with the use of TBA positions and other instruments.
See Notes 3 and 8 to our consolidated financial statements in this Quarterly Report on Form 10-Q for further details regarding our outstanding interest rate swaps as of March 31, 2018 and the related activity for the three months ended March 31, 2018 .
Our derivative agreements typically require that we pledge/receive collateral on such agreements to/from our counterparties in a similar manner as we are required to under our repurchase agreements. Our counterparties, or the clearing exchange in the case of our centrally cleared interest rate swaps, typically have the sole discretion to determine the value of the derivative instruments and the value of the collateral securing such instruments. In the event of a margin call, we must generally provide additional collateral on the same business day.
Similar to repurchase agreements, our use of derivatives exposes us to counterparty credit risk relating to potential losses that could be recognized in the event that the counterparties to these instruments fail to perform their obligations under the contracts. We minimize this risk by limiting our counterparties to major financial institutions with acceptable credit ratings, by maintaining collateral sufficient to cover the change in market value, and by monitoring positions with individual counterparties.
We did not have an amount at risk with any counterparty related to our non-centrally cleared interest rate swap and swaption agreements greater than 1% of our stockholders’ equity as of both March 31, 2018 and December 31, 2017 .
In the case of centrally cleared interest rate swap contracts, we could be exposed to credit risk if the central clearing agency or a clearing member defaults on its respective obligation to perform under the contract; however, the risk is considered minimal due to initial and daily exchange of mark to market margin requirements and the clearinghouse guarantee fund and other resources that are available in the event of a clearing member default.

55



Notes Payable

CHI finances the acquisition of its healthcare related real estate investments primarily through the use of secured mortgage debt.

TBA Dollar Roll Transactions
We enter into TBA dollar roll transactions as a means of acquiring (long TBAs) or selling (short TBAs) agency RMBS in
our investment portfolio. TBA dollar roll transactions represent a form of off-balance sheet financing and are accounted for as derivative instruments in our accompanying consolidated financial statements in this Quarterly Report on Form 10-Q. Inclusive of our net TBA position as of March 31, 2018 , our total “at risk” leverage, net of unsettled securities, was 6.2x our stockholders' equity.

Under certain market conditions, it may be uneconomical for us to roll our TBA contracts to future months and we may take physical delivery of the underlying securities. If we take physical delivery of a long TBA contract, we would have to fund the total purchase commitment with cash or other financing sources and our liquidity position could be negatively impacted. As of March 31, 2018 , we had a net long TBA position with a cost basis and fair value of the underlying securities of $1.6 billion .

Our TBA dollar roll contracts are also subject to margin requirements governed by the Mortgage-Backed Securities Division (“MBSD”) of the Fixed Income Clearing Corporation and by our prime brokerage agreements, which may establish margin levels in excess of the MBSD. Such provisions require that we establish an initial margin based on the notional value of the TBA contract, which is subject to increase if the estimated fair value of our TBA contract or the estimated fair value of our pledged collateral declines. The MBSD has the sole discretion to determine the value of our TBA contracts and of the collateral pledged securing such contracts. In the event of a margin call, we must generally provide additional collateral on the same business day.

Settlement of our net long TBA obligations by taking delivery of the underlying securities as well as satisfying margin requirements could negatively impact our liquidity position. However, since we do not use TBA dollar roll transactions as our primary source of financing, we believe that we will have adequate sources of liquidity to meet such obligations.
Asset Sales and TBA Eligible Securities

We maintain a portfolio of highly liquid agency RMBS. We may sell our agency RMBS through the TBA market by delivering securities into TBA contracts for the sale of securities, subject to “good delivery” provisions promulgated by the Securities Industry and Financial Markets Association (“SIFMA”). We may also sell agency RMBS that have more unique attributes on a specified basis when such securities trade at a premium over generic TBA securities or if the securities are not otherwise eligible for TBA delivery. Since the agency TBA market is the second most liquid market (second to the U.S. Treasury market), maintaining a significant level of agency RMBS eligible for TBA delivery enhances our liquidity profile and provides price support for our TBA eligible securities in a rising interest rate scenario at or above generic TBA prices. As of March 31, 2018 , approximately 90% of our agency RMBS portfolio was eligible for TBA delivery.

OFF-BALANCE SHEET ARRANGEMENTS
As of March 31, 2018 , we did not maintain any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance, or special purpose or variable interest entities, established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. Furthermore, as of March 31, 2018 , we had not guaranteed any obligations of unconsolidated entities or entered into any commitment or intent to provide funding to any such entities.
FORWARD-LOOKING STATEMENTS

This document contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward looking statements are based on estimates, projections, beliefs and assumptions of our management as of the date of this Annual Report on Form 10-K and involve risks and uncertainties in predicting future results and conditions. Our actual performance could differ materially from those projected or anticipated in any forward looking statements due to a variety of factors, including, without limitation, changes in interest rates, the yield curve or prepayment rates; the availability and terms of financing; changes in the market value of our assets; the effectiveness of our risk mitigation strategies; conditions

56



in the market for mortgage securities and other real estate-related investments; or legislative or regulatory changes that affect our status as a REIT or our exemption from the Investment Company Act of 1940 or that affect the markets in which we participate. A discussion of risks and uncertainties that could cause actual results to differ from any of our forward looking statements is included in this document under Item 1A. Risk Factors. We caution readers not to place undue reliance on our forward looking statements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market risk is the exposure to loss resulting from changes in market factors such as interest rates, foreign currency exchange rates, commodity prices and equity prices. The primary market risks that we are exposed to are interest rate risk, prepayment risk, spread risk, liquidity risk, extension risk, credit risk and risks related to our healthcare and other senior living real estate investments.
Interest Rate Risk
Interest rate risk is highly sensitive to many factors, including governmental monetary and tax policies, domestic and international economic and political considerations and other factors beyond our control.
Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest-earning assets and the interest expense incurred in connection with our interest-bearing liabilities, by affecting the spread between our interest-earning assets and interest-bearing liabilities. Changes in the level of interest rates can also affect the rate of prepayments of our securities and the value of the RMBS that constitute our investment portfolio, which affects our net income and ability to realize gains from the sale of these assets and impacts our ability and the amount that we can borrow against these securities.
We may utilize a variety of financial instruments to limit the effects of changes in interest rates on our operations. The principal instruments that we use are interest rate swaps and options to enter into interest rate swaps. We also utilize forward contracts for the purchase or sale of agency RMBS on a generic pool, or a TBA contract basis and on a non-generic, specified pool basis, and we utilize U.S. Treasury securities and U.S. Treasury futures contracts, primarily through short sales. We may also purchase or write put or call options on TBA securities and we may invest in other types of mortgage derivatives, such as interest and principal-only securities, and synthetic total return swaps. Derivative instruments may expose us to certain risks, including the risk that losses on a hedge position will reduce the funds available for payments to holders of our common stock and that the losses may exceed the amount we invested in the instruments.
Our profitability and the value of our investment portfolio (including derivatives used for hedging purposes) may be adversely affected during any period as a result of changing interest rates including changes in forward yield curves. Primary measures of an instrument's price sensitivity to interest rate fluctuations are its duration and convexity. The duration of our investment portfolio changes with interest rates and tends to increase when interest rates rise and decrease when interest rates fall. The “negative convexity” generally increases the interest rate exposure of our investment portfolio by more than what is measured by duration alone.
We estimate the duration and convexity of our portfolio using both a third-party risk management system and market data. We review the duration estimates from the third-party model and may make adjustments based on our Manager's judgment. These adjustments are intended to, in our Manager's opinion, better reflect the unique characteristics and market trading conventions associated with certain types of securities, such as HARP and lower loan balance securities. These adjustments generally result in shorter durations than what the unadjusted third party model would otherwise produce. Without these adjustments, in rising rate scenarios, the longer unadjusted durations may underestimate price projections on certain securities with slower prepayment characteristics, such as HARP and lower loan balance securities, to a level below those of generic or TBA securities. However, in our Manager's judgment, because these securities are typically deliverable into TBA contracts, the price of these securities is unlikely to drop below the generic or TBA price in rising rate scenarios. The accuracy of the estimated duration of our portfolio and projected agency security prices depends on our Manager's assumptions and judgments. Our Manager may discontinue making these duration adjustments in the future or may choose to make different adjustments. Other models could produce materially different results.
The table below quantifies the estimated changes in net interest income (including periodic interest costs on our interest rate swaps) and the estimated changes in the fair value of our investment portfolio (including derivatives and other securities used for hedging purposes) and in our net asset value should interest rates go up or down by 50 and 100 basis points, assuming instantaneous parallel shifts in the yield curve, and including the impact of both duration and convexity.
All changes in income and value are measured as percentage changes from the projected net interest income, investment portfolio value and net asset value at the base interest rate scenario. The base interest rate scenario assumes interest rates and prepayment projections as of March 31, 2018 and December 31, 2017 . We apply a floor of 0% for the down rate scenarios on

57


our interest bearing liabilities and the variable leg of our interest rate swaps, such that any hypothetical interest rate decrease would have a limited positive impact on our funding costs beyond a certain level.
Actual results could differ materially from estimates, especially in the current market environment. To the extent that these estimates or other assumptions do not hold true, which is likely in a period of high price volatility, actual results will likely differ materially from projections and could be larger or smaller than the estimates in the table below. Moreover, if different models were employed in the analysis, materially different projections could result. Lastly, while the table below reflects the estimated impact of interest rate increases and decreases on a static portfolio, we may from time to time sell any of our agency or non-agency securities as a part of our overall management of our investment portfolio.
Interest Rate Sensitivity (1)
 
 
Percentage Change in Projected
Change in Interest Rate
 
Net Interest Income (2)
 
Portfolio Value (3) (4)
 
Net Asset Value (3) (5)
March 31, 2018
 
 
 
 
 
 
+100 basis points
 
5.5
 %
 
(1.5
)%
 
(10.4
)%
+50 basis points
 
2.4
 %
 
(0.7
)%
 
(4.6
)%
-50 basis points
 
(4.2
)%
 
0.4
 %
 
2.8
 %
-100 basis points
 
(9.3
)%
 
0.4
 %
 
3.0
 %
December 31, 2017
 
 
 
 
 
 
+100 basis points
 
6.8
 %
 
(1.2
)%
 
(8.2
)%
+50 basis points
 
3.9
 %
 
(0.5
)%
 
(3.1
)%
-50 basis points
 
(5.4
)%
 
0.1
 %
 
0.3
 %
-100 basis points
 
(14.0
)%
 
(0.4
)%
 
(2.8
)%
————————
(1)  
Interest rate sensitivity is derived from models that are dependent on inputs and assumptions provided by third parties as well as by our Manager, assumes there are no changes in mortgage spreads and assumes a static portfolio. Actual results could differ materially from these estimates.
(2)  
Represents the estimated dollar change in net interest income expressed as a percentage of net interest income based on asset yields and cost of funds as of such date. It includes the effect of periodic interest costs on our interest rate swaps, but excludes TBA dollar roll income and costs associated with other supplemental hedges, such as swaptions and U.S. Treasury securities or TBA positions. Estimated dollar change in net interest income does not include the one time impact of retroactive “catch-up” premium amortization benefit/cost due to an increase/decrease in the projected CPR.
(3)     Includes the effect of derivatives and other securities used for hedging purposes.
(4)     Estimated change in portfolio value expressed as a percentage of the total fair value of our investment portfolio.
(5)  
Estimated change in net asset value expressed as a percentage of stockholders' equity.
Prepayment Risk
    
Because residential borrowers generally have the option to prepay their mortgage loans at par at any time, we face the risk that we will experience a return of principal on our investments faster than anticipated. Various factors affect the rate at which mortgage prepayments occur, including changes in the level of and directional trends in housing prices, interest rates, general economic conditions, loan age and size, loan-to-value ratio, the location of the property and social and demographic conditions. Additionally, changes to GSE underwriting practices or other governmental programs could also significantly impact prepayment rates or expectations. Also, the pace at which the loans underlying our securities become seriously delinquent or are modified and the timing of GSE repurchases of such loans from our securities can materially impact the rate of prepayments. Generally, prepayments on agency RMBS increase during periods of falling mortgage interest rates and decrease during periods of rising mortgage interest rates. However, this may not always be the case.

We may reinvest principal repayments at yields that are lower or higher than the yield on the repaid investment, thus affecting our net interest income by altering the average yield on our assets. Premiums or discounts associated with the purchase of agency RMBS and non-agency securities of higher credit quality are amortized or accreted into interest income over the projected lives of the securities, including contractual payments and estimated prepayments using the effective interest method. Our policy for estimating prepayment speeds for calculating the effective yield is to evaluate published prepayment data for similar securities, market consensus and current market conditions. If the actual prepayment experienced differs from our estimate of prepayments, we will be required to make an adjustment to the amortization or accretion of premiums and discounts that would have an impact on future income.

58


Spread Risk
When the spread between the market yield on our securities and benchmark interest rates widens, our net asset value could decline if the value of our securities falls by more than the offsetting fair value increases on our hedging instruments, creating what we refer to as “spread risk” or “basis risk.” The spread risk associated with our agency and non-agency securities and the resulting fluctuations in fair value of these securities can occur independent of changes in benchmark interest rates and may relate to other factors impacting the mortgage and fixed income markets, such as actual or anticipated monetary policy actions by the Fed, market liquidity, or changes in required rates of return on different assets. Consequently, while we use interest rate swaps and other supplemental hedges to attempt to protect against moves in interest rates, such instruments typically will not protect our net asset value against spread risk.
The table below quantifies the estimated changes in the fair value of our investment portfolio (including derivatives and other securities used for hedging purposes) and in our net asset value should spreads between our mortgage assets and benchmark interest rates go up or down by 10 and 25 basis points for agency securities and 25 and 50 basis points for non-agency securities. These estimated impacts of spread changes are in addition to our sensitivity to interest rate shocks included in the above interest rate sensitivity table. The table below assumes a spread duration of 5.9 years and 5.5 years for agency RMBS and 4.8 years and 4.7 years for non-agency securities based on interest rates and securities prices as of March 31, 2018 and December 31, 2017 , respectively. However, our portfolio's sensitivity of spread changes will vary with changes in interest rates and in the size and composition of our investment portfolio. Therefore, actual results could differ materially from our estimates.
Agency RMBS Spread Sensitivity (1)
 
 
Percentage Change in Projected
Change in Spread
 
Portfolio Market Value (2) (3)
 
Net Asset
Value (2) (4)
March 31, 2018
 
 
 
 
-25 basis points
 
1.3
 %
 
8.5
 %
-10 basis points
 
0.5
 %
 
3.4
 %
+10 basis points
 
(0.5
)%
 
(3.4
)%
+25 basis points
 
(1.3
)%
 
(8.5
)%
December 31, 2017
 
 
 
 
-25 basis points
 
1.2
 %
 
7.9
 %
-10 basis points
 
0.5
 %
 
3.2
 %
+10 basis points
 
(0.5
)%
 
(3.2
)%
+25 basis points
 
(1.2
)%
 
(7.9
)%
Non-Agency Securities Spread Sensitivity (1)
 
 
Percentage Change in Projected
Change in Spread
 
Portfolio Market Value (2) (3)
 
Net Asset
Value (2) (4)
March 31, 2018
 
 
 
 
-50 basis points
 
0.3
 %
 
2.2
 %
-25 basis points
 
0.2
 %
 
1.1
 %
+25 basis points
 
(0.2
)%
 
(1.1
)%
+50 basis points
 
(0.3
)%
 
(2.2
)%
December 31, 2017
 
 
 
 
-50 basis points
 
0.3
 %
 
2.2
 %
-25 basis points
 
0.2
 %
 
1.1
 %
+25 basis points
 
(0.2
)%
 
(1.1
)%
+50 basis points
 
(0.3
)%
 
(2.2
)%

59


————————
(1)  
Spread sensitivity is derived from models that are dependent on inputs and assumptions provided by third parties as well as by our Manager, and assumes there are no changes in interest rates and a static portfolio. Actual results could differ materially from these estimates.
(2)      Includes the effect of derivatives and other instruments used for hedging purposes.
(3)      Estimated dollar change in portfolio market value expressed as a percentage of the total fair value of our investment portfolio as of such date.
(4)  
Estimated dollar change in net asset value expressed as a percentage of stockholders' equity as of such date.
Liquidity Risk
Our primary liquidity risk arises from financing long-term assets with shorter-term borrowings. Our assets that are pledged to secure repurchase agreements are agency and non-agency securities and cash. As of March 31, 2018 , we had unrestricted cash and cash equivalents of $123.4 million and unpledged securities of approximately $267.7 million , excluding unsettled purchases of securities, available to meet margin calls on our repurchase agreements, derivative instruments and for other corporate purposes. However, should the value of our securities pledged as collateral or the value of our derivative instruments suddenly decrease, margin calls could increase, causing an adverse change in our liquidity position. Further, there is no assurance that we will always be able to renew (or roll) our repurchase agreements. In addition, our counterparties have the option to increase our haircuts (margin requirements) on the assets we pledge, thereby reducing the amount that can be borrowed against an asset even if they agree to renew or roll the repurchase agreement. Significantly higher haircuts can reduce our ability to leverage our portfolio or even force us to sell assets, especially if correlated with asset price declines or faster prepayment rates on our assets.
In addition, we may utilize TBA dollar roll transactions as a means of acquiring and financing purchases of agency RMBS. Under certain economic conditions we may be unable to roll our TBA dollar roll transactions prior to the settlement date and we may have to take physical delivery of the underlying securities and settle our obligations for cash, which could negatively impact our liquidity position, result in defaults or force us to sell assets under adverse conditions.
Extension Risk
The projected weighted-average life and estimated duration (or interest rate sensitivity) of our investments is based on our Manager’s assumptions regarding the rates at which borrowers will prepay or default on the underlying mortgage loans. In general, we use interest rate swaps to help manage our funding cost on our investments in the event that interest rates rise. These swaps allow us to reduce our funding exposure on the notional amount of the swap for a specified period of time by establishing a fixed rate to pay in exchange for receiving a floating rate that generally tracks our financing costs under our repurchase agreements.
However, if prepayment rates decrease in a rising interest rate environment, the average life or duration of our fixed-rate assets generally extends. This could have a negative impact on our results from operations, as our interest rate swap maturities are fixed and will, therefore, cover a smaller percentage of our funding exposure on our mortgage assets to the extent that their average lives increase due to slower prepayments. This situation may also cause the market value of our securities collateralized by fixed rate mortgages to decline by more than otherwise would be the case while most of our hedging instruments (with the exception of short TBA mortgage positions, interest-only securities and certain other supplemental hedging instruments) would not receive any incremental offsetting gains. In extreme situations, we may be forced to sell assets to maintain adequate liquidity, which could cause us to incur realized losses.
Credit Risk
We are exposed to credit risk related to our non-agency investments, certain derivative transactions, and our collateral held by funding and derivative counterparties. We accept credit exposure at levels we deem prudent as an integral part of our diversified investment strategy. Therefore, we may retain all or a portion of the credit risk on our investments. We seek to manage this risk through prudent asset selection, pre-acquisition due diligence, post-acquisition performance monitoring, sale of assets where we have identified negative credit trends and the use of various types of credit enhancements. We may also use non-recourse financing, which limits our exposure to credit losses to the specific pool of mortgages subject to the non-recourse financing. Our overall management of credit exposure may also include the use of credit default swaps or other financial derivatives that we believe are appropriate. Additionally, we intend to vary the percentage mix of our investments in an effort to actively adjust our credit exposure and to improve the risk/return profile of our investment portfolio. Our credit risk related to certain derivative transactions is largely mitigated through daily adjustments to collateral pledged based on changes in market value and we limit our counterparties to major financial institutions with acceptable credit ratings. There is no guarantee that our efforts to manage credit risk will be successful and we could suffer significant losses if credit performance is worse than our expectations or if economic conditions worsen.
Risks Related to Healthcare and Other Senior Living Investments.

60


Our healthcare and other senior living real estate investments are exposed to counterparty risk, including, for our equity investments, the ongoing ability of the facility operator to satisfy its lease obligations, or, for potential debt investments, the ability of the borrower to make principal and interest payments. As such, our real estate investments are heavily dependent upon the successful operation of the facilities by our counterparties. These operations may be impacted by factors specific to the healthcare space, including, but not limited to, regulatory changes, government reimbursement reductions and revisions to licensure or certification requirements. Additionally, real estate investments are relatively illiquid, generally cannot be sold quickly, and may be subject to impairment charges based on factors such as market conditions and operator performance. We seek to manage these risks through detailed pre-transaction due diligence of target properties and associated operators, prudent asset selection, and active post-acquisition monitoring.

Item 4. Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Securities Exchange Act of 1934, as amended (the “Exchange Act”) reports is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure based on the definition of “disclosure controls and procedures” as promulgated under the Exchange Act and the rules and regulations thereunder. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

We, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2018 . Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There have been no changes in our “internal control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during our fiscal quarter ended March 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  



61



PART II
Item 1. Legal Proceedings
 
From time to time, we may be involved in various claims and legal actions arising in the ordinary course of business. As
of March 31, 2018 , we are not party to any material litigation or legal proceedings, or to the best of our knowledge, any threatened litigation or legal proceedings, which, in our opinion, individually or in the aggregate, would have a material adverse effect on our results of operations or financial condition.
Item 1A. Risk Factors

There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2017.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults upon Senior Securities

None.
Item 4. Mine Safety Disclosures
None.

Item 5. Other Information
None.
 
Item 6. Exhibits and Financial Statement Schedules
Exhibit No. 
 
Description 
*3.1
 
 
 
 
3.2
 
 
 
 
*3.3
 
 
 
 
*4.1
 
 
 
 
*4.2
 
 
 
 
*4.3
 
 
 
 
*4.4
 
 
 
 
31.1
 
 
 
 
31.2
 
 
 
 
32
 
 
 
 
101.INS**
 
XBRL Instance Document
 
 
 
101.SCH**
 
XBRL Taxonomy Extension Schema Document
 
 
 
101.CAL**
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
101.LAB**
 
XBRL Taxonomy Extension Labels Linkbase Document
 
 
 
101.PRE**
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
101.DEF**
 
XBRL Taxonomy Extension Definition Linkbase Document
————————
*    Previously filed
**     This exhibit is being furnished rather than filed, and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K
†    Management contract or compensatory plan or arrangement

62




SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
MTGE Investment Corp.

By:
 
/s/    SEAN P. REID
 
 
SEAN P. REID
 
 
Chief Executive Officer
(Principal Executive Officer)
 
Date: May 10, 2018
By:
 
/s/    DONALD W. HOLLEY
 
 
DONALD W. HOLLEY
 
 
Chief Financial Officer and
Senior Vice President (Principal Financial Officer)
 
Date: May 10, 2018






63
Exhibit 3.2

MTGE INVESTMENT CORP.

AMENDED AND RESTATED BYLAWS
(as amended)

ARTICLE I
OFFICES

Section 1.     PRINCIPAL OFFICE . The principal office of the Corporation in the State of Maryland shall be located at such place as the Board of Directors may designate.

Section 2.     ADDITIONAL OFFICES . The Corporation may have additional offices, including a principal executive office, at such places as the Board of Directors may from time to time determine or the business of the Corporation may require.

ARTICLE II
MEETINGS OF STOCKHOLDERS

Section 1.     PLACE . All meetings of stockholders shall be held at the principal executive office of the Corporation or at such other place as shall be set in accordance with these Bylaws and stated in the notice of the meeting.

Section 2.     ANNUAL MEETING . An annual meeting of stockholders for the election of directors and the transaction of any business within the powers of the Corporation shall be held on the date and at the time and place set by the Board of Directors. The Corporation shall hold its first annual meeting of stockholders beginning with the year 2012.

Section 3.     SPECIAL MEETINGS .

(a) General . Each of (i) the chair of the board, (ii) the chief executive officer pursuant to a resolution adopted by a majority of the Board of Directors or by a committee of the Board of Directors that has been duly designated by the Board of Directors and whose powers and authority include the power to call such meetings and (iii) the Board of Directors may call a special meeting of stockholders. Except as provided in subsection (b)(4) of this Section 3, a special meeting of stockholders shall be held on the date and at the time and place set by the chair of the board, chief executive officer or Board of Directors, whoever has called the meeting. Subject to subsection (b) of this Section 3, a special meeting of stockholders shall also be called by the secretary of the Corporation to act on any matter that may properly be considered at a meeting of stockholders upon the written request of stockholders entitled to cast not less than a majority of all the votes entitled to be cast on such matter at such meeting.

(b) Stockholder-Requested Special Meetings . (1) Any stockholder of record seeking to have stockholders request a special meeting shall, by sending written notice to the secretary (the “Record Date Request Notice”) by registered mail, return receipt requested, request the Board of Directors to fix a record date to determine the stockholders entitled to request a special meeting (the “Request Record Date”). The Record Date Request Notice shall set forth the purpose of the meeting and the matters proposed to be acted on at it, shall be signed by one or more stockholders of record as of the date of signature (or their agents duly authorized in a writing accompanying the Record Date Request Notice), shall bear the date of signature of each such stockholder (or such agent) and shall set forth all information relating to each such stockholder and each matter proposed to be acted on at the meeting that would be required to be disclosed in connection with the solicitation of proxies for the election of directors in an election contest (even if an election contest is not involved), or would otherwise be required in connection with such a solicitation, in each case pursuant to Regulation 14A (or any successor provision) under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (the “Exchange Act”). Upon receiving the Record Date Request Notice, the Board of Directors may fix a Request Record Date. The Request Record Date shall not precede and shall not be more than ten days after the close of business on the date on which the resolution fixing the Request Record Date is adopted by the Board of Directors. If the Board of Directors, within ten days after the date on which a valid Record Date Request Notice is received, fails to adopt a resolution fixing the Request Record Date, the Request Record Date shall be the close of business on the tenth day after the first date on which a Record Date Request Notice is received by the secretary.

(1) In order for any stockholder to request a special meeting to act on any matter that may




properly be considered at a meeting of stockholders, one or more written requests for a special meeting (collectively, the “Special Meeting Request”) signed by stockholders of record (or their agents duly authorized in a writing accompanying the request) as of the Request Record Date entitled to cast not less than a majority of all of the votes entitled to be cast on such matter at such meeting (the “Special Meeting Percentage”) shall be delivered to the secretary. In addition, the Special Meeting Request shall (a) set forth the purpose of the meeting and the matters proposed to be acted on at it (which shall be limited to those lawful matters set forth in the Record Date Request Notice received by the secretary), (b) bear the date of signature of each such stockholder (or such agent) signing the Special Meeting Request, (c) set forth (i) the name and address, as they appear in the Corporation’s books, of each stockholder signing such request (or on whose behalf the Special Meeting Request is signed), (ii) the class, series and number of all shares of stock of the Corporation which are owned (beneficially or of record) by each such stockholder and (iii) the nominee holder for, and number of, shares of stock of the Corporation owned beneficially but not of record by such stockholder, (d) be sent to the secretary by registered mail, return receipt requested, and (e) be received by the secretary within 60 days after the Request Record Date. Any requesting stockholder (or agent duly authorized in a writing accompanying the revocation of the Special Meeting Request) may revoke his, her or its request for a special meeting at any time by written revocation delivered to the secretary.

(2) The secretary shall inform the requesting stockholders of the reasonably estimated cost of preparing and mailing or delivering the notice of the meeting (including the Corporation’s proxy materials). The secretary shall not be required to call a special meeting upon stockholder request and such meeting shall not be held unless, in addition to the documents required by paragraph (2) of this Section 3(b), the secretary receives payment of such reasonably estimated cost prior to the preparation and mailing or delivery of such notice of the meeting.

(3) In the case of any special meeting called by the secretary upon the request of stockholders (a “Stockholder-Requested Meeting”), such meeting shall be held at such place, date and time as may be designated by the Board of Directors; provided , however, that the date of any Stockholder-Requested Meeting shall be not more than 90 days after the record date for such meeting (the “Meeting Record Date”); and provided further that if the Board of Directors fails to designate, within ten days after the date that a valid Special Meeting Request is actually received by the secretary (the “Delivery Date”), a date and time for a Stockholder-Requested Meeting, then such meeting shall be held at 2:00 p.m., local time, on the 90th day after the Meeting Record Date or, if such 90th day is not a Business Day (as defined below), on the first preceding Business Day; and provided further that in the event that the Board of Directors fails to designate a place for a Stockholder-Requested Meeting within ten days after the Delivery Date, then such meeting shall be held at the principal executive office of the Corporation. In fixing a date for a Stockholder-Requested Meeting, the Board of Directors may consider such factors as it deems relevant, including, without limitation, the nature of the matters to be considered, the facts and circumstances surrounding any request for the meeting and any plan of the Board of Directors to call an annual meeting or a special meeting. In the case of any Stockholder-Requested Meeting, if the Board of Directors fails to fix a Meeting Record Date that is a date within 30 days after the Delivery Date, then the close of business on the 30th day after the Delivery Date shall be the Meeting Record Date. The Board of Directors may revoke the notice for any Stockholder-Requested Meeting in the event that the requesting stockholders fail to comply with the provisions of paragraph (3) of this Section 3(b).

(4) If written revocations of the Special Meeting Request have been delivered to the secretary and the result is that stockholders of record (or their agents duly authorized in writing), as of the Request Record Date, entitled to cast less than the Special Meeting Percentage have delivered, and not revoked, requests for a special meeting on the matter to the secretary: (i) if the notice of meeting has not already been delivered, the secretary shall refrain from delivering the notice of the meeting and send to all requesting stockholders who have not revoked such requests written notice of any revocation of a request for a special meeting on the matter, or (ii) if the notice of meeting has been delivered and if the secretary first sends to all requesting stockholders who have not revoked requests for a special meeting on the matter written notice of any revocation of a request for the special meeting and written notice of the Corporation’s intention to revoke the notice of the meeting or for the chair of the meeting to adjourn the meeting without action on the matter, (A) the secretary may revoke the notice of the meeting at any time before ten days before the commencement of the meeting or (B) the chair of the meeting may call the meeting to order and adjourn the meeting without acting on the matter. Any request for a special meeting received after a revocation by the secretary of a notice of a meeting shall be considered a request for a new special meeting.

(5) The chair of the board, chief executive officer or Board of Directors may appoint regionally or nationally recognized independent inspectors of elections to act as the agent of the Corporation for the purpose of promptly performing a ministerial review of the validity of any purported Special Meeting Request received by the secretary. For the purpose of permitting the inspectors to perform such review, no such purported Special Meeting Request shall be deemed to have been delivered to the secretary until the earlier of (i) five Business Days after receipt by the secretary of such purported request and (ii) such date as the independent inspectors certify to the Corporation that the valid




requests received by the secretary represent, as of the Request Record Date, stockholders of record entitled to cast not less than the Special Meeting Percentage. Nothing
contained in this paragraph (6) shall in any way be construed to suggest or imply that the Corporation or any stockholder shall not be entitled to contest the validity of any request, whether during or after such five Business Day period, or to take any other action (including, without limitation, the commencement, prosecution or defense of any litigation with respect thereto, and the seeking of injunctive relief in such litigation).

(6) For purposes of these Bylaws, “Business Day” shall mean any day other than a Saturday, a Sunday or a day on which banking institutions in the State of Maryland are authorized or obligated by law or executive order to close.

Section 4.     NOTICE . Not less than ten nor more than 90 days before each meeting of stockholders, the secretary shall give to each stockholder entitled to vote at such meeting and to each stockholder not entitled to vote who is entitled to notice of the meeting notice in writing or by electronic transmission stating the time and place of the meeting and, in the case of a special meeting or as otherwise may be required by any statute, the purpose for which the meeting is called, by mail, by presenting it to such stockholder personally, by leaving it at the stockholder’s residence or usual place of business or by any other means permitted by Maryland law. If mailed, such notice shall be deemed to be given when deposited in the United States mail addressed to the stockholder at the stockholder’s address as it appears on the records of the Corporation, with postage thereon prepaid. If transmitted electronically, such notice shall be deemed to be given when transmitted to the stockholder by an electronic transmission to any address or number of the stockholder at which the stockholder receives electronic transmissions. The Corporation may give a single notice to all stockholders who share an address, which single notice shall be effective as to any stockholder at such address, unless such stockholder objects to receiving such single notice or revokes a prior consent to receiving such single notice. Failure to give notice of any meeting to one or more stockholders, or any irregularity in such notice, shall not affect the validity of any meeting fixed in accordance with this Article II or the validity of any proceedings at any such meeting.

Subject to Section 11(a) of this Article II, any business of the Corporation may be transacted at an annual meeting of stockholders without being specifically designated in the notice, except such business as is required by any statute to be stated in such notice. No business shall be transacted at a special meeting of stockholders except as specifically designated in the notice. The Corporation may postpone or cancel a meeting of stockholders by making a public announcement (as defined in Section 11(c)(3) of this Article II) of such postponement or cancellation prior to the meeting. Notice of the date, time and place to which the meeting is postponed shall be given not less than ten days prior to such date and otherwise in the manner set forth in this section.

Section 5.     ORGANIZATION AND CONDUCT . Every meeting of stockholders shall be conducted by the chair of the board or, in the case of a vacancy in the office or absence of the chair of the board, by the chief executive officer or, in the case of a vacancy in the office or absence of the chair of the board and the chief executive officer, by any executive vice president. The secretary, or, in the secretary’s absence, an assistant secretary, or, in the absence of both the secretary and assistant secretaries, an individual appointed by the Board of Directors or, in the absence of such appointment, an individual appointed by the chair of the meeting shall act as secretary. In the event that the secretary presides at a meeting of stockholders, an assistant secretary, or, in the absence of all assistant secretaries, an individual appointed by the Board of Directors or the chair of the meeting, shall record the minutes of the meeting. The order of business and all other matters of procedure at any meeting of stockholders shall be determined by the chair of the meeting. The chair of the meeting may prescribe such rules, regulations and procedures and take such action as, in the discretion of the chair and without any action by the stockholders, are appropriate for the proper conduct of the meeting, including, without limitation, (a) restricting admission to the time set for the commencement of the meeting; (b) limiting attendance at the meeting to stockholders of record of the Corporation, their duly authorized proxies and such other individuals as the chair of the meeting may determine; (c) limiting participation at the meeting on any matter to stockholders of record of the Corporation entitled to vote on such matter, their duly authorized proxies and other such individuals as the chair of the meeting may determine; (d) limiting the time allotted to questions or comments; (e) determining when and for how long the polls should be opened and when the polls should be closed; (f) maintaining order and security at the meeting; (g) removing any stockholder or any other individual who refuses to comply with meeting procedures, rules or guidelines as set forth by the chair of the meeting; (h) concluding a meeting or recessing or adjourning the meeting to a later date and time and at a place announced at the meeting; and (i) complying with any state and local laws and regulations concerning safety and security. Unless otherwise determined by the chair of the meeting, meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure.

Section 6.     QUORUM . At any meeting of stockholders, the presence in person or by proxy of




stockholders entitled to cast a majority of all the votes entitled to be cast at such meeting on any matter shall constitute a quorum; but this section shall not affect any requirement under any statute or the charter of the Corporation for the vote necessary for the approval of any matter. If such quorum is not established at any meeting of the stockholders, the chair of the meeting may adjourn the meeting sine die or from time to time to a date not more than 120 days after the original record date without notice other than announcement at the meeting. At such adjourned meeting at which a quorum shall be present, any business may be transacted which might have been transacted at the meeting as originally notified.

The stockholders present either in person or by proxy, at a meeting which has been duly called and at which a quorum has been established, may continue to transact business until adjournment, notwithstanding the withdrawal from the meeting of enough stockholders to leave fewer than would be required to establish a quorum.

Section 7.     VOTING . A majority of all the votes cast at a meeting of stockholders duly called and at which a quorum is present shall be sufficient to elect a director; provided that if the number of nominees exceeds the number of directors to be elected, each director shall be elected by the vote of a plurality of the votes cast. For purposes of this Section, a majority of the votes cast means that the number of votes cast “for” a director nominee must exceed the votes cast “against” that nominee. Each share may be voted for as many individuals as there are directors to be elected and for whose election the share is entitled to be voted. A majority of the votes cast at a meeting of stockholders duly called and at which a quorum is present shall be sufficient to approve any other matter which may properly come before the meeting, unless more than a majority of the votes cast is required by statute, the charter of the Corporation or these Bylaws. Unless otherwise provided by statute or by the charter, each outstanding share, regardless of class, shall be entitled to one vote on each matter submitted to a vote at a meeting of stockholders. Voting on any question or in any election may be viva voce unless the chair of the meeting shall order that voting be by ballot or otherwise.

Section 8.     PROXIES . A holder of record of shares of stock of the Corporation may cast votes in person or by proxy executed by the stockholder or by the stockholder’s duly authorized agent in any manner permitted by law. Such proxy or evidence of authorization of such proxy shall be filed with the secretary of the Corporation before or at the meeting. No proxy shall be valid more than eleven months after its date unless otherwise provided in the proxy.

Section 9.     VOTING OF STOCK BY CERTAIN HOLDERS . Stock of the Corporation registered in the name of a corporation, partnership, trust, limited liability company or other entity, if entitled to be voted, may be voted by the president or a vice president, general partner, trustee or managing member thereof, as the case may be, or a proxy appointed by any of the foregoing individuals, unless some other person who has been appointed to vote such stock pursuant to a bylaw or a resolution of the governing body of such corporation or other entity or agreement of the partners of a partnership presents a certified copy of such bylaw, resolution or agreement, in which case such person may vote such stock. Any director or fiduciary may vote stock registered in the name of such person in the capacity of such director or fiduciary, either in person or by proxy.

Shares of stock of the Corporation directly or indirectly owned by it shall not be voted at any meeting and shall not be counted in determining the total number of outstanding shares entitled to be voted at any given time, unless they are held by it in a fiduciary capacity, in which case they may be voted and shall be counted in determining the total number of outstanding shares at any given time.

The Board of Directors may adopt by resolution a procedure by which a stockholder may certify in writing to the Corporation that any shares of stock registered in the name of the stockholder are held for the account of a specified person other than the stockholder. The resolution shall set forth the class of stockholders who may make the certification, the purpose for which the certification may be made, the form of certification and the information to be contained in it; if the certification is with respect to a record date, the time after the record date within which the certification must be received by the Corporation; and any other provisions with respect to the procedure which the Board of Directors considers necessary or desirable. On receipt by the Corporation of such certification, the person specified in the certification shall be regarded as, for the purposes set forth in the certification, the holder of record of the specified stock in place of the stockholder who makes the certification.

Section 10.     INSPECTORS . The Board of Directors or the chair of the meeting may appoint, before or at the meeting, one or more inspectors for the meeting and any successor to the inspector. Except as otherwise provided by the chair of the meeting, the inspectors, if any, shall determine the number of shares of stock represented at the meeting, in person or by proxy, and the validity and effect of proxies, (ii) receive and tabulate all votes, ballots or consents, (iii) report such tabulation to the chair of the meeting, (iv) hear and determine all challenges and questions arising in connection with the right to vote, and (v) do such acts as are proper to fairly conduct the election or vote. Each




such report shall be in writing and signed by the inspector or by a majority of them if there is more than one inspector acting at such meeting. If there is more than one inspector, the report of a majority shall be the report of the inspectors. The report of the inspector or inspectors on the number of shares represented at the meeting and the results of the voting shall be prima facie evidence thereof.

Section 11.      ADVANCE NOTICE OF STOCKHOLDER NOMINEES FOR DIRECTOR AND OTHER STOCKHOLDER PROPOSALS .

(a) Annual Meetings of Stockholders . (1) Nominations of individuals for election to the Board of Directors and the proposal of other business to be considered by the stockholders may be made at an annual meeting of stockholders (i) pursuant to the Corporation’s notice of meeting, (ii) by or at the direction of the Board of Directors or (iii) by any stockholder of the Corporation who was a stockholder of record both at the time of giving of notice by the stockholder as provided for in this Section 11(a) and at the time of the annual meeting, who is entitled to vote at the meeting in the election of each individual so nominated or on any such other business and who has complied with this Section 11(a).

(1) For any nomination or other business to be properly brought before an annual meeting by a stockholder pursuant to clause (iii) of paragraph (a)(1) of this Section 11, the stockholder must have given timely notice thereof in writing to the secretary of the Corporation and any such other business must otherwise be a proper matter for action by the stockholders. To be timely, a stockholder’s notice shall set forth all information required under this Section 11 and shall be delivered to the secretary at the principal executive office of the Corporation not earlier than the 150th day nor later than 5:00 p.m., Eastern Time, on the 120th day prior to the first anniversary of the date of the proxy statement (as defined in Section 11(c)(3) of this Article II) for the preceding year’s annual meeting; provided, however, that in connection with the Corporation’s first annual meeting or in the event that the date of the annual meeting is advanced or delayed by more than 30 days from the first anniversary of the date of the preceding year’s annual meeting, notice by the stockholder to be timely must be so delivered not earlier than the 150th day prior to the date of such annual meeting and not later than 5:00 p.m., Eastern Time, on the later of the 120th day prior to the date of such annual meeting, as originally convened, or the tenth day following the day on which public announcement of the date of such meeting is first made. The public announcement of a postponement or adjournment of an annual meeting shall not commence a new time period for the giving of a stockholder’s notice as described above.

(2)
Such stockholder’s notice shall set forth:

(i) as to each individual whom the stockholder proposes to nominate for election or reelection as a director (each, a “Proposed Nominee”), all information relating to the Proposed Nominee that would be required to be disclosed in connection with the solicitation of proxies for the election of the Proposed Nominee as a director in an election contest (even if an election contest is not involved), or would otherwise be required in connection with such solicitation, in each case pursuant to Regulation 14A (or any successor provision) under the Exchange Act;

(ii)
as to any other business that the stockholder proposes to bring
before the meeting, a description of such business, the stockholder’s reasons for proposing such business at the meeting and any material interest in such business of such stockholder or any Stockholder Associated Person (as defined below), individually or in the aggregate, including any anticipated benefit to the stockholder or the Stockholder Associated Person therefrom;

(iii) as to the stockholder giving the notice, any Proposed Nominee and any Stockholder Associated Person,

(A) the class, series and number of all shares of stock or other securities of the Corporation or any affiliate thereof (collectively, the “Company Securities”), if any, which are owned (beneficially or of record) by such stockholder, Proposed Nominee or Stockholder Associated Person, the date on which each such Company Security was acquired and the investment intent of such acquisition, and any short interest (including any opportunity to profit or share in any benefit from any decrease in the price of such stock or other security) in any Company Securities of any such person,

(B) the nominee holder for, and number of, any Company Securities owned beneficially but not of record by such stockholder, Proposed Nominee or Stockholder Associated Person,

(C) whether and the extent to which such stockholder, Proposed Nominee




or Stockholder Associated Person, directly or indirectly (through brokers, nominees or otherwise), is subject to or during the last six months has engaged in any hedging, derivative or other transaction or series of transactions or entered into any other agreement, arrangement or understanding (including any short interest, any borrowing or lending of securities or any proxy or voting agreement), the effect or intent of which is to (I) manage risk or benefit of changes in the price of Company Securities for such stockholder, Proposed Nominee or Stockholder Associated Person or (II) increase or decrease the voting power of such stockholder, Proposed Nominee or Stockholder Associated Person in the Corporation or any affiliate thereof disproportionately to such person’s economic interest in the Company Securities, and

(D) any substantial interest, direct or indirect (including, without limitation, any existing or prospective commercial, business or contractual relationship with the Corporation), by security holdings or otherwise, of such stockholder, Proposed Nominee or Stockholder Associated Person, in the Corporation or any affiliate thereof, other than an interest arising from the ownership of Company Securities where such stockholder, Proposed Nominee or Stockholder Associated Person receives no extra or special benefit not shared on a pro rata basis by all other holders of the same class or series;

(iv) as to the stockholder giving the notice, any Stockholder Associated Person with an interest or ownership referred to in clauses (ii) or (iii) of this paragraph (3) of this Section 11(a) and any Proposed Nominee,
(A) the name and address of such stockholder, as they appear on the Corporation’s stock ledger, and the current name and business address, if different, of each such Stockholder Associated Person and any Proposed Nominee and

(B) the investment strategy or objective, if any, of such stockholder and each such Stockholder Associated Person who is not an individual and a copy of the prospectus, offering memorandum or similar document, if any, provided to investors or potential investors in such stockholder and each such Stockholder Associated Person;

(v) the name and address of any person who contacted or was contacted by the stockholder giving the notice or any Stockholder Associated Person about the Proposed Nominee or other business proposal prior to the date of such stockholder’s notice; and

(vi) to the extent known by the stockholder giving the notice, the name and address of any other stockholder supporting the nominee for election or reelection as a director or the proposal of other business on the date of such stockholder’s notice.

(3) Such stockholder’s notice shall, with respect to any Proposed Nominee, be accompanied by a certificate executed by the Proposed Nominee (i) certifying that such Proposed Nominee (a) is not, and will not become, a party to any agreement, arrangement or understanding with any person or entity other than the Corporation in connection with service or action as a director that has not been disclosed to the Corporation and (b) will serve as a director of the Corporation if elected; and (ii) attaching a completed Proposed Nominee questionnaire (which questionnaire shall be provided by the Corporation, upon request, to the stockholder providing the notice and shall include all information relating to the Proposed Nominee that would be required to be disclosed in connection with the solicitation of proxies for the election of the Proposed Nominee as a director in an election contest (even if an election contest is not involved), or would otherwise be required in connection with such solicitation, in each case pursuant to Regulation 14A (or any successor provision) under the Exchange Act and the rules thereunder, or would be required pursuant to the rules of any national securities exchange on which any securities of the Corporation are listed or over-the-counter market on which any securities of the Corporation are traded).

(4) Notwithstanding anything in this subsection (a) of this Section 11 to the contrary, in the event that the number of directors to be elected to the Board of Directors is increased, and there is no public announcement of such action at least 130 days prior to the first anniversary of the date of the proxy statement (as defined in Section 11(c)(3) of this Article II) for the preceding year’s annual meeting, a stockholder’s notice required by this Section 11(a) shall also be considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be delivered to the secretary at the principal executive office of the Corporation not later than 5:00 p.m., Eastern Time, on the tenth day following the day on which such public announcement is first made by the Corporation.

(5) For purposes of this Section 11, “Stockholder Associated Person” of any stockholder shall mean (i) any person acting in concert with such stockholder, (ii) any beneficial owner of shares of stock of the




Corporation owned of record or beneficially by such stockholder (other than a stockholder that is a depositary) and (iii) any person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such stockholder or such Stockholder Associated Person.

(b) Special Meetings of Stockholders . Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the Corporation’s notice of meeting. Nominations of individuals for election to the Board of Directors may be made at a special meeting of stockholders at which directors are to be elected only (i) by or at the direction of the Board of Directors or (ii) provided that the special meeting has been called in accordance with Section 3(a) of this Article II for the purpose of electing directors, by any stockholder of the Corporation who is a stockholder of record both at the time of giving of notice provided for in this Section 11 and at the time of the special meeting, who is entitled to vote at the meeting in the election of each individual so nominated and who has complied with the notice procedures set forth in this Section 11. In the event the Corporation calls a special meeting of stockholders for the purpose of electing one or more individuals to the Board of Directors, any stockholder may nominate an individual or individuals (as the case may be) for election as a director as specified in the Corporation’s notice of meeting, if the stockholder’s notice, containing the information required by paragraph (a)(3) of this Section 11, is delivered to the secretary at the principal executive office of the Corporation not earlier than the 120th day prior to such special meeting and not later than 5:00 p.m., Eastern Time, on the later of the 90th day prior to such special meeting or the tenth day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. The public announcement of a postponement or adjournment of a special meeting shall not commence a new time period for the giving of a stockholder’s notice as described above.

(c) General . (1) If information submitted pursuant to this Section 11 by any stockholder proposing a nominee for election as a director or any proposal for other business at a meeting of stockholders shall be inaccurate in any material respect, such information may be deemed not to have been provided in accordance with this Section 11. Any such stockholder shall notify the Corporation of any inaccuracy or change (within two Business Days of becoming aware of such inaccuracy or change) in any such information. Upon written request by the secretary or the Board of Directors, any such stockholder shall provide, within five Business Days of delivery of such request (or such other period as may be specified in such request), (A) written verification, satisfactory, in the discretion of the Board of Directors or any authorized officer of the Corporation, to demonstrate the accuracy of any information submitted by the stockholder pursuant to this Section 11, and (B) a written update of any information (including, if requested by the Corporation, written confirmation by such stockholder that it continues to intend to bring such nomination or other business proposal before the meeting) submitted by the stockholder pursuant to this Section 11 as of an earlier date. If a stockholder fails to provide such written verification or written update within such period, the information as to which written verification or a written update was requested may be deemed not to have been provided in accordance with this Section 11.

(1) Only such individuals who are nominated in accordance with this Section 11 shall be eligible for election by stockholders as directors, and only such business shall be conducted at a meeting of stockholders as shall have been brought before the meeting in accordance with this Section 11. The chair of the meeting shall have the power to determine whether a nomination or any other business proposed to be brought before the meeting was made or proposed, as the case may be, in accordance with this Section 11.

(2) For purposes of this Section 11, “the date of the proxy statement” shall have the same meaning as “the date of the company’s proxy statement released to shareholders” as used in Rule 14a-8(e) promulgated under the Exchange Act, as interpreted by the Securities and Exchange Commission from time to time. “Public announcement” shall mean disclosure (A) in a press release reported by the Dow Jones News Service, Associated Press, Business Wire, PR Newswire or other widely circulated news or wire service or (B) in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to the Exchange Act.

(3) Notwithstanding the foregoing provisions of this Section 11, a stockholder shall also comply with all applicable requirements of state law and of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth in this Section 11. Nothing in this Section 11 shall be deemed to affect any right of a stockholder to request inclusion of a proposal in, or the right of the Corporation to omit a proposal from, the Corporation’s proxy statement pursuant to Rule 14a-8 (or any successor provision) under the Exchange Act. Nothing in this Section 11 shall require disclosure of revocable proxies received by the stockholder or Stockholder Associated Person pursuant to a solicitation of proxies after the filing of an effective Schedule 14A by such stockholder or Stockholder Associated Person under Section 14(a) of the Exchange Act.

Section 12.     CONTROL SHARE ACQUISITION ACT . Notwithstanding any other provision of the




charter of the Corporation or these Bylaws, Title 3, Subtitle 7 of the Maryland General Corporation Law, or any successor statute (the “MGCL”), shall not apply to any acquisition by any person of shares of stock of the Corporation. This section may be repealed, in whole or in part, at any time, whether before or after an acquisition of control shares and, upon such repeal, may, to the extent provided by any successor bylaw, apply to any prior or subsequent control share acquisition.

ARTICLE III DIRECTORS

Section 1.     GENERAL POWERS . The business and affairs of the Corporation shall be managed under the direction of its Board of Directors.

Section 2.     NUMBER, TENURE AND RESIGNATION . At any regular meeting or at any special meeting called for that purpose, a majority of the entire Board of Directors may establish, increase or decrease the number of directors, provided that the number thereof shall never be less than the minimum number required by the MGCL, nor more than 15, and further provided that the tenure of office of a director shall not be affected by any decrease in the number of directors, and further provided that the number of directors shall not be increased by fifty percent (50%) or more in any twelve-month period without the approval of at least sixty-six percent (66%) of the entire Board of Directors. Any director of the Corporation may resign at any time by delivering his or her resignation to the Board of Directors, the chair of the board or the secretary. Any resignation shall
take effect immediately upon its receipt or at such later time specified in the resignation. The acceptance of a resignation shall not be necessary to make it effective unless otherwise stated in the resignation.

Section 3.     ANNUAL AND REGULAR MEETINGS . An annual meeting of the Board of Directors shall be held immediately after and at the same place as the annual meeting of stockholders, no notice other than this Bylaw being necessary. In the event such meeting is not so held, the meeting may be held at such time and place as shall be specified in a notice given as hereinafter provided for special meetings of the Board of Directors. The Board of Directors may provide, by resolution, the time and place for the holding of regular meetings of the Board of Directors without other notice than such resolution.

Section 4.     SPECIAL MEETINGS . Special meetings of the Board of Directors may be called by or at the request of the chair of the board, the chief executive officer or a majority of the directors then in office. The person or persons authorized to call special meetings of the Board of Directors may fix any place as the place for holding any special meeting of the Board of Directors called by them. The Board of Directors may provide, by resolution, the time and place for the holding of special meetings of the Board of Directors without other notice than such resolution.

Section 5.     NOTICE . Notice of any special meeting of the Board of Directors shall be delivered personally or by telephone, electronic mail, facsimile transmission, courier or United States mail to each director at his or her business or residence address. Notice by personal delivery, telephone, electronic mail or facsimile transmission shall be given at least 24 hours prior to the meeting. Notice by United States mail shall be given at least three days prior to the meeting. Notice by courier shall be given at least two days prior to the meeting. Telephone notice shall be deemed to be given when the director or his or her agent is personally given such notice in a telephone call to which the director or his or her agent is a party. Electronic mail notice shall be deemed to be given upon transmission of the message to the electronic mail address given to the Corporation by the director. Facsimile transmission notice shall be deemed to be given upon completion of the transmission of the message to the number given to the Corporation by the director and receipt of a completed answer-back indicating receipt. Notice by United States mail shall be deemed to be given when deposited in the United States mail properly addressed, with postage thereon prepaid. Notice by courier shall be deemed to be given when deposited with or delivered to a courier properly addressed. Neither the business to be transacted at, nor the purpose of, any annual, regular or special meeting of the Board of Directors need be stated in the notice, unless specifically required by statute or these Bylaws.

Section 6.     QUORUM . A majority of the directors shall constitute a quorum for transaction of business at any meeting of the Board of Directors, provided that, if less than a majority of such directors is present at such meeting, a majority of the directors present may adjourn the meeting from time to time without further notice, and provided further that if, pursuant to applicable law, the charter of the Corporation or these Bylaws, the vote of a majority or other percentage of a particular group of directors is required for action, a quorum must also include a majority or such other percentage of such group.




The directors present at a meeting which has been duly called and at which a quorum has been established may continue to transact business until adjournment, notwithstanding the withdrawal from the meeting of enough directors to leave fewer than required to establish a quorum.

Section 7.     VOTING . The action of a majority of the directors present at a meeting at which a quorum is present shall be the action of the Board of Directors, unless the concurrence of a greater proportion is required for such action by applicable law, the charter or these Bylaws. If enough directors have withdrawn from a meeting to leave fewer than required to establish a quorum, but the meeting is not adjourned, the action of the majority of that number of directors necessary to constitute a quorum at such meeting shall be the action of the Board of Directors, unless the concurrence of a greater proportion is required for such action by applicable law, the charter of the Corporation or these Bylaws.

Section 8.     ORGANIZATION . At each meeting of the Board of Directors, the chair of the board or, in the absence of the chair, the vice chair of the board, if any, shall act as chair of the meeting. In the absence of both the chair and vice chair of the board, the chief executive officer or, in the absence of the chief executive officer, a director chosen by a majority of the directors present, shall act as chair of the meeting. The secretary or, in his or her absence, an assistant secretary of the Corporation, or, in the absence of the secretary and all assistant secretaries, an individual appointed by the chair of the meeting, shall act as secretary of the meeting.

Section 9.     TELEPHONE MEETINGS . Directors may participate in a meeting by means of a conference telephone or other communications equipment if all persons participating in the meeting can hear each other at the same time. Participation in a meeting by these means shall constitute presence in person at the meeting.

Section 10.     CONSENT BY DIRECTORS WITHOUT A MEETING . Any action
required or permitted to be taken at any meeting of the Board of Directors may be taken without a meeting, if a consent in writing or by electronic transmission to such action is given by each director and is filed with the minutes of proceedings of the Board of Directors.

Section 11.     VACANCIES . If for any reason any or all the directors cease to be directors, such event shall not terminate the Corporation or affect these Bylaws or the powers of the remaining directors hereunder. Except as may be provided by the Board of Directors in setting the terms of any class or series of preferred stock, any vacancy on the Board of Directors may be filled only by a majority of the remaining directors, even if the remaining directors do not constitute a quorum. Any director elected to fill a vacancy shall serve for the remainder of the full term of the class in which the vacancy occurred and until a successor is elected and qualifies.

Section 12.     COMPENSATION . Directors who are not also officers of the Corporation may receive compensation per year and/or per meeting and/or per visit to real property or other facilities owned or leased by the Corporation and for any service or activity they performed or engaged in as directors; provided that the Board of Directors approves such compensation. All directors may be reimbursed for expenses of attendance, if any, at each annual, regular or special meeting of the Board of Directors or of any committee thereof and for their expenses, if any, in connection with each property visit and any other service or activity they perform or engage in as directors. Directors who are officers or employees of the Corporation shall not receive compensation as directors. Nothing herein contained shall be construed to preclude any directors from serving the Corporation in any other capacity and receiving compensation therefor.

Section 13.     RELIANCE . Each director and officer of the Corporation shall, in the performance of his or her duties with respect to the Corporation, be entitled to rely on any information, opinion, report or statement, including any financial statement or other financial data, prepared or presented by an officer or employee of the Corporation whom the director or officer reasonably believes to be reliable and competent in the matters presented, by a lawyer, certified public accountant or other person, as to a matter which the director or officer reasonably believes to be within the person’s professional or expert competence, or, with respect to a director, by a committee of the Board of Directors on which the director does not serve, as to a matter within its designated authority, if the director reasonably believes the committee to merit confidence.

Section 14.     RATIFICATION . The Board of Directors or the stockholders may ratify and make binding on the Corporation any action or inaction by the Corporation or its officers to the extent that the Board of Directors or the stockholders could have originally authorized the matter. Moreover, any action or inaction questioned in any stockholders’ derivative proceeding or any other proceeding on the ground of lack of authority, defective or irregular execution, adverse interest of a director, officer or stockholder, non-disclosure, miscomputation, the application of improper




principles or practices of accounting or otherwise, may be ratified, before or after judgment, by the Board of Directors or by the stockholders, and if so ratified, shall have the same force and effect as if the questioned action or inaction had been originally duly authorized, and such ratification shall be binding upon the Corporation and its stockholders and shall constitute a bar to any claim or execution of any judgment in respect of such questioned action or inaction.

Section 15.     CERTAIN RIGHTS OF DIRECTORS . Any director, in his or her personal capacity or in a capacity as an affiliate, employee, or agent of any other person, or otherwise, may have business interests and engage in business activities similar to, in addition to or in competition with those of or relating to the Corporation.

Section 16.     EMERGENCY PROVISIONS . Notwithstanding any other provision in the charter or these Bylaws, this Section 16 shall apply during the existence of any catastrophe, or other similar emergency condition, as a result of which a quorum of the Board of Directors under Article III of these Bylaws cannot readily be obtained (an “Emergency”). During any Emergency, unless otherwise provided by the Board of Directors, (i) a meeting of the Board of Directors or a committee thereof may be called by any director, the chief executive officer or any executive vice president by any means feasible under the circumstances; (ii) notice of any meeting of the Board of Directors during such an Emergency may be given less than 24 hours prior to the meeting to as many directors and by such means as may be feasible at the time, including publication, television or radio; and (iii) the number of directors necessary to constitute a quorum shall be one-third of the entire Board of Directors.
ARTICLE IV COMMITTEES

Section 1.     NUMBER, TENURE AND QUALIFICATIONS . The Board of
Directors may appoint from among its members an Audit Committee, a Compensation and Corporate Governance Committee and one or more other committees, composed of one or more directors, to serve at the pleasure of the Board of Directors.

Section 2.     POWERS . The Board of Directors may delegate to committees appointed under Section 1 of this Article any of the powers of the Board of Directors, except as prohibited by law.

Section 3.     MEETINGS . Notice of committee meetings shall be given in the same manner as notice for special meetings of the Board of Directors. A majority of the members of the committee shall constitute a quorum for the transaction of business at any meeting of the committee. The act of a majority of the committee members present at a meeting shall be the act of such committee. The Board of Directors may designate a chair of any committee, and such chair or, in the absence of a chair, any two members of any committee (if there are at least two members of the committee) may fix the time and place of its meeting unless the Board shall otherwise provide. In the absence of any member of any such committee, the members thereof present at any meeting, whether or not they constitute a quorum, may appoint another director to act in the place of such absent member.

Section 4.      TELEPHONE MEETINGS . Members of a committee of the Board of Directors may participate in a meeting by means of a conference telephone or other communications equipment if all persons participating in the meeting can hear each other at the same time. Participation in a meeting by these means shall constitute presence in person at the meeting.

Section 5.     CONSENT BY COMMITTEES WITHOUT A MEETING . Any
action required or permitted to be taken at any meeting of a committee of the Board of Directors may be taken without a meeting, if a consent in writing or by electronic transmission to such action is given by each member of the committee and is filed with the minutes of proceedings of such committee.

Section 6.     VACANCIES . Subject to the provisions hereof, the Board of Directors shall have the power at any time to change the membership of any committee, to fill any vacancy, to designate an alternate member to replace any absent or disqualified member or to dissolve any such committee.





ARTICLE V OFFICERS

Section 1.     GENERAL PROVISIONS . The officers of the Corporation shall include a chief executive officer, president, chief financial officer, treasurer and secretary and may
include a chair of the board (who must be a director), a vice chair of the board, one or more vice presidents, a chief operating officer, and one or more assistant secretaries. In addition, the Board of Directors may from time to time elect such other officers with such powers and duties as it shall deem necessary or desirable. The officers of the Corporation shall be elected annually by the Board of Directors, except that the chief executive officer may from time to time appoint one or more vice presidents and assistant secretaries or other officers. Each officer shall serve until his or her successor is elected and qualifies or until his or her death, or his or her resignation or removal in the manner hereinafter provided. Any two or more offices may be held by the same person. Election of an officer or agent shall not of itself create contract rights between the Corporation and such officer or agent.

Section 2.     REMOVAL AND RESIGNATION . Any officer or agent of the Corporation may be removed, with or without cause, by the Board of Directors if in its judgment the best interests of the Corporation would be served thereby, but such removal shall be without prejudice to the contract rights, if any, of the person so removed. Any officer of the Corporation may resign at any time by delivering his or her resignation to the Board of Directors, the chair of the board, the chief executive officer or the secretary. Any resignation shall take effect immediately upon its receipt or at such later time specified in the resignation. The acceptance of a resignation shall not be necessary to make it effective unless otherwise stated in the resignation. Such resignation shall be without prejudice to the contract rights, if any, of the Corporation.

Section 3.     VACANCIES . A vacancy in any office may be filled by the Board of Directors for the balance of the term.

Section 4.     CHAIR OF THE BOARD . The Board of Directors may designate from among its members a chair of the board, who shall not, solely by reason of these Bylaws, be an officer of the Corporation. The Board of Directors may designate the chair of the board as an executive or non-executive chair. The chair of the board shall preside over the meetings of the Board of Directors. The chair of the board shall perform such other duties as may be assigned to him or her by these Bylaws or the Board of Directors.

Section 5.     CHIEF EXECUTIVE OFFICER . The chair of the board shall initially be the chief executive officer and thereafter, at such time as the Board of Directors shall determine, the chief executive officer shall be such officer as the Board of Directors may designate from time to time. The chief executive officer shall have general responsibility for implementation of the policies of the Corporation, as determined by the Board of Directors, and for the management of the business and affairs of the Corporation. He or she may execute any deed, mortgage, bond, contract or other instrument, except in cases where the execution thereof shall be expressly delegated by the Board of Directors or by these Bylaws to some other officer or agent of the Corporation or shall be required by law to be otherwise executed; and in general shall perform all duties incident to the office of chief executive officer and such other duties as may be prescribed by the Board of Directors from time to time.

Section 6.     CHIEF OPERATING OFFICER . The Board of Directors may designate a chief operating officer. The chief operating officer shall have the responsibilities and duties as determined by the Board of Directors or the chief executive officer.

Section 7.     CHIEF FINANCIAL OFFICER . The chief financial officer shall have the custody of the funds and securities of the Corporation, shall keep full and accurate accounts of receipts and disbursements in books belonging to the Corporation, shall deposit all moneys and other valuable effects in the name and to the credit of the Corporation in such depositories as may be designated by the Board of Directors and in general perform such other duties as from time to time may be assigned to him or her by the chief executive officer or the Board of Directors. The chief financial officer shall disburse the funds of the Corporation as may be ordered by the Board of Directors, taking proper vouchers for such disbursements, and shall render to the chief executive officer and Board of Directors, at the regular meetings of the Board of Directors or whenever it may so require, an account of all his or her transactions as chief financial officer and of the financial condition of the Corporation. In the absence of a designation of a treasurer by the Board of Directors, the chief financial officer shall be the treasurer of the Corporation.





Section 8.     PRESIDENT . The Board of Directors may designate a president. The president shall have the responsibilities and duties as determined by the Board of Directors or the chief executive officer.

Section 9.     VICE PRESIDENTS . The Board of Directors may designate one or more vice presidents. Each Vice President shall have the responsibilities and duties as determined by the Board of Directors or the chief executive officer. The Board of Directors may designate one or more vice presidents as executive vice president, senior vice president, or vice president for particular areas of responsibility.

Section 10.     SECRETARY . The secretary shall (a) keep the minutes of the proceedings of the stockholders, the Board of Directors and committees of the Board of Directors in one or more books provided for that purpose; (b) see that all notices are duly given in accordance with the provisions of these Bylaws or as required by law; (c) be custodian of the corporate records and of the seal of the Corporation; (d) keep a register of the post office address of each stockholder which shall be furnished to the secretary by such stockholder; (e) have general charge of the stock transfer books of the Corporation; and (f) in general perform such other duties as from time to time may be assigned to him or her by the chief executive officer, the president or the Board of Directors.

Section 11.     TREASURER . The treasurer, in general, shall perform such duties as shall be assigned to him or her by the chief executive officer or the Board of Directors.

Section 12.     ASSISTANT SECRETARIES . The assistant secretaries, in general, shall perform such duties as shall be assigned to them by the secretary or by the chief executive officer or the Board of Directors.

Section 13.     COMPENSATION . The compensation of the officers shall be fixed from time to time by or under the authority of the Compensation and Corporate Governance Committee and no officer shall be prevented from receiving such compensation by reason of the fact that he or she is also a director.

ARTICLE VI
CONTRACTS, CHECKS AND DEPOSITS

Section 1.     CONTRACTS . The Board of Directors may authorize any officer or agent to enter into any contract or to execute and deliver any instrument in the name of and on behalf of the Corporation and such authority may be general or confined to specific instances. Any agreement, deed, mortgage, lease or other document shall be valid and binding upon the Corporation when duly authorized or ratified by action of the Board of Directors and executed by an authorized person.

Section 2.      CHECKS AND DRAFTS . All checks, drafts or other orders for the payment of money, notes or other evidences of indebtedness issued in the name of the Corporation shall be executed by the chair of the board, any vice chair of the board, the chief executive officer, the president, any vice president or such officers, employees or agents as the Board of Directors or any of such designated officers may direct.

Section 3.     DEPOSITS . All funds of the Corporation not otherwise employed shall be deposited or invested from time to time to the credit of the Corporation as the Board of Directors, the chief executive officer, the chief financial officer, or any other officer designated by the Board of Directors may determine.

ARTICLE VII STOCK

Section 1.     CERTIFICATES . Except as may be otherwise provided by the Board of Directors, all shares of capital stock of the Corporation issued after March 25, 2011 shall be uncertificated shares. Notwithstanding the foregoing, shares of capital stock of the Corporation represented by a certificate issued on or prior to March 25, 2011 shall be certificated shares until such certificate is surrendered to the Corporation. In the event that the Corporation issues shares of stock represented by certificates, such certificates shall be in such form as prescribed by the Board of Directors or a duly authorized officer, shall contain the statements and information required by the MGCL and shall be signed by the officers of the Corporation in the manner permitted by the MGCL. In the event that the Corporation issues shares of stock without certificates, to the extent then required by the MGCL, the Corporation shall provide to the record holders of such shares a written statement of the information required by the MGCL to be included on stock certificates. There shall be no differences in the rights and obligations of stockholders based on whether or not their shares are represented by certificates.





Section 2.     TRANSFERS . All transfers of shares of stock shall be made on the books of the Corporation, by the holder of the shares, in person or by his or her attorney, in such manner as the Board of Directors or any officer of the Corporation may prescribe and, if such shares are certificated, upon surrender of certificates duly endorsed. The issuance of a new certificate upon the transfer of certificated shares is subject to the determination of the Board of Directors that such shares shall no longer be represented by certificates. Upon the transfer of any uncertificated shares, to the extent then required by the MGCL, the Corporation shall provide to the record holders of such shares a written statement of the information required by the MGCL to be included on stock certificates.

The Corporation shall be entitled to treat the holder of record of any share of stock as the holder in fact thereof and, accordingly, shall not be bound to recognize any equitable or other claim to or interest in such share or on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise expressly provided by the laws of the State of Maryland.

Notwithstanding the foregoing, transfers of shares of any class or series of stock will be subject in all respects to the charter of the Corporation and all of the terms and conditions contained therein.

Section 3.     REPLACEMENT CERTIFICATE . Any officer of the Corporation may direct a new certificate or certificates to be issued in place of any certificate or certificates theretofore issued by the Corporation alleged to have been lost, destroyed, stolen or mutilated, upon the making of an affidavit of that fact by the person claiming the certificate to be lost, destroyed, stolen or mutilated; provided, however, if such shares have ceased to be certificated, no new certificate shall be issued unless requested in writing by such stockholder and the Board of Directors has determined that such certificates may be issued. Unless otherwise determined by an officer of the Corporation, the owner of such lost, destroyed, stolen or mutilated certificate or certificates, or his or her legal representative, shall be required, as a condition precedent to the issuance of a new certificate or certificates, to give the Corporation a bond in such sums as it may direct as indemnity against any claim that may be made against the Corporation.

Section 4.     FIXING OF RECORD DATE . The Board of Directors may set, in advance, a record date for the purpose of determining stockholders entitled to notice of or to vote at any meeting of stockholders or determining stockholders entitled to receive payment of any dividend or the allotment of any other rights, or in order to make a determination of stockholders for any other proper purpose. Such date, in any case, shall not be prior to the close of business on the day the record date is fixed and shall be not more than 90 days and, in the case of a meeting of stockholders, not less than ten days, before the date on which the meeting or particular action requiring such determination of stockholders of record is to be held or taken.

When a record date for the determination of stockholders entitled to notice of and to vote at any meeting of stockholders has been set as provided in this section, such record date shall continue to apply to the meeting if adjourned or postponed, except if the meeting is adjourned or postponed to a date more than 120 days after the record date originally fixed for the meeting, in which case a new record date for such meeting may be determined as set forth herein.

Section 5.     STOCK LEDGER . The Corporation shall maintain at its principal office or at the office of its counsel, accountants or transfer agent, an original or duplicate stock ledger containing the name and address of each stockholder of record and the number of shares of each class held by such stockholder.
Section 6.     FRACTIONAL STOCK; ISSUANCE OF UNITS . The Board of
Directors may authorize the Corporation to issue fractional stock or authorize the issuance of scrip, all on such terms and under such conditions as it may determine. Notwithstanding any other provision of the charter or these Bylaws, the Board of Directors may issue units consisting of different securities of the Corporation. Any security issued in a unit shall have the same characteristics as any identical securities issued by the Corporation, except that the Board of Directors may provide that for a specified period securities of the Corporation issued in such unit may be transferred on the books of the Corporation only in such unit.

ARTICLE VIII FISCAL YEAR

The fiscal year of the Corporation shall be the twelve calendar months period ending December 31 in each year, unless otherwise provided by the Board of Directors.





ARTICLE IX DISTRIBUTIONS

Section 1.     AUTHORIZATION . Dividends and other distributions upon the stock of the Corporation may be authorized by the Board of Directors, subject to the provisions of law and the charter of the Corporation. Dividends and other distributions may be paid in cash, property or stock of the Corporation, subject to the provisions of law and the charter.

Section 2.     CONTINGENCIES . Before payment of any dividends or other distributions, there may be set aside out of any assets of the Corporation available for dividends or other distributions such sum or sums as the Board of Directors may from time to time, in its absolute discretion, think proper as a reserve fund for contingencies, for equalizing dividends, for repairing or maintaining any property of the Corporation or for such other purpose as the Board of Directors shall determine, and the Board of Directors may modify or abolish any such reserve.

ARTICLE X
INVESTMENT POLICY

Subject to the provisions of the charter of the Corporation, the Board of Directors may from time to time adopt, amend, revise or terminate any policy or policies with respect to investments by the Corporation as it shall deem appropriate in its sole discretion.

ARTICLE XI
SEAL

Section 1.      SEAL . The Board of Directors may authorize the adoption of a seal by the Corporation. The seal shall contain the name of the Corporation and the year of its incorporation and the words “Incorporated Maryland.” The Board of Directors may authorize one or more
duplicate seals and provide for the custody thereof.

Section 2.     AFFIXING SEAL . Whenever the Corporation is permitted or required to affix its seal to a document, it shall be sufficient to meet the requirements of any law, rule or regulation relating to a seal to place the word “(SEAL)” adjacent to the signature of the person authorized to execute the document on behalf of the Corporation.

ARTICLE XII
INDEMNIFICATION AND ADVANCE OF EXPENSES

To the maximum extent permitted by Maryland law in effect from time to time, the Corporation shall indemnify and, without requiring a preliminary determination of the ultimate entitlement to indemnification, shall pay or reimburse reasonable expenses in advance of final disposition of a proceeding to (a) any individual who is a present or former director or officer of the Corporation and who is made or threatened to be made a party to the proceeding by reason of his or her service in that capacity or (b) any individual who, while a director or officer of the Corporation and at the request of the Corporation, serves or has served as a director, officer, partner, trustee, member or manager of another corporation, real estate investment trust, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise and who is made or threatened to be made a party to the proceeding by reason of his or her service in that capacity. The rights to indemnification and advance of expenses provided by the charter of the Corporation and these Bylaws shall vest immediately upon election of a director or officer. The Corporation may, with the approval of its Board of Directors, provide such indemnification and advance for expenses to an individual who served a predecessor of the Corporation in any of the capacities described in (a) or (b) above and to any employee or agent of the Corporation or a predecessor of the Corporation. The indemnification and payment or reimbursement of expenses provided in these Bylaws shall not be deemed exclusive of or limit in any way other rights to which any person seeking indemnification or payment or reimbursement of expenses may be or may become entitled under any bylaw, resolution, insurance, agreement or otherwise.

Neither the amendment nor repeal of this Article, nor the adoption or amendment of any other provision of the charter of the Corporation or these Bylaws inconsistent with this Article, shall apply to or affect in any respect the applicability of the preceding paragraph with respect to any act or failure to act which occurred prior to such amendment, repeal or adoption.





ARTICLE XIII
WAIVER OF NOTICE

Whenever any notice of a meeting is required to be given pursuant to the charter of the Corporation or these Bylaws or pursuant to applicable law, a waiver thereof in writing or by electronic transmission, given by the person or persons entitled to such notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of such notice. Neither the business to be transacted at nor the purpose of any meeting need be set forth in the waiver of notice of such meeting, unless specifically required by statute. The attendance of any person at any meeting shall constitute a waiver of notice of such meeting, except where such person attends a meeting for the express purpose of objecting to the transaction of any business on the ground that the meeting has not been lawfully called or convened.

ARTICLE XIV
AMENDMENT OF BYLAWS

The Board of Directors is vested with the power to alter, amend or repeal any provision of these Bylaws and to adopt new Bylaws, in each case with the approval of a majority of all directors then in office. In addition, stockholders may alter, amend or repeal any provision of these Bylaws and adopt new Bylaws at an annual meeting of stockholders or special meeting of stockholders called for such purpose, in each case with the approval of a majority of the votes entitled to be cast thereon.

ARTICLE XV
EXCLUSIVE FORUM FOR CERTAIN LITIGATION
Unless the Corporation consents in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland, or, if that Court does not have jurisdiction, the United States District Court for the District of Maryland, Baltimore Division, shall be the sole and exclusive forum for (a) any derivative action or proceeding brought on behalf of the Corporation, (b) any action asserting a claim of breach of any duty owed by any director or officer or other employee of the Corporation to the Corporation or to the stockholders of the Corporation, (c) any action asserting a claim against the Corporation or any director or officer or other employee of the Corporation arising pursuant to any provision of the MGCL, the Charter or these Bylaws, or (d) any action asserting a claim against the Corporation or any director or officer or other employee of the Corporation that is governed by the internal affairs doctrine.


Adopted as of: July 20, 2011
As amended by Amendment No. 1, dated as of July 26, 2011, Amendment No. 2, dated as of October 20, 2015, Amendment No. 3, dated as of March 16, 2017 and Amendment No. 4, dated as of May 2, 2018.





Exhibit 31.1
MTGE Investment Corp.
Certification Pursuant to Section 302(a)
of the Sarbanes-Oxley Act of 2002

I, Sean P. Reid, certify that:

1.    I have reviewed this Quarterly Report on Form 10-Q of MTGE Investment Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:
May 10, 2018
 
By:
/s/  SEAN P. REID
 
 
 
 
Sean P. Reid
Chief Executive Officer





Exhibit 31.2
MTGE Investment Corp.
Certification Pursuant to Section 302(a)
of the Sarbanes-Oxley Act of 2002

I, Donald W. Holley, certify that:

1.    I have reviewed this Quarterly Report on Form 10-Q of MTGE Investment Corp.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:
May 10, 2018
 
By:
/s/    DONALD W. HOLLEY
 
 
 
 
Donald W. Holley
Chief Financial Officer and
Senior Vice President





Exhibit 32

MTGE Investment Corp.
Certification of CEO and CFO Pursuant to 18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

We, Sean P. Reid, Chief Executive Officer, and Donald W. Holley, Chief Financial Officer and Senior Vice President of MTGE Investment Corp. (the “Company”), certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350 that:

1.
The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2018 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:
May 10, 2018
 
By:
/s/  SEAN P. REID
 
 
 
 
Sean P. Reid
Chief Executive Officer
 
 
 
 
 
Date:
May 10, 2018
 
By:
/s/    DONALD W. HOLLEY
 
 
 
 
Donald W. Holley
Chief Financial Officer and
Senior Vice President




A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.